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Caveolin 1 (Cav1) is a versatile membrane protein that plays a role in the pathogenesis of 
hereditary lipodystrophy and neurodegenerative diseases such as Alzheimer. As an essential 
structural component of caveolae, specialized membrane invaginations, it participates in a 
broad spectrum of cellular processes, including the regulation of lipid homeostasis, 
endocytosis as well as cell signaling by acting as adapter molecule for a diverse number of 
signaling molecules, including small RhoGTPases. The loss of Cav1 function in mice causes 
distinct neurological abnormalities, including deficits in motor coordination and strength, 
behavioural changes as well as progressive neurodegeneration. However, the contribution of 
Cav1 to this phenotype is currently under investigation. Here, Xenopus laevis was used as 
model organism to study the developmental relevance of Cav1α with the main focus on the 
neuromuscular system. Morpholino oligonucleotide (MO) mediated knockdown of Cav1α 
results in a striking swimming defect, which is characterized by the paralysis of the injected 
side in combination with a severely disrupted sarcomeric organization of the somitic muscle 
cells. Expression analysis of Cav1 revealed a prominent expression in motoneurons, but not 
in the musculature indicating that Cav1 functions in the neuromuscular system. This could be 
confirmed by targeted injection of the Cav1α MO into neural tissue, which disrupted swimming 
behaviour as well as axonal growth of motoneuron. In contrast, targeted injection of Cav1 into 
muscular tissue had no effect on the swimming behaviour. In addition, neuronal explants 
revealed a striking increase in both lamellipodia as well as filopodia formation in the Cav1α 
morphant axons. By performing rescue experiments, it could be demonstrated that Cav1 
regulates the activity of the small RhoGTPases Cdc42, Rac1 as well as RhoA during axonal 
growth. Further, phosphorylation on tyrosine 14 of the Cav1α protein likely modulates this 
process, as a phosphorylation-null mutant was not able to rescue the morphant swimming 
phenotype. Taken together, this thesis demonstrated a previously unrecognized function of 
Cav1α in the neuromuscular system, by regulating the activity of the small RhoGTPases RhoA, 















Caveolin 1 (Cav1) ist ein vielseitiges Membranprotein, das eine Rolle bei der Pathogenese der 
erblichen Lipodystrophie sowie neurodegenerativen Erkrankungen wie Alzheimer spielt. Als 
wesentlicher struktureller Bestandteil von caveolae sowie der caveolae-vermittelten 
Endozytose, ist es an einem breiten Spektrum zellulärer Prozesse, einschließlich der 
Regulation der Lipidhomöostase, der Endozytose sowie diversen Signalwegen beteiligt, indem 
es als Adaptermolekül für eine große Anzahl von Signalmolekülen fungiert. In Mäusen konnte 
bereits gezeigt werden, dass der Verlust der Cav1-Funktion zu deutlichen neurologischen 
Anomalien, einschließlich Defiziten in der motorischen Koordination und Muskelkraft, 
Verhaltensänderungen sowie einer fortschreitenden Neurodegeneration führt. Der exakte 
molekulare Hintergrund dieser Phänotypen, sowie die genaue Funktion von Cav1 in der 
Entstehung neurodegenerativer Krankheiten ist noch relativ unbekannt und ist derzeit 
Gegenstand vieler wissenschaftlicher Studien. In dieser Arbeit wurde deshalb Xenopus laevis 
als Modellorganismus verwendet, um die entwicklungsbiologische Relevanz von Cav1α, mit 
Schwerpunkt auf dem neuromuskulären System, zu untersuchen. Hierbei konnte gezeigt 
werden, dass der Morpholino Oligonukleotid (MO) -vermittelte Funktionsverlust von Cav1α zu 
charakteristischen Schwimmdefekten, sowie dem Verlust der muskulären Integrität führt. 
Expressionsanalysen zeigten eine Expression von Cav1 in Motoneuronen, jedoch nicht in der 
Muskulatur, was auf eine Funktion von Cav1α in der neuromuskulären Entwicklung hinweist. 
Dies konnte durch gezielte Injektion von Cav1α MO bestätigt werden, da der spezifische 
Verlust der Cav1α Expression in neuralen-, jedoch nicht in muskulären Geweben, die 
charakteristischen Schwimmdefekten reproduzierte. Des Weiteren zeigte sich, dass der 
Funktionsverlust von Cav1α ein fehlerhaftes Auswachsen der Motorneurone in vivo, sowie 
morphologische Veränderungen in kultivierten Neuronen in vitro verursacht. Diese Neurone 
zeigen einen starken Anstieg der Lamellipodien- sowie Filopodienbildung in den Cav1α-
Morphant-Axonen. Durch Durchführung von Rettungsexperimenten konnte gezeigt werden, 
dass Cav1α die Aktivität der kleinen RhoGTPasen Cdc42, Rac1 sowie RhoA während des 
axonalen Wachstums reguliert. Darüber hinaus wurde gezeigt, dass die posttranslationale 
Phosphorylierung des Tyrosin-Rest 14 eine wichtige Funktion in der Modulation der 
RhoGTPasen spielt, da die phosphorylierungs Mutante Cav1α-A14Y nicht in der Lage war die 
oben genannten Phänotypen zu retten.  
Zusammenfassend wurde in dieser Arbeit eine bisher nicht bekannte Funktion von Cav1α in 
der Entwicklung des neuromuskulären Systems, sowie in der Modulation der Aktivität der 
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1.1 Caveolae-versatile membrane invaginations 
 
The interests in caveolae-mediated endocytosis arose almost 70 years ago with the 
morphological discovery of the 50- to 100 nm plasma membrane invaginations and is now, 
along with clathrin-mediated endocytosis, one of the best studied endocytic mechanisms 
(Palade, 1953; Yamada, 1955). Caveolae, also “little-caves” are named after their 
characteristic flask-shaped or cave-like morphology and were first discovered in blood 
capillaries and mouse gall bladder epithelium by George E. Palade and Eichi Yamada (Figure 
1) (Palade, 1953; Yamada, 1955). They most likely represent specialized lipid domains in the 
plasma membrane as caveolae, similar to lipid rafts, are highly enriched in cholesterol and 
sphingolipids such as glycosphingolipids and sphingomyelin (Liu et al., 1997; Ortegren et al., 
2004; Rajendran and Simons, 2005; Simons and Toomre, 2000). Caveolae exist mostly as 
single membrane pits either fused or detached from the plasma membrane, but can also 
assemble to clusters of multiple caveolae. Thereby, they organize to tubular structures as 
well as rosettes dependent on the cell type they are expressed in (Figure 1) (Parton et al., 
1997; Scherer et al., 1994; Simionescu et al., 1975).  
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Figure 1: The morphology of caveolae.  
A Transmission electron micrograph of an 3T3-L1 adipocyte. Caveolae are visible as single pits at the 
plasma membrane. B-D High density of caveolae structures at the cell surface. High ordered caveolae 
structures, called rosettes are highlighted in red. E Scheme of the caveolae morphology. They can 
exist as single membrane or vesicular-like pits, but also organized to grape-like clusters, rosette 
structures or elongated tubules (Modified after Parton, 2018; Razani et al., 2002c) 
 
However, they can also bud from the plasma membrane in response to several signaling 
events and fuse with other cellular components, such as the early endosome, in a Rab5-
dependent manner (Cheng and Nichols, 2016; Mayor et al., 2014; Pelkmans et al., 2004). 
Morphological detectable caveolae are heterogeneously distributed in a variety of cell types, 
with high abundance in adipocytes, epithelial cells, fibroblast and endothelial cells, where 
they can cover up to 70 % of the plasma membrane (Gabella, 1976; Gil, 1983; Mobley and 
Eisenberg, 1975; Palade, 1953; Scherer et al., 1994). Caveolae have been associated with 
a broad range of cellular processes due to their involvement in endocytosis, transcytosis, lipid 
homeostasis as well as cell signalling (Gupta et al., 2014; Navarro et al., 2004; Parton and 
del Pozo, 2013; Parton and Simons, 2007). In particular, as subdomains of lipid rafts they are 
acting as signalling centers and platforms for a diverse number of signalling molecules. 
Among these are the EGFR family of protein kinases, MAP kinases, Src-kinases, small 
RhoGTPases and endothelial nitric oxide synthase (eNOS) (Couet et al., 1997b; Engelman 
et al., 1998a; Feron et al., 1996; Gingras et al., 1998; Oka et al., 1997; Razani and Lisanti, 
2001). Further, they also play a remarkable role during mechanoprotection by acting as 
stretch-sensors and by serving as membrane reservoirs during mechanical stress (Dulhunty 
and Franzini-Armstrong, 1975; Joshi et al., 2008; Parton and del Pozo, 2013; Sinha et al., 
2011).  
In the following sections, the cellular function of caveolae are discussed in more detail.  
 
1.2 Structural components and biogenesis of caveolae 
 
Although caveolae were initially described as uncoated vesicles, high resolution scanning 
electron microscopy and tomography revealed that they possess a characteristic striated coat 
that wraps in spirals around this pits (Figure 2) (Lebbink et al., 2010; Palade, 1953; Peters et 
al., 1985; Richter et al., 2008; Yamada, 1955). This coat is formed by high molecular weight 
complexes of approximately 160 Caveolin (Cav) and 60-80 Cavin monomers (Hayer et al., 
2010).  
Introduction  3 
 
 
1.2.1 Caveolin protein family- key regulators for caveolae formation 
 
It took almost 40 year after the initial discovery of caveolae to identify the first core structural 
components of this membrane vesicles: the Cav protein family (Glenney, 1989; Kurzchalia et 
al., 1992; Scherer et al., 1996b; Way and Parton, 1996). Similar to caveolae, they are 
associated with a broad spectrum of signaling events by regulating the activity, 
compartmentalization as well as internalization of signaling molecules in the context of cell 
proliferation, survival as well as cellular integrity (Cohen et al., 2004). 
The first Cav protein discovered was Cav1, which was originally described as a 
phosphorylation substrate of the Rous sarcoma virus protein V-src (Glenney, J R Jr, 1989; 
Kurzchalia et al., 1992). Following this, a few years later, two additional members of the Cav 
protein family were discovered in a search for homologous Cav proteins: Cav2 and Cav3 
(Scherer et al., 1996b; Way and Parton, 1996). Cav proteins are highly conserved among 
vertebrate and even some invertebrate species, including Caenorhabditis elegans and the 
honey bee (Apis mellifera), but are absent in fungi and plants (Field et al., 2007; Kirkham et 
al., 2008). Cav1 and 3 are the key structural components of caveolae, as they facilitate the 
formation of caveolae in a broad spectrum of cells (Drab et al., 2001; Galbiati et al., 2001a; 
Kirkham et al., 2008; Lipardi et al., 1998). While Cav1 is expressed almost ubiquitously in 
most cell types, except muscle cells, Cav3 is the Cav homologue driving the formation of 
caveolae in smooth and striated muscle cells (Carpentier et al., 1977; Kurzchalia et al., 1992; 
. Figure 2: Caveolae possess a characteristic 
striated coat. 
Figure shows different budding stages of 
caveolae at the plasma membrane of 
myotubes; (1) flat, unbudded caveolae. A 
characteristic striated coat is visible, 
highlighted in purple. (2) circular caveolae. (3) 
fully budded caveolae. (Lamaze et al., 2017) 
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Liu et al., 1999; Newman et al., 1999; Scherer et al., 1997; Scherer, 1996a; Way and Parton, 
1996). Cav2, which is co-expressed with Cav1 and is also a component of the caveolae coat, 
lacks the ability to form caveolae (Scherer et al., 1997; Scherer et al., 1996b). Interestingly, 
while Cav proteins facilitates the formation of caveolae in all vertebrates and most 
invertebrate species, C.elegans expresses two caveolin genes (cav1 and 2), however, lacks 
identifiable caveolae structures (Kirkham et al., 2008). This implies, that the function of Cav 
proteins is not limited to caveolae formation. 
Cav proteins are small ~20-24 kDA integral membrane proteins, which are highly associated 
with cholesterol and sphingolipids within the plasma membrane (Figure 3), but also exist as 
cytosolic or secreted proteins (Liu et al., 1999; Uittenbogaard and Smart, 2000). The protein 
structure of the three Cav proteins is evolutionary conserved among different species and 
can be subdivided into five functional domains: the N-terminal domain (NTD), the 
oligomerization domain (OD), the scaffolding domain (CSD), the intramembrane domain 
(IMD) and the C-terminal domain (CTD) (Figure 3). Cav proteins are inserted into the plasma 
membrane through a hairpin-like structure formed by the hydrophobic IMD (Figure 3). 
Thereby, both the hydrophilic N-terminal domain as well as the C-terminal domains face the 
cytoplasm, whereby the NTD protrudes into the cytoplasm and the CTD is associated with 
lipids of the membrane via palmitoylation sites (Dietzen et al., 1995; Monier et al., 1995; 
reviewed in Root et al., 2019; Scherer et al., 1995; Uittenbogaard and Smart, 2000). The 
NTD of Cav1 and 2 contains several phosphorylation sites, which are important not only for 
the trafficking of Cav but also for signal transduction and protein-protein interaction, for 
example with ERKs (extracellular signal-regulated kinases) and IGFs (insulin-like growth 
factors) (Glenney, 1989; Kwon et al., 2009; Li et al., 1996a; Schlegel et al., 2001; Sowa et 
al., 2008; Wang et al., 2004). Similarly, the Cav scaffolding domain facilitates the interaction 
and regulation of numerous signaling proteins, including eNOS, Src-tyrosine family kinases, 
small GTPases as well as G-protein coupled receptors (Couet et al., 1997a; Couet et al., 
1997c; Grande-García et al., 2007; Ju et al., 1997; Li et al., 1996a; Nethe et al., 2010; Ostrom 
and Insel, 2004). In addition, the scaffolding domain plays an important role for the 
association of Cav with the membrane by regulating the interaction of Cav proteins with 
cholesterol and other lipids (Arbuzova et al., 2000; Carozzi et al., 2002; Fielding et al., 2004; 
Schlegel and Lisanti, 2000; Wanaski et al., 2003).  
Cav proteins are inserted into the plasma membrane as high molecular mass homo-
oligomers as well as hetero-oligomers (Li et al., 1998; Monier et al., 1995). The process of 
oligomerization is mediated by the Cav oligomerization domain, which facilitates the 
interaction of Cav monomers with other Cav proteins (Li et al., 1998; Sargiacomo et al., 1995). 
Interestingly, while both Cav1 and 3 can form homo-oligomeric structures, Cav2 requires 
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Cav1 for hetero-oligomerization and membrane localization (Li et al., 1998; Scherer et al., 
1996b). Similar to the oligomerization domain, the C-terminal domain also appears to be 
required for Cav oligomerization. In contrast to the oligomerization domain, the CTD only 
mediates homotypic interactions by associating with both the N-terminal and the C-terminal 
domains of neighboring Cav monomers (Schlegel and Lisanti, 2000; Song et al., 1997). 
Further, a specialized region within the CTD, also known as the C-terminal membrane 
attachment domain (C-MAD), is required for the exit of newly synthesized Cav proteins from 
the Golgi apparatus and for membrane localization. Deletion of this domains leads to the 
accumulation of newly synthetized Cav in the Golgi (Machleidt et al., 2000; Schlegel and 
Lisanti, 2000). Further, Cav1 can be palmitoylated on three cysteine residues located in the 
CTD (Figure 3) (Dietzen et al., 1995). Although this posttranslational modification is not 
required for the membrane localization of Cav1 per se, it has been shown to be necessary 
for cholesterol binding (Dietzen et al., 1995; Uittenbogaard and Smart, 2000). 
 
 
Figure 3: Membrane topology and structure of Cav1.  
A Two Cav proteins forming a dimer within the plasma membrane are shown. Cav proteins are inserted 
into the membrane via a hairpin like structure, with both the amino and carboxy terminus facing the 
cytoplasm. Cav proteins are associated with lipids within the plasma membrane. B Scheme of a Cav1 
monomer and its functional domains. (Modified after Williams and Lisanti, 2004). 
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1.2.2 Cavin protein family-structural coat proteins driving the formation of 
caveolae 
 
It was originally suggested that the characteristic striated coat of caveolae is formed by 
oligomers of Cav proteins (Fernandez et al., 2002; Peters et al., 1985; Rothberg et al., 1992). 
However, when Cav1 is over expressed in bacterial cells, which do not express Cav proteins 
themselves, the induced caveolae lacks the characteristic striated coat observed in 
vertebrate cells (Walser et al., 2012). In the past decade, the Cavin protein family was 
identified as another structural component that regulate both the formation as well as 
stabilization of caveolae. This family, originally described in a caveolae-independent context, 
comprises four isoforms: Cavin 1 (Polymerase I and transcript release factor; PTRF), which 
is involved in transcription termination, Cavin 2 (serum deprivation response protein; SDRP) 
and Cavin 3 (sdr-related gene product that binds to c-kinase; SRBC) both associated with 
cell survival after serum starvation and the muscle specific Cavin 4 (muscle-restricted coiled-
coil protein; MURC) (Burgener et al., 1990; Gustincich and Schneider, 1993; Izumi et al., 
1997; Jansa, 1998; Mason et al., 1997; Ogata et al., 2008). Cavin proteins show a expression 
pattern similar to Cav proteins, with Cavin 4 being mainly expressed in skeletal muscle cells 
and Cavin 1 being rather ubiquitously expressed (Bastiani et al., 2009; Hansen et al., 2013; 
Hill et al., 2008; Liu et al., 2008; McMahon et al., 2009). Similar to Cav1 and 3, Cavin 1 is 
essential to drive the formation of caveolae and is also associated with the regulation of 
Caveolin protein levels (Figure 4). The loss of Cavin 1 decreases or completely abolishes 
caveolae formation in both non-muscle and muscle cells and additionally reduces Cav1 
expression levels (Hansen et al., 2013; Hill et al., 2008; Liu et al., 2008). Cavin 2 is also 
required to some extent for caveolae formation in a tissue-specific manner. In contrast to the 
loss of Cavin 1 expression, however, which abolishes the formation of caveolae in all tissues, 
the loss of Cavin 2 expression only leads to a depletion of caveolae in the lungs and in the 
fat endothelium (Hansen et al., 2013). Moreover, Cavin 2 both controls caveolae morphology 
as well as the size of the Cavin complexes incorporated into the caveolae membrane (Figure 
4) (Hansen et al., 2013). Although Cavin 3 and 4 are not essential for caveolae formation per 
se, they are important regulators for caveolae dynamics (reviewed in Briand et al., 2011; 
Hansen et al., 2013). It has been shown that Cavin 3 coordinates the intracellular trafficking 
of caveolae and functions as adaptor molecule that links caveolae to microtubules (Figure 4) 
(McMahon et al., 2009). Cavin 4 expression is restricted to muscle cells, and its function is 
required for the proper localization of Cav3 to the plasma membrane (Bastiani et al., 2009; 
Faggi et al., 2015; Naito et al., 2015).  
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Figure 4: Cavin protein function in the biogenesis of caveolae. 
Scheme showing the different function of Cavin proteins in the biogenesis as well as trafficking of 
caveolae. Cavin 1 is essential for caveolae formation and its loss-of-function results in the depletion of 
these membrane structures. Cavin 2 is required for the caveolae morphology as well as the size of the 
Cavin complexes incorporated into the caveolae membrane. Cavin 3 regulates caveolae trafficking 
along microtubules (Briand et al., 2011).  
 
Cavin proteins are highly conserved with a characteristic domain arrangement. They possess 
two conserved, positively charged helical regions, HR1 and HR2, which are each flanked and 
separated by the poorly conserved, acidic disordered regions DR1, 2 and 3 (Figure 6A) 
(Kovtun et al., 2014). While both the HR1 and 2 domain are required for the association of 
the Cavin proteins with lipids of the plasma membrane, including phosphatidylinositol (4,5) 
bisphosphate (PtdIns (4,5)P2) and phosphatidylserine (PtdSer), the HR1 domain also 
mediates the Cavin oligomerization (Hansen et al., 2009; Kovtun et al., 2014; McMahon et 
al., 2009). Cavin proteins can form homo- and hetero-oligomeric complexes, independently 
of Cav proteins (Gambin et al., 2013; Hayer et al., 2010; Kovtun et al., 2014; Ludwig et al., 
2013). Further, while Cavin 1 can induce caveolae formation even in the absence of other 
Cavin proteins, Cavin 2 and 3 require Cavin 1 to form hetero-oligomeric complexes and to be 
incorporated into the plasma membrane (Bastiani et al., 2009; Gambin et al., 2013; Ludwig 
et al., 2013).  
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1.2.3 Caveolae accessory proteins-additional regulators controlling caveolae 
endocytosis  
 
In addition to Caveolin and Cavin proteins several accessory proteins, which are required for 
caveolae internalization, have been identified: The Dynamin-2 GTPase and the Dynamin-like 
ATPase EHD2 (Eps-15-homology domain-containing protein 2) have been found to be 
associated with the caveolae neck and are required for caveolae stabilization and dynamics 
(Ludwig et al., 2013; Oh et al., 1998; Stoeber et al., 2012). While EHD2 acts as negative 
regulator for caveolae endocytosis, dynamin positively affects caveolae internalization by 
mediating caveolae scission (Henley et al., 1998; Morén et al., 2012; Oh et al., 1998; Stoeber 
et al., 2012). Further, Pascin 3 (PKC and casein kinase substrate in neurons 2), another 
caveolae associated protein, has been linked to caveolae formation and endocytosis (Hansen 
et al., 2011; Seemann et al., 2017). 
1.3 Caveolae biogenesis-the assembly of Caveolin and Cavin proteins 
 
Caveolin as well as Cavin proteins assemble in two separate steps to form the caveolae coat. 
Caveolins are synthesized in the endoplasmic reticulum (ER) as integral membrane proteins, 
where they adapt their characteristic hairpin-like conformation and oligomerize to low 
molecular weight 8S complexes (Figure 5). These consist either of approximately 14-25 
Cav1-Cav2 heteromers or, in muscle cells, of Cav3 homomers (Hayer et al., 2010; Monier et 
al., 1995; Scheiffele et al., 1998). If the appropriate oligomeric size is reached, these 8S 
complexes travel in a COPII (coat protein complex II) dependent manner to the Golgi 
apparatus, where they undergo a second round of oligomerization to form large 70S 
complexes containing approximately 160 Cav molecules (Figure 5) (Hayer et al., 2010; 
Scherer et al., 1997; Tang et al., 1996). Both the assembly of these complexes as well as the 
following transport to the plasma membrane is tightly associated with and dependent on 
cholesterol (Pol et al., 2005). Once these 70S complexes are introduced into the plasma 
membrane, they facilitate the assembly of lipids including sphingomyelin, GD3 and GM1 
gangliosides, PtdIns (4,5)P2 and PtdSer (Figure 5) (reviewed in Sonnino and Prinetti, 2009). 
This creates specialized lipid nanodomains, which in turn initiate the recruitment of other 
caveolae accessory proteins including EHD2, dynamin-2 and cavin proteins (reviewed in 
Kovtun et al., 2015; Morén et al., 2012; Senju et al., 2011; Simone et al., 2013; Wanaski et 
al., 2003; Yao et al., 2005).  
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Figure 5: Biogenesis of Cav proteins. 
Scheme of the biogenesis of Cav proteins. Cav proteins are expressed within the endoplasmic 
reticulum and are assembled as low weight 8S complexes to homo-oligomers. These complexes exit 
the ER in a COPII-dependent manner and travel to the Golgi apparatus. Cav oligomers undergo a 
second cholesterol-depended oligomerization process to form large 70S complexes, which are then 
inserted into the plasma membrane. Caveolae structures are stabilized by Cavin proteins. (Modified 
after Hayer et al., 2010). 
 
Cavin proteins are synthesized into the cytoplasm and form, independently of Cav 
expression, heterotrimers consisting of either three Cavin 1 monomers or two Cavin 1 and 
one Cavin 2 or Cavin 3 monomer (Figure 6B) (Gambin et al., 2013; Hansen et al., 2013; 
Hansen et al., 2011; Hayer et al., 2010; Kovtun et al., 2014). This is mediated by the HR1 
domain of the Cavin 1 protein, which determines the Cavin-Cavin specificity (Kovtun et al., 
2014). Once trimerized, the HR2 domain of the Cavin proteins folds into a helical structure, 
facilitating the assembly of higher Cavin multimers of approximately 60-80 monomers 
(Gambin et al., 2013; Hayer et al., 2010; Kovtun et al., 2014). It has been shown that the 
composition of these complexes can differ between tissues (Hansen et al., 2013; Hayer et 
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al., 2010). These high-order Cavin oligomers then get stably inserted into the plasma 
membrane and induce the stabilization and invagination of caveolae membrane curvatures 
(Figure 6B) (Hansen et al., 2009; Kovtun et al., 2014). This process strongly depends on the 
high affinity of Cavin proteins to specific lipids found in these Cav-rich microdomains (Kovtun 
et al., 2014). The exact mechanism how Cavin proteins interact with the Cav proteins to form 
the characteristic striped coat is still a subject of ongoing research (Kovtun et al., 2015). 
However, cholesterol is known to play an essential role in this process, since cholesterol 
depletion leads to the flattening of this membrane curvatures, Cav1-Cavin 1 dissociation as 
well as degradation of Cavin 2 (Breen et al., 2012; Hailstones et al., 1998; Hill et al., 2008). 
 
Figure 6: Ultrastructure and stepwise assembly of Cavin proteins 
A Heterotrimeric structure of three Cavin proteins. B Scheme of the assembly of cavin hetero-oligomer 
complexes and insertion into the plasma membrane. 1) Single Cavin proteins are shown. 2) Cavin 1 
proteins either form homo-oligomeric structures containing three Cavin 1 proteins, or oligomerize with 
either one Cavin 2 or one Cavin 3 protein to form hetero-oligomeric trimers. 3) The HR2 domain of the 
Cavin proteins folds into a helical structure, facilitating the assembly of higher Cavin multimers (4). 5) 
At the plasma membrane, Cavin multimers associated with specific lipids found in Caveolin-rich 
microdomains (Modified after Kovtun et al., 2014; Tillu et al., 2019). 
 
1.4 Caveolae are stable membrane structures linked to the actin 
cytoskeleton  
 
Caveolin as well as Cavin proteins are not only required for the formation of caveolae, but 
also connect this membrane structures to the actin cytoskeleton and microtubules. While 
Cavin 1 is directly associated with the actin cytoskeleton, Cav1 facilitates this interaction via 
the actin binding protein filamin A (for more details see Echarri and del Pozo, 2015; Liu and 
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Pilch, 2008; Muriel et al., 2011; Richter et al., 2008; Stahlhut and van Deurs, 2000; Sverdlov 
et al., 2009). The caveolae dynamic is highly dependent on the actin cytoskeleton. In contrast 
to clathrin-coated pits, caveolae are relatively immobile and only 5-20% of the caveolae exist 
as mobile vesicles (Hommelgaard et al., 2005; Stahlhut and van Deurs, 2000; van Deurs et 
al., 2003). It has been shown that caveolae are immobilized by the actin cytoskeleton at the 
plasma membrane. The remodelling of the actin cytoskeleton, by for example through 
okadaic acid, leads to a rapid reorganization and internalization of caveolae from the plasma 
membrane (Parton et al., 1994; Thomsen et al., 2002). Interestingly, activated Abl tyrosine 
kinases and formin mDIA1, which play a role in the formation of stress fibers, affect the 
dynamics of caveolae (Echarri et al., 2012). Silencing of one of these proteins leads to the 
clustering of Cav1 and inhibition of caveolae endocytosis. Likewise, actin depolarization by 
cytochalasin D blocks the internalization of caveolae (Parton et al., 1994; Thomsen et al., 
2002), highlighting the importance of the actin cytoskeleton and stress fibers for caveolar 
dynamics.  
Similarly, microtubules are also required for caveolae dynamics. For example, microtubules 
regulate the trafficking of caveolae back to the plasma membrane in an β-Integrin and 
Integrin-linked kinase (ILK) mediated manner. The loss of one of these two proteins depletes 
caveolae from the membrane and leads to the accumulation of caveolae vesicles in 
intracellular structures (Singh et al., 2010; Wickström et al., 2010). It is proposed, that β-
Integrin and Integrin-linked kinases promote local microtubule stabilization by recruiting the 
F-actin binding protein IOGAP1 as well as mDIA1 to the cell cortex and promoting the 
trafficking of caveolae to the membrane (Wickström et al., 2010).  
 
1.5 Caveolae are important regulators for mechanoprotection and -
sensing 
 
Caveolae have been ascribed to a diverse number of cellular processes, including 
endocytosis, lipid regulation and signal transduction (for more details see Cheng and Nichols, 
2016; Harvey and Calaghan, 2012; van Deurs et al., 2003). However, the most remarkable 
function of caveolae, which has attracted the interest of many scientists in recent years, is its 
role in mechanosensing and mechanoprotection (reviewed in Parton and del Pozo, 2013). 
Caveolae are particularly abundant in cells that are exposed to high mechanical stress, such 
as fibroblast, endothelial cells and in particular in muscle cells (Gabella, 1976; Gil, 1983; 
Mobley and Eisenberg, 1975; Palade, 1953; Scherer et al., 1994). Early studies in muscle 
cells demonstrated that these specialized membrane invaginations are sensitive to 
mechanical strain: increased membrane tension results in the flattening of caveolae, which 
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in turn increases the surface area of the plasma membrane (Dulhunty and Franzini-
Armstrong, 1975; Sinha et al., 2011). This mechanism has been shown to protect cells 
against membrane damage in response to extensive mechanical strain and increased cell 
tension (Lo et al., 2016; Sinha et al., 2011). Loss-of-function studies resulting in the depletion 
of caveolae emphasized the importance of these membrane structures for the protection 
against mechanical-induced damage. In mice, the loss of either Cavin 1 or Cav3 expression 
in the musculature, results in an increased sensitivity of the muscle cells to membrane 
tension, disorganization of the sarcolemmal organization as well as aberrant T-tubule 
structures (Galbiati et al., 2001a; Galbiati et al., 2000b; Hagiwara et al., 2000; Lo et al., 2015). 
Similarly in zebrafish, the muscle-specific depletion of either Cavin 1 or the expression of a 
Cav3 mutant, which is associated with human limp-girdle muscular dystrophy, leads to 
mechanical induced damage of the muscles in response to excessive muscle activity (Lo et 
al., 2016; Lo et al., 2015; Nixon et al., 2005). Likewise, the loss of caveolae in the zebrafish 
notochord through Cavin 1 depletion caused severe cellular damage upon mechanical stress 
induced by swimming (Figure 7) (Garcia et al., 2017; Lim et al., 2017).  
 
Figure 7: Caveolae protect the notochord against mechanical stress. 
A Cavin 1 knockout leads to the global loss of caveolae structures. Swimming induced bending of the 
notochord results in cellular lesions of the notochord. B Cavin 1 KO zebrafish showing various degrees 
of cellular damage within the notochord, ranging from mild to severe (Modified after Lim et al., 2017).  
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In the recent years it has been shown that caveolae not only play a role in mechanoprotection 
through physical enlargement of the membrane surface, but also contribute to 
mechanosensitive signaling in response to membrane stretching, shear stress as well as cell 
detachment during migration (Figure 8) (Boyd et al., 2003; Grande-García et al., 2007; Muriel 
et al., 2011; Radel and Rizzo, 2005). Mechanosensing plays an important role in many 
cellular processes that involve morphological changes, including cell migration and 
differentiation, as it converts mechanical forces into biochemical signals 
(mechanotransduction). This leads for example to the rearrangement of the actin 
cytoskeleton allowing cells to respond to mechanical stimuli (for more detail see: Jaalouk and 
Lammerding, 2009; Ohashi et al., 2017; Orr et al., 2006; Vogel and Sheetz, 2006). It has 
been demonstrated that Cav as well as Cavin proteins contribute to mechanotransductive 
pathways by indirectly regulating the reorganization of the actin cytoskeleton and focal 
adhesion stability as well as the positive regulation of caveolae formation (del Pozo et al., 
2005; Dewulf et al., 2019; reviewed in Echarri and del Pozo, 2015; Grande-García et al., 
2007; Nethe et al., 2010; and Parton and del Pozo, 2013). The phosphorylation of Cav1α on 
tyrosine 14 plays a crucial role in these processes: Cav1α can be phosphorylated on tyrosine 
14 (pY14) in a Src-, Fyn- or Abl-dependent manner in response to mechanical force or 
oxidative stress (Cao et al., 2004; Glenney, 1989; Joshi et al., 2012; Li et al., 1996b; Radel 
and Rizzo, 2005; Sanguinetti et al., 2003; Sanguinetti and Mastick, 2003; Wary et al., 1998; 
Zhang et al., 2007). This phosphorylation has been associated with Integrin-dependent focal 
adhesion dynamics and the modulation of RhoGTPase activity during cell migration (Figure 
8) (del Pozo et al., 2005; Goetz et al., 2008a; Grande-García et al., 2007). In endothelial cells, 
shear stress mediates the recruitment of mechanical sensitive Integrins to Integrin adhesion 
sites located in caveolae-signaling domains (Radel and Rizzo, 2005; Yang et al., 2011). The 
interaction of these Integrins with Cav1α initiates the inhibition of the Src/p190RhoGAP 
pathway and consequently the positive regulation of RhoA activity, inducing the remodeling 
of the actin cytoskeleton as well as stabilization of focal adhesion sites (Figure 8) (del Pozo 
et al., 2005; Goetz et al., 2008a; Grande-García et al., 2007; Yang et al., 2011). Tyrosine 
phosphorylated Cav1α also regulates the expression of core caveolae components in a 
positive feedback loop in response to mechanical force: pT14Cav1 inhibits the transcription 
factor Egr-1, which normally represses the expression of both caveolin 1 and cavin 1, in a 
PKC- and RhoA-dependent manner (Figure 8). This leads to the positive regulation of 
caveolae formation to buffer the increased membrane tension (Joshi et al., 2012). In view of 
the important function of Cav and Cavin proteins in mechanosensing and -protection, it is not 
surprising that dysfunction of these proteins contributes to the pathogenesis of many 
diseases, such as muscular dystrophy, cardiomyopathy, lipodystrophy and cancer (reviewed 
in Razani et al., 2002c; Sohn et al., 2016). 
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Figure 8: Caveolin proteins participate in a diverse number of mechanotransduction 
pathways. 
Overview of the signaling pathways regulated by Caveolin proteins. In response to mechanical force, 
caveolae membrane domains regulate the actin cytoskeleton dynamic and stress fiber formation by 
the modulation of the small RhoGTPases RhoA and Rac1 at focal adhesion sites (FA). Cav1 
expression positively regulates RhoA activity by inhibiting the p190RhoGAP pathway and inhibiting 
Rac1 activity. Src-mediated Cav1 phosphorylation inhibits the Erg1-dependent transcriptional 
repression of caveolae protein components, which leads to the positive regulation of caveolae 
formation (modified after Echarri and del Pozo, 2015). 
 
1.6 Caveolin 1- functional role in cellular processes 
 
Cav1 was the first caveolae component to be discovered and is considered as the key 
structural component of caveolae. Cav1 is involved in a variety of physiological and 
pathophysiological processes as it regulates many cellular processes that play an essential 
role in maintaining the general health of the organism. These include endocytosis, cell 
signaling, lipid and cholesterol homeostasis (Razani et al., 2002c). 
The cav1 gene is highly conserved among different species and contains three exons. The 
encoded protein of approximately 178 amino acids in length is expressed as an α - and β-
isoform. These isoforms differ in their size due to alternative splicing and alternative 
translating start sides: While the Cav1α isoform is considered to be the full length protein, the 
β-isoform lacks the first 32 N-terminal amino acids of the α-isoform (Kogo and Fujimoto, 2000; 
Scherer et al., 1995). Both isoforms are capable to induce caveolae formation and show 
overlapping expression profiles (Fujimoto et al., 2000; Li et al., 1996c; Scherer et al., 1995). 
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Although detailed studies analyzing the isolated function of these two isoforms have not yet 
been performed in higher vertebrate, loss-of-function studies in zebrafish suggest that Cav1α 
and β have distinct but overlapping functions during development (Fang et al., 2006). While 
the Morpholino-mediated knockdown of both Cav1α and Cav1β in zebrafish resulted in 
defects in neuronal and notochord structures as well as in disorganized actin structures of 
the somites, only Cav1α loss-of-function caused impaired formation of vascular-endothelial 
tissue (Fang et al., 2006).  
The main difference between these two isoforms is the tyrosine phosphorylation site at 
position 14 (Y14) of the Cav1α-isoform, which is associated with caveolae internalization, 
focal adhesion dynamics, cell motility and polarization (Beardsley et al., 2005; del Pozo et 
al., 2005; Goetz et al., 2008a; Grande-García et al., 2007; Radel and Rizzo, 2005; Wary et 
al., 1998; Zimnicka et al., 2016).  
1.6.1 Cav1α is a modulator for RhoGTPase activity 
 
The small RhoGTPases Cdc42 (cell division cycle 42), Rac1 (Ras-related C3 botulinum toxin 
substrate 1) and RhoA (Ras homologous member A) act as molecular switches controlling a 
variety of cellular processes, including actin remodeling during cell polarity and cell migration 
(reviewed in Etienne-Manneville and Hall, 2002). They are constantly cycling between an 
“active” and an “inactive” state by the hydrolysis of GTP to GDP and vice versa. In general, 
Rac1 regulates lamellipodia formation and Cdc42 filopodia extension by promoting actin 
polymerization (Kozma et al., 1995; Nobes and Hall, 1995; Ridley et al., 1992). In contrast, 
RhoA functions in microtubule stabilization and stress fiber formation by counteracting Rac1 
and Cdc42 activity (Nobes and Hall, 1995; Ridley and Hall, 1992).  
The Src-dependent phosphorylation of Cav1α on tyrosine 14 (pY14Cav1α) has been 
associated with focal adhesion maturation and dynamics by modulating the activity of these 
small RhoGTPases in the process of cell migration and polarization (Grande-García et al., 
2007; Nethe et al., 2010; Wei et al., 1999). Activated Rac1 at nascent focal adhesion contacts 
mediates the recruitment as well as the Src-dependent phosphorylation of Cav1α at Integrin 
adhesion sites located at the leading edge of migrating cells (Nethe et al., 2010; Radel and 
Rizzo, 2005). This re-localization both promotes the clustering and stabilization of Integrins 
and subsequently focal adhesion assembly by the inhibition of Rac1 and the activation of 
RhoA (Figure 8, Figure 9) (Gaus et al., 2006; Goetz et al., 2008a; Grande-García et al., 2007; 
Joshi et al., 2008; Nethe et al., 2010). Nethe and colleagues were able to demonstrate, that 
focal-adhesion-localized pY14Cav1α negatively modulates the activity of Rac1 by regulating 
the ubiquitylation and consequently the degradation of active Rac1 (Figure 9) (Nethe et al., 
2010). Further, in a negative feedback loop, pY14Cav1α mediates the recruitment of the Src 
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inhibitor csk (C-terminal Src kinase), which phosphorylates and inhibits Src-kinases localized 
at focal adhesion sites. This results in the inhibition of p190RhoGAP and activation of RhoA, 
which in turn stabilizes newly formed focal adhesion sites (Cao et al., 2004; Grande-García 
et al., 2007; Radel and Rizzo, 2005). Consistently, mouse embryonic fibroblasts from cav1 
knockout mice display impaired focal adhesion maturation and stabilization as well as loss of 
cell polarity and migration due to elevated Rac1 and decreased RhoA activity (Grande-García 
et al., 2007; Nethe et al., 2010). In addition, pY14Cav1α not only modulates the stabilization 
of focal adhesion sites, but also regulates the turnover of focal adhesions complexes through 
endocytosis. It is proposed, that de-phosphorylation of Cav1α by focal adhesion resident 
phosphatases, such as protein tyrosine phosphatase 1b (PTP1B) and its homologue 
activating T cell protein-tyrosine phosphatase (TCPTP), results in its destabilization and 
subsequent internalization (Borza et al., 2010; Lee et al., 2006). This in turn leads to the 
turnover of FA components together with Cav1α by caveolae-mediated endocytosis (Figure 
9) (del Pozo et al., 2005; Nethe and Hordijk, 2011).  
The role of Cav1 in the regulation of Cdc42 activity is still a subject of ongoing research. 
Nevis and Thurmond proposed a model where Cav1 functions as Cdc42 guanine nucleotide 
dissociation inhibitor in pancreatic β-cells, as Cav1 maintains Cdc42 in its inactive state under 
basal condition in these cells (Nevins and Thurmond, 2006). Thus, although Cav1 may not 
be a major factor for the direct regulation of RhoGTPase activity, it seems to be required for 
the fine-tuning of their spatial-temporal activity during cell migration. 
 
Figure 9: Model for Caveolin 1 dependent Rac1 regulation.  
A Activated Rac1 recruits Src-kinases as well as Cav1 to focal adhesion sites (FA). B-C The 
association of Cav1 with Src-kinases drives the phosphorylation of Cav1Y14 and the accumulation of 
phosphorylated Cav1 at focal adhesion sites. D-E FA-associated tyrosine phosphatases 
dephosphorylate Cav1, which causes the internalization of Cav1 together with FA components. F 
Localization of Rac1 at Integrin attachment domains (1) is either regulated by the cycling GTP 
hydrolysis (2) but also by the Cav1-mediated polyubiquitylation pathway (3-4) (Modified after Nethe et 
al., 2010; Nethe and Hordijk, 2011).  
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1.6.2 The role of Cav proteins in health and disease  
 
The misexpression of Cav1 in humans is associated with the pathogenesis of various 
diseases, including Berardinelli-Seip congenital lipodystrophy, cardiac diseases and cancer 
but also with age-related diseases such as vascular and pulmonary dysfunction, impaired 
wound healing and fibrosis as well as Alzheimer disease (Cao et al., 2008; Gaudreault et al., 
2004; Parton and del Pozo, 2013; Rhim et al., 2010; Volonte et al., 2009) 
A better understanding of the pathophysiological function of Cav proteins in human diseases 
has been gained through the establishment of several animal models; Cav1 null mice, which 
show a complete loss of caveolae formation in all non-muscle cells, are surprisingly viable 
and fertile. However, they display a broad spectrum of abnormalities such as a reduced live 
span (Park et al., 2003), cardiac hypertrophy, and pulmonary defects (Razani et al., 2001) as 
well as abnormal lipid homeostasis (Razani et al., 2002a). Cav1 KO mice are lean with an 
abnormal adipocyte’s physiology including a reduced diameter of adipocytes, resistance for 
diet-induced obesity and insulin resistance (Le Lay and Kurzchalia, 2005; Razani et al., 
2002a). One of the highest expression level of Cav1 can be detected in adipocytes, 
suggesting that Cav1 functions in lipid metabolism (Scherer et al., 1997; Scherer et al., 1994). 
And indeed, while cholesterol is essential for Cav trafficking and caveolae formation, Cav1 
has been shown to regulate cholesterol homeostasis by modulation its trafficking to the 
plasma membrane or other cellular compartments (Bist et al., 1997; Fielding et al., 1997; Le 
Lay et al., 2006; Murata et al., 1995).  
 
The function of Cav1 is also associated with cell proliferation, differentiation and survival 
(reviewed in Goetz et al., 2008b). In mouse embryonic fibroblasts, Cav1 negatively regulates 
cell proliferation by mediating the p53/p21-dependent G0/G1 cell cycle arrest (Galbiati et al., 
2001b; Razani et al., 2001). Furthermore, it has been shown that Cav1 regulates cell cycle 
progression via the Ras-p42/44 MAP kinase pathway (Galbiati et al., 2001b; Sanna et al., 
2007; Williams and Lisanti, 2005). The loss of Cav1 expression in C. elegans results in a 
burst of egg laying, due to an elevated activation of the Ras/MAP-kinase pathway and 
consequently an increased cell division (Scheel et al., 1999). Cav1 also negatively regulates 
the Wnt/β-Catenin-dependent Cyclin D1 transcription by inhibiting the translocation of β-
catenin in the nucleus and the Lef1-mediated transcription of Cyclin1D (Galbiati et al., 2000a). 
Consistently, cav1 KO mice display pulmonary defects characterized by a thickening of the 
alveolar septa due to increased cell proliferation (Razani et al., 2001). Further, mice deficient 
for Cav1 expression exhibit deficits in wound healing and also show a higher susceptibility to 
carcinogens (Capozza et al., 2003; Razani et al., 2001), suggesting that Cav1 might be 
involved in tumorigenesis. Indeed, Cav1 has been found to be mis-regulated in many tumors:  
it is downregulated in breast, gastrointestinal and multidrug resistant cancers and 
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upregulated in lung, brain and prostate cancer (Barresi et al., 2006; Bryant et al., 2011; Goetz 
et al., 2008b; Ho et al., 2002). For this reason, Cav1 is believed to function both as tumor 
suppressor as well as tumor promoter, depending on the type of cancer in which Cav1 is 
expressed.  
 
Similar to the observed phenotype in mice, the loss-of-function of cav1 also leads to cardiac 
dysfunctions in zebrafish (Fang et al., 2006; Grivas et al., 2020). Morpholino-mediated 
knockdown of Cav1 results in a disruption of vascular endothelial tissue, including enlarged 
pericardial heart sacs and abnormal heart chambers formation (Fang et al., 2006). In 
contrast, while the knockout of cav1 does not cause developmental defects of the zebrafish 
heart, heart regeneration was affected due to decreased cardio-myocyte proliferation and 
reduced cardiac elasticity in the adult zebrafish (Grivas et al., 2020). In addition, Cav1 is 
required for notochord, lateral line, neural as well as vascular development in this model 
organism. Morpholino-mediated knockout of Cav1α results in a deformed notochord, 
abnormal development of both eye and neural tissue, disrupted patterning of the vascular 
endothelium (Fang et al., 2006) as well as impaired maturation of the neuromasts (Fang et 
al., 2006; Nixon et al., 2007). 
Taken together, although Cav1 may not be essential for survival, there is a growing body of 
evidence that Cav1 is required for cell and tissue integrity and health.  
 
1.6.3 Functions of Cav1 in the nervous system 
 
The function of Cav1 is not only associated with metabolic diseases. Increasing evidence 
shows that dysfunctions of this protein is also linked to the progression of a variety of 
neurodegenerative diseases, including Alzheimer disease, schizophrenia and Huntington 
(Allen et al., 2011; Eser Ocak et al., 2019; Gaudreault et al., 2004; Kassan et al., 2017; 
Trushina et al., 2006a). Further, progressive neurodegenerative spinal cord and cerebellar 
dysfunctions were found in patients with atypical partial lipodystrophy caused by a Cav1 
frame shift mutation (Berger et al., 2002; Cao et al., 2008). These neurological conditions 
were characterized by severely reduced lower extremity weakness, spastic-ataxia gait, an 
inability to perform rapid, alternating movements (dysdiadochokinesis) and bilateral Babinski 
signs, indicating dysfunctions of the corticospinal tract (Berger et al., 2002; Cao et al., 2008). 
Similarly, by analyzing the brain of Cav1 KO mice, it has been shown that the loss of Cav1 
expression leads to an age-dependent decrease in both brain size and weight due to 
accelerated neuronal aging and degeneration (Head et al., 2010; Trushina et al., 2006a). 
They also display distinct neurological abnormalities, which include deficits in motor 
coordination, gait abnormalities and muscle weakness (Figure 10) (Gioiosa et al., 2008; Head 
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et al., 2010; Trushina et al., 2006a). Additionally, Cav1 KO mice show behavioral changes 
associated with cholinergic dysfunction, characterized by impaired spatial memory, increased 
anxiety and reduced exploratory behavior in a new environment (Gioiosa et al., 2008). 
Interestingly, the most striking phenotype of Cav1 KO mice was observed during a tail-
suspension test; when suspended on their tail, these mice exhibit a phenotype referred as 
“clasping”, where the mice press all their four paws against the body, or a unique spinning 
phenotype, in which the mice spin in horizontal plane upon tail suspension (Figure 10) 
(Trushina et al., 2006a). Interestingly, the clasping phenotype is associated with transgenic 
mice models for neurodegenerative diseases, including Huntington and Alzheimer disease 
(Lalonde and Strazielle, 2011). Similarly the spinning behavior has been previously observed 
in mice with vestibular dysfunction (Gnedeva and Hudspeth, 2015; GORRILL, 1956) or 
cerebellar deficits (Cemal et al., 2002).  
 
Figure 10: Cav1 loss-of-function in mice causes impaired motor control and behavioral 
abnormalities. 
A Gait abnormalities in Cav1 KO mice in comparison to wild type littermates (Bl6). Gait behavior of 
wild type mice is shown in grey and those of Cav1 KO mice in red. Cav1 KO mice display a shorter 
stride length (a) as well as a wider overlap between paws (b). B Representative behavior of wild type 
(Bl6) or Cav1 KO mice during a tail suspension test. Wild type mice display normal behavior upon tail 
suspension. Cav1 KO mice shows an age-dependent clasping and spinning phenotype (Modified after 
Trushina et al., 2006a). 
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Caveolin proteins are expressed in various areas and cell types of the brain such as 
astrocytes, Schwann cells, dorsal root ganglia cells and microvessels (Cameron et al., 1997; 
Galbiati et al., 1998; MacDonald et al., 2018; Mikol et al., 1999; Virgintino et al., 2002). It has 
been shown that Cav1 is important for the blood brain barrier integrity and physiology by 
negatively regulating the degradation of tight junction proteins through the inhibition of 
Metalloproteases during ischemic stroke (Choi et al., 2016; Gu et al., 2012; Li et al., 2015). 
In contrast, Cav1 also increases the blood brain barrier permeability by regulating the 
caveolae-dependent trafficking of tight junction proteins (Liu et al., 2016; Stamatovic et al., 
2009). Further, Cav1 appears to have a function in glia cells, as it is upregulated during 
myelination of Schwann cells (glia cell of the PNS) and oligodendrocytes (glia cell of the 
CNS).  
 
Expression studies of the murine brain have also shown that Cav1 is expressed in neurons 
of the cerebral cortex, hippocampus, cerebellum and the midbrain (Kang et al., 2006). 
Thereby, protein expression seems to be age-dependent, as Cav1 expression levels are the 
lowest in the brain of young and the highest in aged rats (Kang et al., 2006). Similarly, 
Shikanai and colleagues demonstrated that Cav1 shows a spatial and temporal expression 
in hippocampal neurons, with high expression in the neurites and somas of immature neurons 
and a decreased or non-detectable expression in mature hippocampal neurons of young mice 
(Shikanai et al., 2018). Further, they also reported that Cav1 regulates early pruning 
processes and leading process elongation of hippocampal neurons during neuronal 
maturation and migration in vivo (Figure 11) (Shikanai et al., 2018). Loss-of-function of Cav 
1 in these neurons resulted in an increased number of immature neurites as well as a shorter 
leading process compared to wild type neurons, due to the impaired trafficking and recycling 
of N-cadherin from immature neurites to the leading process (Figure 11) (Shikanai et al., 
2018). 
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Figure 11: Cav1 regulates neuronal maturation. 
A Neural specific loss-of-function of Cav1 (Cav-sh490) impairs neurite pruning and leading process 
elongation during early neuronal maturation. Neurons from the upper intermediate zone (u-IZ), which 
are depleted of Cav1 expression, show an increased number of primary neurites (B) as well as an 
increased number of branched leading processes (C) in comparison to control neurons (Modified after 
Shikanai et al., 2018).  
 
Cav1 is a negative regulator for cell proliferation. Up-regulation of this protein has been 
associated with cellular senescence (Galbiati et al., 2001b; Park et al., 2005; Park et al., 
2000). Interestingly, the loss of Cav1 expression in the brain leads to an increased VEGF 
(vascular endothelial growth factor)-dependent proliferation of neural stem cells in the 
subventricular zone and the hippocampal dentate gyrus of adult mice (Jasmin et al., 2009; Li 
et al., 2011). Further, Cav1 has been found to be upregulated in the brain of aged murine 
models and rats as well as in patients with Alzheimer diseases (Gaudreault et al., 2004; Kang 
et al., 2006) indicating a function for Cav1 in neuronal senescence. Interestingly, findings of 
age-related expression and function of Cav1 in the brain are inconclusive. While some 
studies showed an age-dependent increase of Cav1 in the hippocampus (Gaudreault et al., 
2004; Kang et al., 2006) others reported the opposite (Head et al., 2010; Liu et al., 2013). 
Similarly, both the knockout (Eisinger et al., 2020; Li et al., 2011) as well as overexpression 
(Head et al., 2011; Mandyam et al., 2017) of Cav1 are reported to enhance dendritic number, 
length and arborization of neurons in vivo and in vitro.  
 
Introduction  22 
 
Interestingly, while increased expression of Cav1 has been associated with elevated amyloid-
β (Aβ) secretion and the pathogenesis of Alzheimer and Huntington disease (Kang et al., 
2006; Trushina et al., 2014; Trushina et al., 2006b), the loss of Cav1 in the brain is also linked 
with neuronal degradation, loss of synaptic plasticity, increased astrogliosis and increased 
amyloid-β (Aβ) and P-Tau expression (Head et al., 2010). The amyloid-β (Aβ) peptides, 
proteolytic byproducts of the amyloid precursor protein (APP), are the major components of 
the senile plaques found in brains of Alzheimer’s patient and are associated with 
neurodegeneration and cognitive regression in Alzheimer’s disease (Knowles et al., 1999; 
Malek-Ahmadi et al., 2016). 
In addition, Cav1 misregulation has been associated with dysregulated cholesterol 
homeostasis in the brain (Gaudreault et al., 2004). It has been shown that mutant huntingtin 
protein, the key-role player in the pathogenesis of Huntington’s disease, interacts with Cav1 
and inhibits Caveolin-mediated endocytosis in neurons, which leads to abnormal 
accumulation of cholesterol (Trushina et al., 2006b). Interestingly, depletion of Cav1 in a 
mouse model for Huntington’s disease rescues the abnormal cholesterol accumulation and 
also delays Huntington-related phenotypes (Trushina et al., 2014).  
While the overexpression of Cav1 is associated with the pathogenesis of neurodegenerative 
disease, Sawada et al. were able to show that neuronal targeted overexpression of Cav1 
improves the overall pathophysiology of amyotrophic lateral sclerosis (ALS) mice (Sawada 
et al., 2019). Moreover, several studies demonstrated that neuronal targeted Cav1 positively 
modulates intracellular signaling including Trk tyrosine kinase receptor family- as well as 
Rac1/cdc42 signaling in membrane lipid rafts, thereby improving both synaptic plasticity and 
neuronal survival (Wang et al. 2019; Bilderback et al. 1999; Stern und Mermelstein 2010).  
Given the similarities between loss-of-function and overexpression phenotypes, it seems 
likely that a balanced expression of Cav1 is required for a healthy development and aging of 
the brain.  
 
1.7 The development of the Xenopus neuromuscular system  
 
1.7.1 The organization of the spinal cord circuit 
Due to the well-characterized and low complexity of its nervous system, the model organism 
Xenopus laevis provides a useful system to study the early development of the central 
nervous system (CNS). The spinal cord of Xenopus tadpoles contains eight easy 
distinguishable types of neurons: Rohon-Beard neurons (RB), motoneurons (mn), Kolmer-
Adghur cells (KA) and five types of interneurons (Figure 12) (Hartenstein, 1989b; Roberts, 
2000b; Roberts and Clarke, 1982). Rohon-Beard neurons are touch-sensitive sensory 
neurons that innervate the skin. The soma of these neurons is located dorsally of the neural 
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tube and extents three axons: a peripheral axon, which innervates the skin and two central 
axons that are located within the neural tube. These transmit excitations via interneurons to 
the ventrally located motoneurons to generate coordinated motor responses (Clarke et al., 
1984; Li et al., 2003; Roberts et al., 2010; Roberts, 2000b). Another class of sensory neurons 
found in the Xenopus spinal cord are the so called Kolmer-Agduhr cells (Dale et al., 1987). 
These cells are cerebrospinal fluid‐contacting neurons which contain multiple cilia and 
microvilli reaching into the neurocoele of the spinal cord (Dale et al., 1987). The cholinergic 
primary motoneurons are located in the ventral portion of the spinal cord. The soma of these 
neurons is multipolar with an ipsilateral descending axon that innervates the axial 
musculature (Roberts et al., 1999; Soffe and Roberts, 1982). Xenopus interneurons can be 
divided into three classes depending on their axonal projection: ascending interneurons, 
commissural interneuron and descending interneurons (Li et al., 2001). There are overall five 
types of interneurons described in the Xenopus spinal cord: excitatory dorsolateral 
commissural (dla) and inhibitory commissural interneurons (cIN), excitatory dorsolateral 
ascending (dlc) and inhibitory ascending interneurons (aIN) as well as excitatory descending 
interneurons (dIN) (Li et al., 2001; Roberts et al., 1981).  
 
Figure 12: Neuron types in the Xenopus laevis embryo.  
Schema of the neuronal types as well as axonal tracts in the spinal cord of Xenopus embryos 
in a transverse section (top) as well as horizontal cross-section (bottom). Rohon-Beard 
neurons (RB) are shown in yellow, motoneurons (mn) in green, excitatory dorsolateral 
commissural interneurons (dlc) in orange, excitatory descending interneurons (dIN) in brown, 
inhibitory commissural interneurons (cIN) in dark purple, inhibitory ascending interneurons 
(aIN) in blue and excitatory dorsolateral interneurons (dla) in red. Kolmer-Agdhur (KA) 
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1.7.2 Early neurogenesis in Xenopus laevis 
 
Similar to other anamniote species, Xenopus neurogenesis occurs in two distinct stages, 
including the primary neurogenesis, which provides the rudimentary nervous system 
controlling early embryonic behaviour and the secondary neurogenesis forming the adult 
central nervous system (CNS) (Hartenstein, 1989b; Thuret et al., 2015; Wullimann et al., 
2005). The establishment of the primary neural circuit starts with neural induction, in which 
the neural plate is formed by a fate change of epidermal cells to neural precursors during 
gastrulation (Harland, 2000). This process is mediated by secreted factors produced by the 
adjacent mesoderm, which inhibit the Bone Morphogenetic Protein (BMP) signaling in the 
prospective neural plate and prime the epidermal cells to adopt a neural fate. Among these 
factors are the BMP antagonists Chordin and Noggin as well as Xenopus Nodal-related 3 
(Xnr3), which are secreted from the blastula Chordin- and Noggin expressing (BCNE) centre 
(Fainsod et al., 1997; Kuroda et al., 2004; Piccolo et al., 1996; Smith et al., 1995; Zimmerman 
et al., 1996). Similarly, the fibroblast growth factor (FGF) as well as canonical Wnt signalling 
promote neural fate by acting antagonistically to BMP signaling (Baker et al., 1999; Delaune 
et al., 2005; Pera et al., 2003; Wilson et al., 2000) and further modulate the posteriorization 
of the neuroectoderm together with retinoic acid (Blumberg et al., 1997; McGrew et al., 1997). 
Following the establishment of the presumptive neural ectoderm, the inhibition of BMP 
signaling induces the expression of a set of pan-neural markers in broad overlapping regions 
(reviewed in Moody and Je, 2002). These factors regulate the stabilization and maintenance 
of the neural fate as well as the following initiation of neuronal differentiation (Mizuseki et al., 
1998a; Rogers et al., 2008). While members of the SoxB (sex determining region Y (SRY)- 
box,  Sox 1-3) as well as the Zic (Zinc finger of the cerebellum; Zic1 and Zic3) protein-family 
modulate the sensitivity of the neuroectoderm in respond to neural inductive signals such as 
Noggin and FGF (Brewster et al., 1998; Kishi et al., 2000; Kuo et al., 1998; Mizuseki et al., 
1998a; Nakata et al., 1997), the coiled-coil protein Geminin as well as FoxD (Forkhead-Box 
D), a member of the forkhead/winged helix family of transcription factors, maintains the 
immature state of the neural progenitors by inhibiting their differentiation (Seo and Kroll, 2006; 
Sullivan et al., 2001). Downstream of the early neural stabilizing genes, SoxD as well as the 
Iroquois gene family (Xiro 1-3) promote the initiation of neuronal differentiation by the 
regulation of the basic helix-loop-helix (bHLH) proneural genes (Bellefroid, 1998; Gomez-
Skarmeta, 1998; Gómez-Skarmeta et al., 2001; Mizuseki et al., 1998b). 
The newly formed neuroectoderm is comprised of undifferentiated neuronal progenitor cells, 
from which only a restricted number will differentiate into primary neurons (Hartenstein, 
1989b). The open neural plate of the Xenopus embryo consists of a bi-layered epithelium, a 
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so called deep and a sensorial layer, which later intercalates during neural tube closure to 
form the neural tube (Figure 13) (Davidson and Keller, 1999). While the progenitors of the 
primary neurons are located within the deep layer of the neural tube, secondary neurons 
arise both equally from the deep as well as the superficial layer, but stay differentially inactive 
until the onset of metamorphosis (Hartenstein, 1989b; Thuret et al., 2015; Wullimann et al., 
2005).  
 
Figure 13: Formation of the neural tube in Xenopus embryos 
A The neural plate of Xenopus embryos is a bi-layered epithelium, containing a deep/inner layer and 
a superficial or sensorial layer. B-D Upon neural tube closure, involving the invagination (B) of the 
neural plate, the two layer intercalates (C) to form a neural tube (D). ng = neural groove, n-nect = non-
neural ectoderm (Modified after Werner et al., 2019). 
 
The exact molecular mechanism of how the spatial-temporal expression of these distinct 
neuronal populations is regulated is still not well understood. However, it is proposed that 
Geminin, which is both expressed in the deep as well as superficial layer, modulates the 
spatiotemporal regulation of neuronal differentiation (Seo et al., 2005). With the onset of 
primary neurogenesis Geminin expression is eliminated in the primary neuronal progenitor 
cells, while it remains expressed in progenitors for secondary neurons (Seo et al., 2005).  
The neuronal differentiation of primary neurons takes place in so called neurogenic regions, 
which are determined by secreting factors from the midline. Among these, shh as well as 
retinoic acid regulate the expression of Gli and Zic2 genes, which are required to restrict the 
expression of proneural genes within the three longitudinal neurogenic domains on each 
side of the embryonic midline (Figure 14) (Brewster et al., 1998; Franco et al., 1999). 
Proneural genes are transcription factors belonging to the bHLH gene class and are 
subdivided into distinct protein families such as the atonal family (Math1 and 2), olig family 
(Olig 1-3), neuroD family (NeuroD), neurogenin family (Ngnr1-3) as well as the achaete-
scute family (ash) (Bertrand et al., 2002). These proneural genes function as positive 
regulators for neurogenesis by providing initial positional information for the prospective 
neuronal identity and regulating the expression of genes, which are required for neuronal 
differentiation (Bertrand et al., 2002).  
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Figure 14: Primary neurogenesis in Xenopus laevis. 
Schematic scheme of the neural plate (red) and the neurogenic regions (yellow) is shown. The 
expression of Zic 2 restricts the expression of proneural genes, including x-ngnr 1, within the three 
longitudinal neurogenic domains on each side of the embryonic midline. These domains represent the 
future position of primary neurons. The medial (m) domain gives rise to motoneurons, interneurons 
are derived from the intermediate (I) domain and sensory Rohon-Beard neurons from the lateral (l) 
domain. An additional domain (trigeminal ganglion (tg) is shown. X-ngnr 1 functions as positive 
regulator for neurogenesis by providing initial positional information for the prospective neuronal 
identity (Corral and Storey, 2001). 
 
Despite the potential of the neuronal precursors to differentiate into mature neuronal cells, 
only a subset of cells undergo differentiation. In a process called lateral inhibition, mediated 
by the Delta-Notch pathway, the number of neuronal precursor cells, that are committed to a 
neuronal fate, gets restricted (Figure 15). The expression of the bHLH proneural gene 
neurogenin-related 1 (ngnr-1) promotes the expression of the membrane bound Notch ligand 
X-Delta within a nascent neuroblast (Chitnis et al., 1995; Haenlin et al., 1994; Kunisch et al., 
1994). The binding of X-Delta to its receptor Notch, which is presented on neighboring cells, 
induces the proteolytic cleavage and release of the intracellular domain (NICD) of Notch and 
its subsequent translocation into the nucleus (Figure 15) (Brou et al., 2000; Mumm et al., 
2000; Schroeter et al., 1998; Strooper et al., 1999). Within the nucleus, the NICD facilitates 
as transcriptional co-activator together with the transcription factor Suppressor of hairless 
(SU(H)) the expression of genes, such as the transcriptional repressors Enhancer of split 
E(spl) and Hairy (Her), which inhibit neuronal differentiation (Figure 15) (Dawson et al., 1995; 
Jennings et al., 1994; Lecourtois and Schweisguth, 1995; Wettstein et al., 1997). 
Consequently, while cells expressing the X-Delta1 protein undergo neuronal differentiation, 
the expression of E(spl) and Her in the neighboring cells antagonize neuronal differentiation 
by repressing the transcription of proneural genes such as ngnr-1, but also the ligand X-
Delta1 (Dawson et al., 1995; Oellers et al., 1994). Besides the transcription of X-Delta, ngnr-
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1 also facilitates the expression of regulators for terminal differentiation, such as X-NeuroD, 
X-MyT1 and Xebf3 (Bellefroid et al., 1996; Chitnis and Kintner, 1996; Lee et al., 1995; Pozzoli 
et al., 2001).  
 
Figure 15: The Delta-Notch pathway mediates lateral inhibition during early neurogenesis. 
N-tubulin shows the localization of neuronal progenitors in three longitudinal domains on both sites of 
the midline. Lateral inhibition, mediated by the Delta-Notch pathway restricts the number of neuronal 
progenitors that are subjected to neuronal differentiation (purple). The proneural protein X-ngnr-1 
induces the expression of the Notch ligand Delta. Binding of Delta to its receptor Notch presented on 
the neighboring cell, leads to proteolytic cleavage of the intracellular domain of Notch (ICD) and its 
translocation into the nucleus. Together with Su(H), the ICD mediates the expression of genes required 
for the transcriptional repression of proneural genes and the subsequent inhibition of neuronal 
differentiation (Henningfeld et al. 2007).  
 
Differentiated neurons are positive for the neural-specific marker neuron specific class II β 
tubulin (n-tubulin), which is expressed in a punctuated pattern within three longitudinal stripes 
on each side of the embryonic midline (Oschwald et al., 1991). The position of these 
expression domains represents the identity of the neuronal subtypes that are found in the 
closed embryonic neural tube. Thereby, neuroblasts located in the lateral stripe give rise to 
the Rohon-Beard neurons, the interneurons derive from the intermediate stripe and the 
primary motoneurons from the medial stripe (Oschwald et al., 1991; Roberts, 2000b). During 
the process of neurogenesis, the neural plate begins to fold to form a closed spinal cord, 
involving the apical constriction and elongation as well as the convergent extension of the 
neuroepithelium (Figure 13) (Davidson and Keller, 1999; reviewed in Sokol, 2016). In 
Xenopus, the neural plate is formed by two layers, the superficial sensory layer as well as 
the deep layer. While the deep layer primarily gives rise to primary neurons, the superficial 
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layer contains neural precursors of both primary and secondary neurons (Hartenstein, 1989b; 
Roberts, 2000b; Thuret et al., 2015). These neurons remain in an undifferentiated state until 
the onset of metamorphosis (St.54 onwards), where they begin to differentiate to form the 
adult central nervous system (Chalmers et al., 2002; Thuret et al., 2015). During the process 
of neural tube closure, the deep as well as the superficial layer undergo radial intercalation 
to form a single-layered neural tube (Edlund et al., 2013). Within the closed neural tube three 
distinct regions can be identified: the ventricular layer in which neural stem cells as well as 
neural precursors reside, the intermediate layer, consisting out of proliferating postmitotic 
cells as well as the mantel layer, where the neuronal differentiation takes place and mature 
primary neurons locate (Figure 16) (Corral and Storey, 2001).  
 
Figure 16: Domains of the closed spinal cord. 
Schematic of a cross-section of the closed spinal cord. Proliferating cells are located in the ventricular 
layer. Postmitotic neuronal cells are present in the intermediate layer, while differentiating and mature 
neurons are found in the mantle layer (Corral and Storey, 2001). 
 
Thereby, the positional identity of primary neurons is determined by their position within the 
neural tube and is specified by secreted morphogens from the floorplate as well as the roof 
plate of the spinal cord (Briscoe and Ericson, 1999). Each progenitor domain or neuronal 
subtype is characterized by the expression of a distinct subset of homeodomain transcription 
factors, including Pax6 and 7, Nkx 6.1, Nkx 2.2, Irx3 as well as Dbx 1 and 2, whose 
expression is determined by a gradient of sonic hedgehog (Shh), Bone morphogenic protein 
(BMP) as well as Wnt (Briscoe et al., 2000; Briscoe and Ericson, 1999; Briscoe and Novitch, 
2008; Ulloa and Martí, 2010). Shh is secreted from the floor plate, resulting in a ventral to 
dorsal gradient. In turn, BMP and Wnt are expressed in the roof plate, which create a dorsal 
to ventral gradient within the neural tube and function antagonistically to the Shh morphogen 
(Megason and McMahon, 2002; Timmer et al., 2002). While, high levels of Shh and the lack 
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of BMP/Wnt in the most ventral region of the spinal cord induces the differentiation of 
motoneurons (Ericson et al., 1997; Ericson et al., 1996; Yu et al., 2008), high levels of 
BMP/Wnt and no expression of Shh in the most dorsal part of the neural tube gives rise to 
sensory neurons (Timmer et al., 2002). 
1.7.3 The establishment of the early neuromuscular system 
 
The first neuronal differentiation can be observed in the anterior region of the embryonic 
spinal cord between developmental stage 22-25 (NF), starting with Rohon-Beard neurons 
followed closely by motoneurons and interneurons (Hartenstein, 1993; Hartenstein, 1989a). 
Differentiation of primary neurons precedes in an anterior to posterior direction until stage 
37/38 to form the embryonic CNS (Hartenstein, 1993).  
The development of the musculature and the establishment of early neuromuscular circuits 
are temporally coupled. In Xenopus, myotomal segmentation starts at stage 17 and precedes 
until stage 40, with 45 somite-pairs forming in an average rate of 0.9 somite pairs per hour in 
an anterior to posterior direction (Chanoine and Hardy, 2003; Gurdon et al., 1997). This if 
followed by the growth of the first motoneuron axons into the intermyotomal clefts at a rate of 
0.7 clefts per hour. At stage 25/26, which is referred as “early swimming stage”, the first 
involuntary movements can be observed. At this stage, 15 somite pairs have been formed 
with the first three myotomal segments being innervated and showing synaptic activity 
(Blackshaw and Warner, 1976; van Mier et al., 1989). The first rhythmic swimming behaviour 
can be observed between stage 27 and 30, in which at least 6 to 10 somites are functionally 
innervated (van Mier et al., 1989). Around stage 37, in the so called “free swimming stage”, 
a neural connectivity required for rhythmic swimming movements has been established in 
the spinal cord and primary motoneurons innervate a large number of somitic segments 
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1.8 Aim of this study 
 
Caveolin 1 is an essential component of caveolae membrane domains and participates in a 
vast amount of cellular processes, including endocytosis, lipid homeostasis as well as signal 
transduction. During recent years, the participation of Cav1 in the pathogenesis of age-
related neurodegenerative diseases, such as Alzheimer's, has sparked interest in the 
neuronal function of Cav1. However, the exact mechanism of how misexpression of Cav1 
might contribute to neurodegeneration is still not well understood. Thus, the aim of this thesis 
is to add to the understanding of the neuronal function of Cav1, by using the model organism 
Xenopus laevis. Previous loss-of-function studies have shown that the injection of a 
translation blocking Morpholino of Cav1α (Cav1α MO) causes severe swimming defects in 
Xenopus embryos (Berger, 2016), suggesting that Cav1 might function in the neuronal 
circuits controlling swimming behavior. In this thesis the exact role of Cav1α in the 
development of Xenopus embryos as well as its function in the locomotor system will be 
examined in more detail by performing loss-of-function studies by using a Splice-blocking 
Morpholino (Cav1α-Spl MO) in addition to the Cav1α MO. Profound expression analysis of 
Cav1 during embryonic development will be performed by in situ hybridization as well as 
immunofluorescence staining. In addition, to characterize the mechanism causing the 
swimming defects, targeted injections will be performed. Therefore, the Morpholinos will be 
injected either into neural or muscular tissue, to distinguish between a neural or muscular 
function of Cav1α. If it is confirmed, that Cav1α functions in neuronal tissue, the nervous 
system of these embryos will be examined by immunofluorescence staining. Moreover, spinal 
cord explantation assays will be performed to gain insights into potential consequences of 
Cav1α loss-of-function on neuronal morphology.  
As it is well known that Cav proteins also have a mechano-protective function within the 
notochord, the notochord of the morphant embryos will be analyzed by electron microscopy. 
In addition to that, Morpholino-mediated loss-of-function of Cavin 1 will be performed, to 
address how impaired notochord integrity contributes to the aberrant swimming behavior.  
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2 Material and Methods 
 
2.1 Chemicals 
The chemicals used in this work were purchased from the following companies: Carl Roth 
(Karlsruhe), Thermo Fisher Scientific (Waltham, MA, USA), Sigma -Aldrich (Munich), Roche 
(Mannheim), Applichem (Darmstadt), Merck (Darmstadt),  
 
2.2 Buffers and Media 
 
Table 1: Buffers and Media 
Buffers and Media 
APB (alkaline phosphatase-buffer): 
100 mM Tris (pH 9.5) 
50 mM MgCl2 
100 mM NaCl 
0.1 % Tween20 (Roth) 
APB/NBT/BCIP: 
NBT/ BCIP stock-solution (Roche) 
diluted 1:50 in APB 
BA/BB: 
1:2 Benzylalcohol/ Benzylbezoate (Sigma-
Aldrich) 
Bleaching solution (whole mount 
in situ hybridization): 
1 % H2O2 
5 % Formamide (Sigma) 
0.5 % SSC 
Blocking reagent (BR): 
10 % BSA (Roth) in MAB 
heat to dissolve 
Blockingsolution (Western blot): 
1 xPBS 
5 % non-fat dry milk powder 
0.1 % Tween 20 
Blockingsolution (whole mount 
immunofluorescence staining): 
0,1 M glycine 
2 % powdered milk 
5 % serum (goat, horse) 
in PBS-TD 
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Buffers and Media 
Cacodylatbuffer (0,1M): 
0.2 M Cacodylat (Fuca/Sigma) 
0.2 N HCl 
pH. 7,2 
CoIP buffer: 
50 mM Tris (pH 7.5) 
150 mM NaCl 
0.5 % NP-400 
Danilchicks Medium for Amy (DFA) 
53 mM NaCl 
5 mM Na2CO3 
4.5 mM Potassium Gluconate 
32 mM Sodium Gluconate 
1 mM CaCl2 
1 mM MgSo4 
pH to 8.3 with 1 M Bicine 
Add 0.5 g/ml BSA 
Sterile filter into a 50 ml Falcon 
store at -20°C 
Denhardts (100x): 
2 % BSA 
2 % Polyvinylpyrrolidon (Sigma) 
2 % Ficoll 400 in ddH2O 
Dent’s fixative: 
80 % methanol 
20 % dimethylsulfoxide (DMSO) 
Gelatin/albumin embedding medium: 
4.4 % gelatin 
27 % bovine serum albumin (BSA) 
18 % saccharose in 1x PBS 
Glutaraldehyd: 
6.25 % Glutaraldehyd (Roth) 
0.1 M Cacodlyat 
pH 7.2 
Hyaloronidase in sodium acetate: 
1 µg/ml hyloronidase (Sigma) 
in 50 mM sodium acetate. 
Material and Methods  33 
 
Buffers and Media 
Hybridization mix (Hybmix): 
50 % (v/v) Formamid 
5 x SSC 
1 mg/ml Torula RNA (Sigma) 
100 µg/ml Heparin (Roth) 
1 x Denhardts 
0.1 % (v/v) Tween-20 
0.1 % (v/v) CHAPS (Sigma) 
10 mM EDTA 
Store at -20°C 
Injection buffer: 
1 x MBS 
2 % (w/v) Ficoll400 (Roth) 
Laemmli loading buffer (6x): 
350 mM Tris-HCl (pH 6.8) 
9.3 % Dithiotreit 
30 % (v/v) Glycerol 
10 % SDS 
0.02 % Bromphenolblue (Roth) 
Laemmli running buffer (10x): 
250 mM Tris-base 
2.5 M Glycine 
0.1 % SDS 
LB-Agar: 1.5 % (w/v) agar-agar (Roth) in LB-medium 
Loading Dye: 6 x Loading Dye Solution (Fermentas) 
Luria-Bertani (LB)- Medium: 
1 % (w/v) Bacto-Trypton (Roth) 
0.5 % (w/v) yeast extract (Roth) 
1 % (w/v) NaCl 
pH 7.5 
MAB (5x): 
0,5 M maleinacid (Roth) 
0.75 M NaCl 
pH 7.5 
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Buffers and Media 
MBS (Ringersche Lösung, 1 x): 
10 mM Hepes (Roth), pH 7.0 
88 mM NaCl 
1 mM KCl 
2.4 mM NaHCO3 
0.82 mM MgSo4 
0.41 mM CaCl2 
0.66 mM KNO3 
MEM (10 x): 
1 M MOPS (Roth) 
20 mM EGTA (Roth) 
10 mM MgSo4 
heat and light sensitive 
MEMFA: 
1 x MEM 
3.7 % (v/v) Formaldehyd (Roth/Merck) 
Mowiol: 
5 g Mowiol (Calbiochem) in 20 ml 1x PBS 
stirring 16 hours 
10 ml Glyceros, stirring 16 hours 
Centrifuge at 20.000rpm for 30 min 
Store at -20°C 
NBT/BCIP (Roche): 
17.7 mg/ml NBT 
50 mg/ml BCIP 
67 % DMSO 
PBS (10x): 
1.37 M NaCl 
27 mM KCl 
100 mM Na2HPO4 
18 mM KH2PO4 
pH 7.4 
PBS-TD (1 x): 
1 % Triton X-100 
1 % DMSO 
Proteinase K-solution (Merck): 
Stock solution 600U/ml; 
0.25 µl/ml in PTw 
PTw (1x) + FA: 4 % Formaldehyd in PTw 
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Buffers and Media 
PTw (1x): 
1 xPBS, 
0.1 % Tween20 
SSC (20x): 
0.3 M Sodium citrate 
3 M NaCl 
pH 7.0 
SSC (2x)/ RNase: 
2 mg/ml RNase A, 5000 U/ml RNaseT1 
(Thermos Scientific); 1:10000 in 2 x SSC 
TAE (10x): 
2 M Tris 
100 mM EDTA (Roth) 
pH 7.7 with acetate 
Transfer buffer (10x): 
250 mM Tris 
1.9 M glycine 
20 % methanol 
Triethanolamin (0,1 M): 
1.86 % (w/v) Triethanolamin-Hydrochlorid pH 
7.5 
X-gal staining solution: 
1 mg/ml X-Gal (Roth) 
5 mM K3Fe(CN)6 (Roth) 
5 mM K4Fe(CN)6 (Roth) 
2 mM MgCl2 
1 x PBS 
 
2.3 Enzymes and Kit 
Table 2: Enzymes and Kits 
Enzymes and Kits 
Collagenase 
Sigma Aldrich 
DNase I (1 U/μl): GE Healthcare 
Dream Taq Polymerase (5 U/µl) Thermo Fischer Scientific 
Fast Digest Restriction Endonucleases,  Thermo Fischer Scientific 
Hyaloronidase from bovine testes (400-1000 U/mg) Sigma 
IllustraTM RNA Mini Spin Kit GE Healthcare 
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Enzymes and Kits 
Phusion DNA Polymerase (2 U/μl), Fynnzymes Thermo Fischer Scientific 
Proteinase K (20 mg/ml), Merck Carl Roth 
RNase A (2 mg/ml) Thermo Fischer Scientific 
RNase free water Amresco 
RNase Out (40 U/μl) Invitrogen 
RNase T1 1000 U/μl  Thermo Fischer Scientific 
RNeasy Mini Kit Quiagen 
SP6 and T7 mMESSAGE mMACHINE Kit Invitrogen 
SP6, T3, T7 RNA Polymerases (20 U/μl) Thermo Fischer Scientific 
SuperSignal West Dura Extended Duration Substrate kit Thermo Fischer Scientific 
T4 DNA Ligase (1 U/μl) Fermentas 
Zymoclean Gel DNA Recovery Kit Zymo Research 
 
2.4 Additional Chemicals 
 
Table 3: Chemicals and Reagens 
Additional Chemicals and Reagens 
Benzocaine Sigma Aldrich 
DAKO Deutschland GmbH 
DAPI (1mg/ml) Roth 
DNA Ladder 1kb Plus Thermo Fischer Scientific 
Fibronectin  
Gel-Red (10.000x) Biotium 
Human Choriongonadotropin (hcG) Sigma Aldrich 
Laminin  Sigma Aldrich 
Loading Dye (6x) Thermo Fischer Scientific 
Material and Methods  37 
 
Additional Chemicals and Reagens 
Phalloidin (TRITC, 0.5 mg/ml in DMSO) Sigma Aldrich 
Poly-D Lysine Sigma Aldrich 
X-gal (5-Bromo-4chloro-3indolyl α-D-galactopyranoside) Roth 
α-bungarotoxin (10 mg/ml, tetramethylrhodamine) Sigma 
 
2.5 Technical Hardware 
 
Table 4: Technical Hardware 
Technical Hardware 
Spinning Disc Zeiss 
Imaging System for Gel-Electrophoresis and Western 
blot LI-COR ODDYSEY 
Microsoft Office 2010 Microsoft 
Prism8 GraphPad 
Axio Observer Z1 inverted microscope Zeiss 
Confocal laser scan microscope (TCS-SP5) Leica 
Magnetic Glass Microelectrode Horizontal Needle Puller, 
PN-13)  
Narishige AG 
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2.6 Constructs  
 
2.6.1 .. Expression constructs for in situ hybridization/overexpression 
 
Table 5: Plasmids for in situ hybridization/ overexpression 
Insert / Vector Insert  Reference / clone strategy: 
Caveolin 1α /pCS2+ 
Full length Xenopus laevis 
caveolin1α  
cloned by Hanna Peradziryi, 
unpuplished data, Xenopus 
laevis full length Caveolin 1α 
was amplified using primers  
xcav1a F EcorI  
Xcav1a R xhoI  
RZPD, catalogue number 
IRBMp990B0725D 
Caveolin 1α -HA 
/pCS2-HA 
Full length Xenopus laevis 
caveolin 1α fused with HA-tag 
cloned by Hanna Peradziryi, 
PhD thesis, full length 
caveolin 1a was amplified 
using primers  
Xcav1a F EcorI  
Xcav1a R XhoI .  




Xenopus laevis caveolin 1α 
with deleted MO binding site 
Cloned by Hanna Berger, 
PHD thesis (Berger, 2016, 
PhD). the caveolin 1α rescue 
construct was amplified from 
the Caveolin 1α-HA plasmid 
using following primers; 
Cav1a new ATG NheI for  
Cav1a new ATG NheI rev.  
Caveolin 1α-rescue-
S82A/ pCS2-HA 
Xenopus laevis caveolin 1α 
with deleted MO binding site 
and a mutated serine residue 
82 to alanine, 
Amplified by two step 
mutagenesis PCR using the 
Caveolin 1α-rescue-HA as 






Xenopus laevis caveolin 1α 
with deleted MO binding site 
and a mutated serine residue 
82 to glutamine, constitutive 
active 
Amplified by two step 
mutagenesis PCR using the 
Caveolin 1α-rescue-HA as 
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Insert / Vector Insert  Reference / clone strategy: 






Xenopus laevis caveolin 1α 
with deleted MO binding site 
Amplified by two step 
mutagenesis PCR using the 
Caveolin 1α-rescue-HA as 




Caveolin 1α Y14A/ 
pCS2-HA 
dominant negative mutant of 
caveolin 1a with a mutation in 
the thyrosin residue 14 
Cloned by Hanna Peradziryi 
Amplified from pCS2 / cav 
1a-HA by site-directed 
mutagenesis using following 
primers: 
cav1 Y14A F: 
cav1 Y14A R:  
Sema3A 
Xenopus full length 
semaphorin 3A 
(Koestner et al., 2008) 
Sema3F 
Xenopus full length 
semaphorin 3F 
(Koestner et al., 2008) 
RFPRuby-N1-
Lifeact; pcDNA 3.1 
Lifeact tagged with RFP unknown 




(Moriyoshi et al., 1996) 
Pax3 Xenopus leavis, Pax3 unknown 
Sox2 Xenopus leavis, Sox2 unknown 
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Insert / Vector Insert  Reference / clone strategy: 
caCdc42 V12 / 
pCDNA3.1 
Constitutive active cdc42 
(Homo sapiens) 
(Schambony and Wedlich, 
2007) 
dnCdc42 N17 / 
pCS2+ 
 
Dominant negative cdc42 
(Xenopus leavis) 
 
(Choi and Han, 2002) 
 
caRac1 V12 / 
pCS2+ 
Constitutive active Rac1 
(Homo sapiens) 
Cloned from the pCDNA3.1 
vector into the pCS2+ vector 
by Anita Grund  
Original plasmid: (Kashef et al., 
2009; Schambony and 
Wedlich, 2007) 
dnRac1 N17 / 
pCS2+ 
Dominant negative Rac1 
(Homo sapiens) 
Cloned from the pCDNA3.1 
vector into the pCS2+ vectro 
by Anita Grund  
Original plasmid: (Kashef et al., 
2009; Schambony and 
Wedlich, 2007) 
caRhoA V12/V14 / 
pCS2+ 
Constitutive active RhoA 
(Homo sapiens) 
Cloned from the pCDNA3.1 
vector into the pCS2+ vectro 
by Anita Grund  
Original plasmid: (Kashef et al., 
2009; Schambony and 
Wedlich, 2007) 
dnRhoA N19 / 
pCS2+ 
Dominant negative RhoA 
(Homo sapiens) 
Cloned from the pCDNA3.1 
vector into the pCS2+ vectro 
by Anita Grund  
Original plasmid: (Kashef et al., 
2009; Schambony and 
Wedlich, 2007) 
n-tubulin 
Beta II tubulin; Cytoskeletal 
protein/neural specific, 
plasmid backbone unknown 
Oschwald R. et al Int J Dev Biol 
1991,35,399-405,  
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2.6.2 .... Linearization of DNA constructs for in vitro transcription 
 
Table 6: Plasmids for in vitro transcription 
Construct name sense RNA antisense RNA 
enzyme polymerase enzyme polymerase 
Caveolin 1α NotI SP6 SalI T7 
Caveolin 1α-GFP NotI SP6   
Caveolin 1α-HA NotI SP6   
Caveolin 1α-rescue NotI SP6   
Caveolin 1α-
rescue-S82E 
NotI SP6   
Caveolin 1α-
rescue-C135A 
NotI SP6   
Caveolin 1α Y14A NotI SP6   
RFPRuby-N1-
Lifeact 
DraIII T7   
lacZ NotI SP6   
xtwist   EcoRI T7 
mGFP NotI SP6   
Pax3   SalI T7 
Sox2   EcoRI T3 
N-tub   BamHI T3 
 
2.6.3 .... Oligonucleotides  
DNA primers were purchased from Eurofins MWG Synthesis GmbH. 
 
Table 7: Oligonucleotides 
Name Sequence 5`-3` 
Cav1a_S82E_fw 5' GATGGGACACATGAGTTCGATGGCATCTGG 3' 
Cav1a_S82E_rv2 5' CCAGATGCCATCGAACTCATGTGTCCCATC-3’ 
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Name Sequence 5`-3` 
cav1 Y14A F: 5’-TGAAGAGGGTGTTCTCGCCACCACGCCGGTCATC-3’ 
cav1 Y14A R 5‘-GATGACCGGCGTGGTGGCGAGAACACCCTCTTCA-3’ 
Cav1a_S82A_fw2 5' GATGGGACACATGCTTTCGATGGCATCTGG-3’ 
Cav1a_S82A_rv2 5' CCAGATGCCATCGAAAGCATGTGTCCCATC 3' 
Cav1a new ATG 
NheI for 
5’- ATGCTAGCATGGAAGAGGGTGTTCTCTACAC-3’ 
Cav1a new ATG 
NheI rev 
5’- ATGCTAGCGAATCGATGGGATCCTGCAAA-3’ 
xcav1a F EcorI  5’-TTGAATTCAGCATGTCTGGTGGCAAATACATAG-3’ 








2.7 DNA Methods and cloning procedure 
 
2.7.1 .... Plasmid DNA preparation  
 
For analytical purpose, Plasmid DNA from E.coli was isolated using the geneJET Plasmid 
Miniprep Kit (Thermo scientific). To yield larger, preparative amounts of DNA the 
NucleoBond® Xtra Midi Kit (Machery-Nagel) was used. Plasmid isolation was performed 
according to the manufracurer’s instructions. The DNA was eluted in an appropriate colume 
of milliQ water and concentration was measured using the Nano Drop-2000 Spectrometer 
(Thermo Scientific.). 
 
2.7.2 .... Polymerase chain reaction (PCR) 
 
Amplification of DNA fragments was performed by Polymerase chain reaction. Therefore, an 
amount of 10-100 ng template DNA and a concentration of 10µM of Oligonucleotides was 
used. In the case of analytical purposes, DreamTaq™ DNA Polymerase, and for cloning 
procedures, Phusion™ High Fidelity DNA Polymerase was performed according to 
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maufracturer’s instructions. PCR fragments were purified using the Gene Jet PCR purification 
or the Zymoclean Gel DNA Recovery Kit. 
 




Initial denaturation 98°C/ 30 sec 95°C/ 60 s 
Denaturation 98°C/ 10 sec 95°C/ 30 s 
Annealing 
Specific annealing temperature according to used primers/ 30 
sec 
Extension 72°C/ 20 sec/bp 72°C/ 1 min/bp 
Final extension 72°C/ 10 min 72°C/ 10 min 
 












Side directed mutagenesis was performed to specifically mutate a desired amino acid residue 
within a protein. For this purpose two primer pairs were designed; a primer pair flanking the 
desired DNA fragment (A, B), and an internal primer pair, with complementary ends, 
containing the desired mutation (a,b). The mutagenesis was performed in two independent 
nested-PCR steps. In the first step, a PCR reaction with primer pair Aa and Bb, amplifying 
fragment 1 and 2, respectively, was performed to amplify the fragments containing the 
desired mutation. Subsequently the amplified fragments were purified by gel-extraction using 
the Zymoclean Gel DNA Recovery Kit (Zymo Research). In a second PCR, fragment 1 and 
2 were mixed and amplified using primer pair A and B, to create the final construct containing 
the mutation. PCR fragments were purified using the the Zymoclean Gel DNA Recovery Kit 
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and were used for cloning. Phusion High-fidelity DNA-Polymerase and an amount of 10 ng 
template DNA and a concentration of 10 µM of Oligonucleotides were used. 
 
Table 9: PCR cycling instruction 
Cycle step 
1th PCR 2nd PCR 
Temperature/Time Temperature/Time 
Initial denaturation 98°C/ 60 sec 98°C/ 60 s 
Denaturation 98°C/ 10 sec 99°C/ 10 s 
Annealing 
Specific annealing temperature according to used primers/ 45 
sec 
Extension 72°C/ 20 sec/bp 72°C/ 20 sec/bp 
Final extension 72°C/ 10 min 72°C/ 10 min 
 
2.7.3 .. DNA restriction digest 
 
Restriction digests of DNA were performed with type II FastDigest® restriction 
endonucleases (Thermo Scientific) for 30 min at 37°C. Therefore 0.2-1 µg DNA was mixed 
with 1x FastDigest® buffer (10x) and 1 µl of FastDigest® restriction enzyme in a total volume 
of 20 µl. Nuclease free water was used to adjust the final volume.  
 
2.7.4 .. Gel electrophoresis of nucleic acids 
 
To qualify or purificate DNA or RNA, samples were separated by gel electrophoresis in a 
horizontal 1-2 % agarose gel according to standard protocol procedure. Nucleic acids were 
visualized by application of Gel Red (0.5 µl/ 10 ml) to the agarose gel.  
 
2.7.5 .. Ligation of DNA fragments 
 
Ligation of two DNA fragments was performed using an equimolar ratio of 1:3 of linearized 
vector and insert. 
insert mass [ng]= 3 * (
insert bp
vector bp
) * vector mass [ng] 
The purified DNA was incubated in a mixture of 1 µl T4-DNA ligase (Fermentas); 2 µl T4 
Ligase buffer in a total volume of 20 µl for at least 4 h at room temperature. Reaction was 
terminated by incubation for 10 min at 65°C. 
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2.8 RNA Methods 
 
2.8.1 .... In vitro transcription of sense RNA 
 
For microinjection into Xenopus embryos, capped sense mRNA was in vitro synthezised 
using the SP6 or T7 mMassage mMachine kit (Ambion). Therefore, 1.2 µg of template RNA 
was used in a 20 µg reaction volume and incubated for 2 h at 37°C. Template DNA was 
removed by the addition of 1 µl of TurboDNaseI (Ambion) and the subsequent incubation for 
15 min at 37°C. The newly synthesized mRNA was purified using the llustra RNAspin Mini 
RNA Isolation Kit (GE Healthcare) according to the maufracturer’s protocol. The mRNA- 
concentration was meassured using the Nano Drop-2000 Spectrometer (Thermo Scientific). 
 
2.8.2 .. In vitro transcription of labeled antisense RNA 
 
Expression analysis of mRNA was performed by whole mount in situ hybridization using 
Digoxigenin labelled antisense RNA probes. These were synthesized according to following 
protocol:  
 
5x Transcription buffer (Fermentas)    5 µl 
Digoxygenin-mix (Fermentas)    4 µl 
0,75M DTT       1 µl 
RNAse Out (Invitrogen)     1 µl 
T3, T7 or SP6 polymerase (20 U/µl, Fermentas)  1 µl 
linearized DNA template     1µg 
add RNAse-free water to an end volume of:    25 µl 
 
The synthesis of RNA was performed at 37°C for 2h, following a 15 min treatment at 37°C 
with 1 µl Turbo DnaseI (Ambion) to remove the residual DNA. Purification was performed 
using the he llustra RNAspin Mini RNA Isolation Kit (GE Healthcare) according to the 
maufracturer’s protocol. Quality and quantity of the synthetized RNA was estimated by gel 
electrophoresis in a 1% TAE agarose-gel. Dependent on the RNA quantity, RNA was diluted 
in Hybix and stored at -20°C.  
2.8.3 .. cDNA synthesis / Reverse Transkriptase PCR  
 
For verification of the Splice-blocking Morpholino as well as the time course analysis of 
endogenous Caveolin 1 mRNA, total RNA was isolated from Xenopus embryos at different 
developmental stages. RNA was isloated using the the GE Healthcare illustra RNAspin Mini 
Isolation Kit. cDNA was synthetized according to following protocol: 
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Following reaction was mixed and total volume was adjusted with nuclease free water: 
 
Total RNA 1 ng- 5 µg  
Random hexamer primer (Thermo Scientific) 0.2 µg  
dNTP Mix (50 μM; Thermo Scientific) 1 mM 
Total Volume 10 µl 
 
Reaction mix was incubated for 5 min at 65°C and then put on ice. In a separate RNase-
free microfuge tubes following reaction was mixed and adjusted to the total volume with 
nuclease free water.  
 
MuLV Reverse transcriptase (Thermo Fischer 
Scientific) 
20 units 
5x RT Reaction Buffer (Thermo Scientific) 2 µl 
RnaseOUt (Invitrogen) 20 units 
Total volume 10 µl 
 
The mixture was combined with the first reaction and incubated at 25°C for 5 min and 
subsequently for one hour at 42°C. The reaction was terminated in a brief incubation step for 
20 min at 65°C. The cDNA was either used directly for following PCR analyzes or stored at -
80°C.  
 
2.9 Protein methods 
 
2.9.1 .. Antibodies 
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2.9.2 .. Lysis of Xenopus laevis embryos for Western blotting 
 
Protein extracts were prepared by the lysis of injected Xenopus embryos with insulin syringes 
in 10 µl/embryo Lysis buffer (CoIP buffer, 0.1% SDS, EDTA-free protease inhibitor cocktail 
tablet (Roche)). Lysates were centrifuged for 15 min by 16.000 g at 4°C and supernatant was 
transferred to a fresh Eppendorf tube. Protein lysates were diluted 1:6 with 6× Laemmli 
loading buffer and denatured for 5 min at 95°C before it was loaded to a 10 or 12 % SDS-
PAGE gel.  
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2.9.3 .. Western Blotting 
 
Proteins were separated by a 10-12 % SDS-PAGE in an electrical field. After separation, 
proteins were transferred to a nitrocellulose membrane (Whatman) by wet- or semi-dry 
blotting using either Bio-Rad wet blot cell (Bio-Rad), containing 1x transfer buffer/20% EtOH, 
at 100V for 1hour or semi dry Transfer system (Trans Blot-Turbo, Bio-Rad) at 25 V for 45 
min. 
Membrane was blocked in TBST-blocking buffer containing 5 % nonfat dried milk for at least 
30 min. The antibody was removed by washing three times for 10 min each in blocking 
solution and the secondary antibody was applied for 1 h at room temperature. Proteins were 
detected using Pierce™ ECL Western Blotting Substrate (Thermo Scientific) and 
Odyssey® Fc Imaging System (LI-COR Bioscience). 
2.9.4 .. Cultivation and Transformation of E. coli Xl1-blue 
 
For bacterial transformation experiments, the chemo competent E. coli strain XL1-bue was 
cultivated in LB-medium supplemented with 100 mg/ml ampicillin (Roth) at 37°C and 200 
rpm.  
Transformation was performed by carefully mixing 5 µl plasmid DNA with 100 µl thawed 
chemo competent E. coli. The reaction was incubated for 30 min on ice. Afterwards, E. colis 
were heat shocked at 42°C for 30 seconds and immediately placed on ice for 1 -2 min. 800 
µl prewarmed LB-medium was added to the tube following incubation for 1 hour at 37°C and 
200 rpm. The culture was centrifuged for 1 min at 6000 rpm and 800 µl of the supernatant 
was removed by pipetting. The remaining pellet was carefully resuspended in the remaining 
medium and bacteria were plate out on LB agar containing 100 mg/ml Ampicillin. The plate 
was incubated over night at 37°C and colonies were picked for further analysis the following 
day.  
 
Genotype: endA1 gyrA96(nalR) thi-1 recA1 relA1 lac glnV44 F'[ ::Tn10 proAB+ lacIq 
Δ(lacZ)M15] hsdR17(rK- mK+) 
2.10 Xenopus Methods 
 
2.10.1 Statistical analysis 
 
All experiments, if not indicated otherwise, were conducted at least three times. The total 
number of analyzed embryos (n) is indicated for each experiment. Normality of datasets was 
tested using D’Agostine & Pearson test, Shapiro-Wilk test and Kolmogorov-Smirnov test 
Significance was calculated by using either a two-tailed unpaired student’s t-test or Mann-
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Whitney test (Box blots) (* p-value ≤ 0.05; **p-value ≤0.01; ***p-value ≤ 0.001) using Microsoft 
excel (2013) or GraphPad Prism8. Standard errors of the mean (s.e.m) are shown for each 
graph.  
2.10.2 .. Xenopus laevis testis macerates  
 
Testis macerates were prepared by first euthanizing male Xenopus frogs in 0.05% 
benzocaine for 20-30 min at room temperature. To test if the frog was sufficiently euthanized, 
the male frog unresponsiveness was tested by pinching the skin between the toes with a 
tweezer. Additionally, as a second euthanasia method the spinal cord was severed by 
cervical section using a sharp knife. Both testes were dissected through opening the 
abdominal cavity and removal of the yellow body fat in the area of the genitourinary system 
with a sharp scissor and scalpel. The testes can be found directly attached to the kidney on 
both sites of the aorta. They were cut out and cleaned of residual fat and vascular tissue. 
Testes were stored up to two weeks in 1x MBS at 4°C. For fertilization of Xenopus oocytes, 
an appropriate amount of testes was macerated using a scalpel and stored in 1 ml of 1x MBS 
in a petri dish.  
2.10.3 .. In vitro fertilization of Xenopus laevis eggs 
 
Ovulation in female Xenopus frogs was stimulated by the subcutaneously injection of 
chorionic gonadrotropin (Ovogest, MSD, 500 units) into the dorsal lymph sac approximately 
15 hours before the desired egg laying using insulin syringes.  
Eggs from stimulated female frogs were collected in a petri dish by applying pressure at the 
pelvis region on both sites of the spinal-cord. The oocytes were fertilized with 100-200 µl 
testes macerate diluted 1:10 with H2O bidest through gently mixing. After fertilization, eggs 
were covered with 0.1 x MBS and stored at 14-18 °C until the desired developmental stage 
for injection. Embryos were staged according to. (Nieuwkoop and Faber, 1994) 
2.10.4 .. Removal of the jelly coat and microinjection 
 
Xenopus eggs are covered with a thick layer of jelly coat. To dejelly the embryos, they were 
incubated for at least 5 min in 2% L-cysteine (pH 8.0) at 14-18°C in a petri dish by 
occasionally stirring the embryos with a pipette tip. After the complete removal of the jelly 
coat, embryos were carefully washed three times in 0.1x MBS and stored at 14-18 °C until 
the desired developmental stage for injection.  
For microinjection, injection needles were prepared from glass capillaries via a Needle puller 
(Magnetic Glass Microelectrode Horizontal Needle Puller, Narishige PN-13) and a 
micromanipulation system (PV820 Pneumatic Pump, M3301 Micromanipulator, World 
Precision Instruments) was used. The needle was calibrated to the desired injection volume 
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corresponding to 5 -10 nl of injection volume. Therefore, the diameter of the droplet size was 
measured using a micrometer scale and adjusted by carefully pinching the tip of the glass 
needle with forceps. Embryos were kept prior and after the injection in injection buffer on a 
coolin plate at 14°C. For microinjection, embryos were transferred to small petri dishes 
containing injection buffer as well as a plastic mesh with a grid diameter of ~1mm to allow 
better orientation of embryo. Embryos were oriented according to the desired injection 
localization and the appropriate volume of injection solution was injected. In general, an 
injection volume of 10 nl for one- as well as two-cell stage embryos and 5 nl for 4- as well as 
8-cell embryos was used. Embryos were kept in injection buffer for at least 1 hour at 14 °C 
and subsequently washed three times and cultivated at 14-18 °C in 0.1x MBS.  
 
2.10.5 .. Morpholino Oligonucleotides 
 
Antisense Morpholino oligonucleotides were used for knockdown studies and were 
generated by Gene Tools, LLC (Philomath, OR, USA). Morpholinos were diluted in RNase-
free water to an end concentration of 80ng/10nl. 
Table 11: Morpholino Oligonucleotides 
Morpholino 
name 







































10-20 ng 10 ng 
 
2.10.6 .. Neural tube explants 
 
The protocol for neural tube explants was adapted from Lowery et al. (Lowery et al., 2012). 
Prior to explantation, plated coverslips have to be prepared. Therefore, 8 well chambered 
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coverslips (Sarstedt) were covered with 200 µl per chamber of 150-200 µg/ml poly-L-Lysine 
(P-1399 Sigma-Aldrich) and incubated for one hour at room temperature or overnight at 4°C. 
Solution was washed out by rinsing three times with 1x PBS. During preparation of the second 
coating, chambers were dried. The coverslips were then covered with 200 µl of 10µg/ml 
Laminin (L2020, Sigma-Aldrich) and incubated for one hour at 37°C. Solution was washed 
out by rinsing three time with 1x PBS and replaced with DFA medium. During this, it should 
be avoided to let the coated surface to be exposed to air. Spinal cords were explanted from 
stage 19-22 Embryos in 0.8x MBS and explants were cultivated in DFA medium. Embryos 
were sorted according to their fluorescence and the vitelline membrane was carefully 
removed using sharp forceps in agarose coated petri-dishes. Additionally, the ventral portion 
of the embryo was carefully removed, by making several incisions right beneath the head 
and the posterior end of the embryos. The remaining dorsal explants, which should consist 
of the head, somites, notochord and spinal cord, were placed in an Eppendorf tube containing 
2mg/ml collagenase in 0.8 xMBS for 15-20 min depending on the developmental stage. 
Collagenase treatment loosens the tissue, which makes it easier to separate somitic tissue 
and epidermis from the spinal cord. The older the embryo, the stronger is the adhesion 
between the neural tube and the surrounding tissue. By using sharp forceps to stabilize the 
embryo and an eyebrow sword, the surrounding tissue was carefully dissected from the 
neural tube. Explanted neural tubes were then cut in small, evenly pieces and placed on the 
coated chamber slides for 12-24 h at 18 °C. Outgrowth of neurites were imaged using the 
Zeiss Axio Observer Z1 inverted microscope (63x oil objective). Outgrowth as well as 
morphology of spinal neurons was counted for each explant individually. Axon length, 
filopodia as well as lamellipodia area was determined using ImageJ. The area covered by 
lamellipodia was calculated by subtracting the area of the axon (Aa) from the total area 
including lamelipodia (Ta). Lamellipodia area was then normalized to the total area (Ta) per 
axon. Number of filopodia per axon was calculated by normalizing the number of counted 
filopodia (Fn) with the axon length (AL). The growth cone was excluded in both calculations. 
Filopodia number: (Fn/ AL)*100 µm; Lamellipodia area: (Ta- Aa)/ Ta 
 
2.10.7 .. Fixation and X-gal staining of Xenopus embryos 
 
To distinguish between injected and uninjected side, β-galactosidase (lacZ) mRNA was co-
injected into the embryos as lineage tracer. Prior staining the embryos were fixed in 
MEMFA for 30-45 min and washed three times in 1x PBS for 10 min each. For the 
visualization of the β-galactosidase activity, embryos were incubated in X-gal solution in the 
dark until a blue staining was observed. Embryos were then immediately rinsed with 1-PBS 
until all of the yellow X-gal solution was removed and re-fixed overnight in MEMFA. For 
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long term storage or for following in-situ hybridization embryos were transferred to 100 % 
ethanol. 
 
2.11 Histological analysis of Xenopus laevis tadpoles 
 
2.11.1 Embedding for Electron microscopy 
 
Embryos were fixed first for 30 min in MEMFA and afterwards in 6.25 % glutaraldehyde in 
0.1 M acodylate buffer overnight. The fixative was washed out by washing three times in 
Cacodylate buffer for 30 min each. To contrast the samples for electron microscopy, embryos 
were incubated in 1 % OsO4 in 0.1 M Cocadylate (pH 7.2) for 60-90 min while gently shaking. 
To avoid contamination of the embedding medium, the Osmium had to completely removed 
by several washes as well as overnight incubation in 0.1 M Cacodylate. If the medium was 
completely depleted of Osmium, embryos were embedded in 2.5 % Agar-Agar in small cryo-
mold forms or a small petri dish and trimmed to small square blocks to orientation of the 
embryos during embedding in Spurr’s resin. For the embedding in Spurr, embryos were first 
dehydrated in an ascending alcohol series (50%, 70% ethanol) for 30 min each and finally 
incubated in Dioxan for 45 min until the embryos sank down in the solution. Afterwards, 
embryos were infiltrated twice in a mixture of Spurr’s resin and Dioxan (1:1; 2:1) for 90 min 
each and then in pure Spurr overnight. The Spurr’s resign was replaced with fresh Spurr and 
incubated 5-8 h under constant stirring. For embedding, the in Spurr infiltrated embryos were 
transferred into embedding molds and embedded in Spurr for 16 h at 70 C.  
For histological analysis and electron microscopy, semi-thin as well as ultra-thin sections 
were prepared. For preparing 2 µm semi-thin sections, the embedded embryos were trimmed 
and sectioned using a LKB-Pyramitom and contrasted in a methylene blue solution at 70 °C 
for 2-3 minutes for following light microscopy. For electron microscopy, ultra-thin sections of 
50-80 nm thickness were prepared Ultracut microtome (Reichert). Therefore, the previously 
trimmed Spurr blocks containing the samples, were sectioned with diamond knifes and 
collected on Cu/Rh nets (75 x 300 stiches). The sections were then contrasted by incubating 
them first in lead acetate for 15 min and subsequently briefly rinsed in H2O bidest and 
incubated in uranyl acetate for 5 min. Afterwards, the nets were carefully washed two times 
in H2O bidest to remove residual uranyl acetate. 
 
2.11.2 Embedding for Vibratom sectioning 
 
For vibratom sectioning and following immunofluorescence procedures, embryos were 
injected with GFP as lineage tracer. Before embedding, embryos were sorted according to 
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their fluorescence and fixed in MEMFA or 8 % Paraformaldehyde overnight. Embryos were 
then either embedded in 4 % low melting agarose or in a gelatin/albumin mixture. For 
embedding in agarose, embryos were washed three times in 1x PBS to remove the fixature 
and then placed in cryomolds. After the agarose was carefully poured in the cryomolds 
(Tissue-Tek®Cryomold® Biopsie, 10x10x5mm), embryos were quickly oriented in the 
desired position using forceps. For embedding with gelatin/albumin, embryos were 
transferred to 25 % glutaraldehyde and placed cryomolds. Residual fluids were removed by 
pipetting. In a separate pan placed on ice, a 1/10 mixture of the gelantin/albumin and 25 % 
glutaraldehyde was prepared and immediately poured in the cryomolds containing the 
embryos. The formation of small air bubbles should be avoided during the embedding. 
Embryos were again oriented into the right position using a small pipette tip. Embedded 
embryos stored in a humid atmosphere at 4°C. Embedded embryos were then trimmed to 
square blocks and sections of 40-50 µm of thickness were prepared using the Leica Vt1000S 
vibratom and caught on a coated microscope slides (Roth). 
 
2.12 Immunofluorescence staining of Xenopus embryos 
 
For immunostaining, the probes were permeabilized in PBS containing 0.2 % TritonX for 10 
min and subsequently blocked in blocking buffer (1x PBS +1 % BSA) for one hour at room 
temperature. The first antibody was diluted in blocking solution and applied to the slides over 
night at 4°C. The following primary antibodies were used; GFP (Abcam, 278239, 1:1000). 
The antibodies were removed by washing three times in 1x PBS. Subsequently the probes 
were incubated with secondary antibodies diluted in blocking solution for 2 h at room 
temperature or overnight at 4°C. The following antibodies were used: anti-mouse Alexa 488 
(Invitrogen, A11029, 1:400), anti-rabbit Alexa 488 (A-21206, 1:400), Phalloidin-TRITC 
(Sigma-Aldrich (Merck), SLBG6854V, 1:250). Antibodies were removed by washing three 
times with 1x PBS and probes were mounted with fluorescence mounting medium (Dako, 
Deutschland GmbH, Hamburg, Germany). Immuno-stained sections were imaged with the 
Leica TCS SP5 microscope (40x oil objective). 
 
2.12.1 ..  Immunostaining of Vibratome sections 
 
All following steps were performed in a humid atmosphere. Samples were permeabilized in 
1x PBS containing 0.2 % TritonX for 10 min, by submerging the sections in the solution on 
the coated microscope slide. For blocking, the solution was removed, the sections rinsed 
three times in 1x PBS and then blocked in 1x PBS containing 1 % BSA for 1 hour at room 
temperature. Meanwhile, first antibody was diluted in blocking solution and then applied to 
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the slices over night at 4 °C. The antibody was removed by washing three times with 1x PBS 
for 5 min each and then replaced with the secondary antibody, diluted in blocking solution. 
Incubation occurred for at least 2 h at room temperature or overnight at 4°C. Antibody was 
removed by three washing steps with 1x PBS and slices were mounted with fluorescence 
mounting medium (Dako, Deutschland GmbH, Hamburg, Germany). Immunostained 
sections were imaged with the Leica TCS SP5 microscope (40x oil objective). 
 
2.12.2 .. Whole mount Immunofluorescence staining 
 
For the following procedure embryos were fixed in in ice-cold Dents over-night at 4°C. 
Embryos were rehydrated in 1x PBS and photo-bleached in 2% H2O2 in 1x PBS for 4-5h 
under a light source. Afterwards, the bleaching solution was removed by rinsing with PBS-
TD and washed twice in 50 mM sodium acetate buffer (pH 6) for 5 min each. Following, 
embryos were permeabilized with 1 mg/ml bovine testicular hyaluronidase (Sigma, 
SLBH0986V) in 50 mM sodium acetate buffer (pH 6,0) for 45 min at room temperature. 
Embryos were again washed twice in PBS-TD and then blocked in PBS-TD containing 0.1 M 
glycine, 2 % nonfat dried milk, and 5 % FBS at room temperature. Primary antibody was 
diluted in blocking solution and applied to the embryos overnight at 4 °C. Antibody was 
removed and embryos washed six times in PBS-TD for one hour each and then incubated in 
secondary antibody overnight at 4 °C. Embryos were washed six times for one hour each in 
PBS-TD at room temperature and then re-fixated in Dents overnight.  
As Xenopus embryos are opaque, they have to be cleared for imaging. To this end embryos 
were thoroughly dehydrated two times in 100 % ethanol and cleared in Benzyl-
alcohol/Benzyl-Benzoate (Sigma Aldrich) (BA/BB; 1:2) for 10 min in a glass bowl until all 
embryos sank down. For imaging BA/BB was replaced with fresh BA/BB. 
Embryos were imaged using the Zeiss Spinning Disc system (Axio Observer Z1 with a 25x 
or 40x water objective) or a fluorescence stereo-microscope (Leica, M165-FC). 
 
2.13 Whole mount in situ hybridization 
 
The whole mount in situ hybridization protocol was adapted from standard protocols (Harland 
1991). All embryos were fixed in MEMFA overnight and then stored in 100 % ethanol prior to 




Embryos were rehydrated in a descending ethanol series according to table 7  
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Table 12: Rehydration of embryos 
Solution Incubation time 
100 % ethanol 5 min 
75 % ethanol in H2O 5 min 
50 % ethanol in H2O 5 min 
25 % ethanol in H2O  5 min 
1x PTw 4 x 5 min 
 
Proteinase K treatment 
 
The accessibility of the RNA to the tissue was facilitated by the treatment of the embryos with 
proteinase K (0.5 µl proteinase K / 1 ml PTw). Thereby the incubation time and temperature 
have to be adjusted to the developmental stage of the embryos as indicated in table 13. 
 
Table 13: Proteinase K treatment 
Developmental stage  Incubation time (min) Temperature 
9 - 10.5 5 room temperature 
14 - 16 7 - 8 room temperature 
20 - 25 7 - 8 room temperature 
36 7 - 8 room temperature 




To avoid increased background of the staining, unspecific binding sites of the RNA probes 
has to be blocked. To this end embryos were treated with acetic anhydride (AA) and 
subsequently re-fixed in 4 % formaldehyde as described in table 14 
 
Table 14: Aceltylation 
Solution Incubation time 
4 ml 0,1 M TEA 2x; 5 min 
4 ml 0,1 M TEA +12.5 µl AA 5 min 
+ 12.5 µ AA 5 min 
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Solution Incubation time 
4 ml 1x PTw 2x; 5 min 
2 ml 4 % formaldehyde in PTw 20 min 




After the last washing step, 1 ml PTW as well as the same amount of HybMix was added to 
the embryos and incubated for 10 min at 65°C in a shaking water bath. The solution was 
replaced by 1 to 2 ml fresh HybMix and incubated for at least 4 h at 65°C. For the 
hybridization, the HybMix was completely removed and immediately replaced by the 




The unbound RNA probe was removed, by several washing steps as well as RNase A/RNase 
T1 (1:10000) treatment as described in table 15. 
 
Table 15: Washing and RNase treatment 
Buffer Incubation time Temerpature 
HybMix 1x 10 min 65°C 
2x SSC 3x 15 min 65°C 
2x SSC/RNase 1x; 60 min 37°C 
2x SSC 1x; 5 min room temperature 
0.2x SSC 2x; 30 min 65°C 




Unspecific binding sites were blocked by the incubation of the embryos in 2% BMB and 20 
% horse serum. An alkaline phosphatase-coupled anti-Dig labelled antibody was used to 
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MAB/ 2 % BMB 15 min room temperature 
MAB/ 2 % BMB/ 20 % horse serum 40 min room temperature 
MAB/ 2 % BMB/ 20 % horse 
serum/ 1:5000 α-DIG antibody 
4 h room temperature 
MAB 3x 10 min room temperature 
MAB overnight 4°C 
 
Staining reaction  
 
Unbound antibody was removed by several washing steps in MAB and then staining reaction 
was initiated by the incubation in the substrates BCIP (5-Bromo-4-chloro-3-indolyl 
phosphate) and NBT (Nitro blue tetrazolium chloride) as described in table 17. If a strong 
blue staining was visible, reaction was attenuated by rinsing the embryos in MAB and re-
fixation in MEMFA overnight at 4°C.  
In case of a strong background, embryos were incubated in a descending series of methanol 
prior fixation, as described in table 18. 
 
Table 17: Washing and staining reaction 
Solution Incubation Time 
MAB 5x 5 min 
fresh APB 2x 5 min 
APB/NBT/BCIP Up to 3 days at 4°C 
 
Table 18: Reduction of background /optional 
Solution Incubation time 
100 % MeOH 1 min 
75 % MeOH in 25 % H2O 1 min 
50 % MeOH in 50 % H2O 1 min 
25 % MeOH in 75 % H2O 1 min 
MEMFA 15 min 
MEMFA overnight at 4°C 
 




If the pigmentation of the embryos interferes with the in situ signal, embryos were bleached 
in H2O2 as described in Table 19. 
Table 19: Bleaching /optional 
Solution Incubation time 
PTw 3x;10 min 
0.5x SSC 2x; 5 min 
bleaching solution 20 - 40 min on a light source 
1x PBS 3x; 5 min 
MEMFA overnight at 4°C 
 
  




3.1 Knockdown of Cav1α results in morphological abnormalities 
 
Although it has already been shown that the knockdown of Cav1α expression in Xenopus 
embryos leads to swimming defects (Berger, 2016), the underlaying mechanism causing this 
defect has not yet been analyzed. For this purpose, knockdown studies were carried out to 
assess the role of Cav1α during early development and its function in the locomotor system 
of Xenopus embryos.  
In Xenopus the full length caveolin 1 gene is encoded on the L-(long) chromosome and is 
composed of three exons (E) (Figure 17A): E1. The first 30 bp exon containing the translation 
start site of the α-isoform. E2. The 171 bp second exon containing the tyrosine (Y14) 
phosphorylation site as well as the translation start site for the β-isoform. E3. The 342 bp 
third exon encoding the oligomerization, scaffolding and transmembrane domain and the 
serine (S80) phosphorylation site of the caveolin 1 protein (Figure 17A, B). For the loss-of-
function experiments in this study, two different types of Morpholinos were used: a 
translation-blocking morpholino (Cav1α MO) that specifically binds the first 8 base pairs of 
the ATG region of the endogenous cav1α RNA (Figure 17B, red dashed box) and a Splice-
blocking Morpholino (Cav1α-Splice MO), which specifically targets the second exon-intron 
boundary of the cav1α pre-mRNA (Figure 17B, blue dashed box). Injection of the Cav1α-Spl 
Morpholino ideally results in an aberrant spliced RNA and in the translation of a non-
functional protein as shown in Figure 17B. Both Morpholinos were tested for their efficiency 
in vivo by Western blot analysis (Figure 17D-E) and by amplification of the cDNA from 
morphant embryos via reverse transcription-polymerase chain reaction (RT-PCR) (Figure 
17C). To this end the Morpholinos were injected into one-cell stage embryos at a 
concentration of 20 ng in combination with mGFP RNA as a lineage tracer. Expression of 
cav1 was analyzed in stage 20 (RT-PCR) and stage 30 (Western blot) embryos, respectively. 
Embryos injected with 20 ng Co MO served as a control.  
The amplification of cav1 from a cDNA prepared from Cav1α-Splice morphant embryos 
showed a shorter transcript variant (2) with an approximate size of 370 bp in addition to the 
full-length cav1 RNA (1) (Figure 17C). Sequence analysis of this transcript variant by Sanger 
sequencing confirmed that the injection of the Cav1α-Spl MO leads to the exclusion of exon 
2 as predicted in Figure 17B. Uninjected control embryos and embryos injected with Co MO 
served as controls and both showed the wild-type cav1 transcript of approximately 540 bp 
(Figure 17C). In all conditions an additional band of 300 pb was amplified, however the 
identity of this transcript is still unknown.  
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Western blot analysis verified that both Morpholinos (Cav1α MO and Cav1α-Spl MO) 
efficiently knocked down the endogenous Cav1 protein (Figure 17D-E). To detect the Cav1 
protein (20-22 kDa), a monoclonal antibody was used that specifically recognizes the Cav1α 
isoform. The Cav1α expression level was determined in relation to GAPDH expression and 
normalized to Co MO-injected embryos. Convincingly, injection of either Cav1α MO or 
Cav1α-Spl MO significantly reduced endogenous Cav1 protein levels in Xenopus embryos 
(Figure 17D-E). In comparison to controls, the Cav1 protein level was reduced by 
approximately 50 % in the presence of the Cav1α MO and by 70 % in the presence of the 
Cav1α-Spl MO (Figure 17D-E). 
 
To analyze the morphological consequence of the Cav1α knockdown, the Cav1α 
Morpholinos were injected unilaterally at a concentration of 20 ng into two-cell stage embryos. 
As control, a 5 mismatch Cav1α MO (Cav1α-5mis MO) was injected at the same 
concentration and co-injection of 80 pg GFP served as a lineage tracer. Embryos injected 
with either the splice-blocking Morpholino or the translation-blocking Morpholino are both 
referred to as Cav1α morphants. While control embryos showed a wild-type phenotype 
(Figure 17F), Cav1 morphant embryos displayed mild morphological abnormalities such as 
a shortening of the body axis, craniofacial malformations and edema formation in the heart 
region (Figure 17G-H). These phenotypes were more pronounced in embryos injected with 
the splice blocking Morpholino, which is consistent with the results obtained by western 
blotting (Figure 17D-E). Interestingly, although the loss-of-function of Cav1α causes 
morphological abnormalities in Xenopus embryos, no significant effects on the mortality of 
these embryos were observed, indicating that Cav1α expression is not essential for the 
viability of these embryos (data not shown).  
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Figure 17: The knockdown of Cav1α leads to morphological abnormalities in Xenopus. 
A Schematic of the Cav1α gene organization. Xenopus Cav1α consists of 3 coding Exons (E) encoding 
for the Cav1α translation start side, the tyrosine (Y14) phosphorylation site and Cav1β translation start 
site. B Schematic of the Morpholino design: The translation blocking MO (Cav1α MO, red dashed box) 
binds to the 5’ end ATG region of the endogenous cav1α RNA and the splice blocking MO (Cav1α-Spl 
MO, blue dashed box) the non-coding region of the second intron, directly at the exon 2/ intron 2 
boundary. Different splicing outcomes are shown: (1) A correctly spliced wild-type transcript of approx. 
543 bp or (2) a deletion of the exon 2 resulting in a truncated transcript of approx. 372 bp in size. C 
The functionality of the Cav1α-Spl MO was tested on lysates of embryos injected with 20 ng of either 
the Spl-MO or a 5 base pair mismatch Morpholino by RT-PCR at stage 20. The primer combination 
indicated by green arrows in B was used. The gel electrophoresis shows the predicted results indicated 
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in A. D, E Cav1α MO and the Cav1α-Spl MO inhibit the expression of Xenopus Cav1α protein. D 
Xenopus embryos were injected with 20 ng MO at the one cell stage and Cav1α and GAPDH 
expression was analyzed by Western blotting at stage 27. E Graph summarizing the relative Cav1α 
expression determined in relation to GAPDH expression and normalized to Co MO injected embryos. 
Data from four experiments are presented as the ± S.E.M. ***p-value ≤ 0.001. F-H Xenopus embryos 
were injected with 20 ng MO and mGFP RNA in one blastomere at the two-cell stage and analyzed at 
stage 42: injected (F-G) and uninjected side (F’-H’) as well as a dorsal view (* marks injected side) of 
each embryo are shown. Injection of the Cav1α or Cav1α-Spl MO leads to craniofacial malformations 
and edema formation (arrowhead). 
 
3.2 Loss of Cav1α expression affects embryonic mobility and muscular integrity 
 
Knockdown of Cav1α leads to relatively mild morphological abnormalities in the morphant 
embryos. The most noticeable phenotype observed in these embryos, however, was a 
striking swimming defect, as described in previous studies (Berger, 2016, PhD; Breuer, 2016, 
M.Sc.). Morphant embryos, injected with the translation blocking Morpholino (Cav1α MO) 
showed a characteristic circular swimming behavior, caused by the paralysis of the injected 
side (Supplementary Movie 2). In order to confirm that this defect is specially caused by 
Cav1α knockdown, the swimming behavior of embryos injected with 20 ng Cav1α-Spl MO 
was analyzed and compared to those of Cav1α morphant embryos. Injection of Co MO at the 
same concentration served as control. mGFP RNA was co-injected as a lineage tracer at the 
concentration of 80 pg. Similar to embryos injected with the Cav1α MO, the injection of the 
Cav1α-Spl MO caused severe swimming defects (Figure 18C, Supplementary Movie 3). 
While control embryos showed a normal swimming behavior (Supplementary Movie 1, 4), 
Cav1α morphant embryos moved in circles when injected unilaterally (Supplementary Movie 
2-3), or were completely paralyzed when injected into both blastomeres at the two-cell stage 
(Supplementary Movie 5). For the quantification of the swimming defects, a distinction was 
made between mild and severe defects. The swimming behavior was counted as normal, if 
unilaterally injected embryos were able to move their tail in both directions. In contrast, the 
phenotype was considered mild, if the embryo could still move forward but showed a visible 
impairment of its swimming behavior. If the embryos were completely paralyzed on the 
injected side and were unable to move forward, this was considered a severe swimming 
defect. The percentage of embryos with swimming defects was significantly increased in 
embryos injected with the Cav1α MO (10 % ±4 % mild; 87% ±4 % severe) or Cav1α-Spl MO 
(13 % ±4 % mild; 76% ±7 % severe) in comparison to control embryos (1 % ±0 % mild) (Figure 
18C). In addition, rescue experiments were carried out to verify that the swimming defects 
are specifically caused by Cav1α knockdown and not due to off-target effects. For the 
following rescue experiments 10 ng Morpholino was injected into one blastomere of two cell 
stage embryos in combination with the respective cav1α RNA and 80 pg mGFP RNA. The 
specificity of the translation blocking morpholino was previously verified by the partial rescue 
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of swimming defects by the dose-dependent co-injection of a caveolin 1α-rescue construct 
(Berger, 2016, PhD; Breuer, 2016, M.Sc.). In this construct, the morpholino binding site is 
deleted, thereby preventing the morpholino from binding to the caveolin 1 rescue RNA 
(Berger, 2016, PhD; Breuer, 2016, M.Sc.) (Figure 18D). Co-Injection of 300 pg Cav1α-res 
RNA significantly improved the swimming behavior by 50 % (35% ±4%) in relation to injection 
of the Cav1α MO alone (70% ±7%) (Figure 18D). Similarly, the co-injection of 200 pg wild-
type cav1α RNA could also significantly rescue the severity of the swimming defects in the 
Cav1α-Spl morphant embryos (Figure 18E). In this case the swimming defects per embryo 
were improved from 76% (36% ±4% mild; 40% ±5% severe) in the Cav1α splice morphants 
to 47% (34% ±4% mild; 13% ±4% severe) upon co-expression of cav1α RNA. This confirms 
that the swimming defects are specifically caused by Cav1α loss of function. 
 
Impaired embryonic mobility can be caused by defects in muscular as well as neuromuscular 
development. It has been previously shown by phalloidin staining that the depletion of Cav1α 
expression leads to severe muscle defects (Berger, 2016, PhD; Breuer, 2016, M.Sc.). To 
verify, that the injection of the splice Morpholino causes similar muscular defects, muscular 
actin was stained in embryos that were injected unilaterally with 20 ng Cav1α MO or Cav1α-
Spl MO, respectively. mGFP was co-injected as a lineage tracer and Phalloidin was used to 
stain the actin cytoskeleton of the embryos (Figure 18F-H). As previously shown, the 
knockdown of Cav1α expression in morphant embryos led to a drastic loss of muscular 
integrity (Figure 18G-H). While control embryos and the non-injected side of the Cav 1α 
morphants showed a highly organized muscular actin cytoskeleton, muscle cells of Cav1α 
morphant embryos contained highly disorganized and wavy actin fibers. Injection of the 
Cav1α MO or Cav1α-Spl MO likewise caused these defects (Figure 18G-H). In comparison 
to morphant embryos injected with the translation blocking Morpholino, the phenotype was 
more severe in the splice blocking morphant embryos. Here, the actin signal was severely 
reduced and the nuclei of the muscle cells were misaligned, indicating that injection of the 
splice blocking Morpholino also severely affected muscular integrity (Figure 18H).  
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Figure 18: Cav1α loss-of-function causes swimming defects and severely affects sarcomeric 
organization of the muscles.  
A-B Tracks of the swimming movement in a time frame of 4 sec are shown. Co MO embryos moved 
rapidly away after a tactile stimulus (A), while Cav1α morphants responded with a circling and tumbling 
behavior (B); (modified after Breuer, 2016, M.Sc.). C Graph summarizing the percentage of mild (light 
grey) or severe (dark grey) swimming defects of embryos unilaterally injected with 20 ng Co MO, 
Cav1α MO or Cav1α-Spl MO. Data from six independent experiments are presented as the mean ± 
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S.E.M. ***p-value ≤ 0.001. Number of analyzed embryos are shown above each column. D Graph 
summarizing the percentage of swimming defects of embryos unilaterally injected with Co MO or 
Cav1α MO (5 - 7.5ng) alone or in combination with res-cav1α RNA (+= 100 pg, ++= 200 pg, +++= 300 
pg), a cav1 construct lacking the MO binding side; ± S.E.M. and number of injected embryos of five 
independent experiments are shown for each column (modified after Breuer, 2016, M.Sc.) E Graph 
summarizing the percentage of swimming defects of embryos injected with Co MO or Cav1α-Spl MO 
(10 ng) in combination with full-length cav1α-HA (200 pg) RNA of six independent experiments; ± 
S.E.M and number of injected embryos are shown for each column. Significance of the total number 
of swimming defects was calculated by using the Student’s t-test and ordinary one-way ANOVA. * p-
value < 0.05; **p-value < 0.01; ***p-value < 0.001. F-H Muscle morphology of Co MO, Cav1α MO or 
Cav1α-Spl MO (20ng) injected embryos analyzed at stage 37, injected side is marked by an asterisk. 
Phalloidin (red) staining visualizes sarcomeric actin; DAPI staining (blue) marks the nuclei. Higher 
magnification of the boxed areas is shown in F’-H’. Controls (F-F’) show normal actin organization, 
while morphants (G-H’) display wavy and disorganized actin fibers. Nc = notochord 
 
3.3 Knockdown of Cav1α impairs convergent extension during gastrulation 
 
Loss of Cav1α expression in Xenopus embryos leads to a shortening of the body axis. 
Impaired axis elongation can be caused either by defects during convergent extension (CE) 
movements or impaired notochord stability. It has recently been shown that Cav1 is involved 
in the convergent extension process by mediating the endocytosis of Wnt5a / RhoA during 
gastrulation (Puzik et al., 2019). On the other hand, the loss of caveolae formation in the 
zebrafish notochord leads to the mechanically induced collapse of notochord cells, which 
also results in a shortening of the body length (Lim et al., 2017). In order to investigate which 
of these two processes affects the Cav1α morphant body length, first the notochord was 
examined by histological analyzes (Figure 19A-B). In addition, in situ hybridization against 
the neural border specifier Pax3 was carried out to test for convergent extension defects 
(Figure 19C-F). 
Histological and electron microscopic analyzes were carried out to assess whether Cav1 
knockdown affects the notochord integrity and the formation of caveolae in this structure( 
Figure 19A-B). To this end, embryos were injected into both blastomeres with 10 ng Cav1α 
MO or Co MO in combination with GFP as a lineage tracer. Similar to control embryos (Figure 
19A), the notochord of the Cav1α morphant embryos contained highly vacuolated cells with 
no apparent cellular damage (Figure 19A-B). However, the Cav1α morphant notochord 
appeared broarder in its diameter in comparison to control embryos. While the majority of the 
vacuolated cells are aligned in two rows within the notochord of control embryos (Figure 19A), 
notochord cells of the morphants failed to intercalate properly, which is likely due to impaired 
convergent extension (Figure 19B).  
To verify that Cav1α knockdown results in impaired convergent extension in morphant 
embryos, pax3 expression was analyzed in embryos injected unilaterally with 20 ng Cav1α 
MO or Co MO in combination with LacZ RNA as a lineage tracer (Figure 19-F). While pax3 
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expression was restricted to the neural plate border in control embryos (Figure 19C-D), it was 
significantly expanded on the injected side in 66% ±5 % of the Cav1α morphant embryos 
(Figure 19E-F) implying indeed a deficiency in convergent extension.  
In summary, Cav1α functions in convergent extension movements during early development 
of Xenopus embryos, thereby likely affecting the notochord morphology. Caveolae could still 
be detected in the Cav1α morphant notochord, indicating that other caveolin proteins likely 
compensate for the loss of Cav1α expression in this tissue. 
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Figure 19: Convergent extension is disrupted by Cav1α loss-of-function. 
A-B Histological (A-B) as well electron microscopic (A’-B’) analysis of the notochord from embryos 
injected with 12 ng MO in each blastomere of two cell stage embryos. A Histological section of a Co 
MO embryo. A’ Electron microscopic picture of a Co MO notochord. Caveolae are marked with white 
arrowheads. Red dashed box shows a magnified area from E. VC = vacuolated cell, SC= sheath cell. 
B Histological section of a Cav1α morphant notochord. Asterisk within the notochord mark incorrectly 
intercalated cells. B’ Electron microscopic picture of a Cav1α morphant notochord. Caveolae are 
marked with white arrowheads. Red dashed box shows a magnified area from F. VC = vacuolated cell, 
SC= sheath cell. Scale bar = 0.5 µm C-F pax3 expression was analyzed in stage 18 control embryos 
or embryos injected with 20 ng MO in combination with 75 pg LacZ RNA as lineage tracer. Dorsal (A-
C) as well as posterior view (A’-C’) is shown. Asterisk marks the injected site C-D’ pax3 is expressed 
in the anterior neural fold and neural plate border in control embryos (C-C’) and embryos injected with 
Co MO (D-D’). E-E’ Cav1α knockdown leads to an expansion of the pax3 expression domain on the 
injected side. F Graph showing the percentage of embryos with expanded pax 3 expression. Data from 
three experiments are presented as the mean ± S.E.M. ***p-value ≤ 0.001. Significance was calculated 
by using the student’s t-test.  
 
3.4 Knockdown of Cav1α results in morphological abnormalities 
 
Knockdown of Cav1α causes morphological abnormalities, including craniofacial 
malformations and edema formation (Figure 17G-H). As craniofacial abnormalities are often 
caused by defective cartilage formation, stage 43 morphants embryos were stained for 
collagen to visualize the cartilage of these embryos. The cartilage in Xenopus embryos is 
subdivided into the neural crest derived Meckel’s and Quadrate (Me), Ceratoyal (Ce) and 
Branchial/Gill (Br) cartilage as well as the mesodermal-derived Infrarostral (In) and Basihyal 
(Ba) cartilage (Figure 20D-E) (Gross and Hanken, 2008). In comparison to control embryos 
(Figure 20D-E), which showed normal craniofacial structures, 50% ±14% of the Cav1α MO 
and 87% ±0 % of the Cav1α-Splice MO injected embryos showed severely reduced cartilage 
structures on the injected side (Figure 20F-G). Interestingly, knockdown of Cav1α lead to a 
severe reduction of the neural crest-derived Meckel’s and Quadrate (Me), Ceratoyal (Ce) as 
well as Branchial/Gill (Br) cartilage while the mesodermal-derived Infrarostral (In) as well as 
Basihyal (Ba) cartilages were unaffected (Figure 20F-G). These findings indicate that Cav1α 
may have a function in neural crest development as the knockdown of Cav1α expression 
leads to the loss of the neural crest-derived cartilage.  
 
Edema in Xenopus laevis embryos are often caused by defects in pronephros development 
as the pronephros has an important function in osmoregulation (Nieuwkoop and Faber, 
1994). In order to analyse whether the edema in the Cav1α morphants is caused by defective 
kidney development, the embryonic pronephros was stained by whole mount 
immunofluorescence staining. β-Dystroglycan is highly expressed in the developing 
pronephros and was therefore used as a marker (Figure 20K-M). The Xenopus pronephric 
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kidney can be subdivided into four tubular parts: the proximal tubule, the intermediate tubule, 
the distal tubule and the connecting tubule (Figure 20K). Embryos unilaterally injected with 
the Cav1α MO, which causes mild edema formation, showed a strong reduction of the 
proximal tubule size (Figure 20M’) in comparison to the uninjected side (Figure 20M). In 
contrast, Cav1α-Spl morphant embryos displayed a severely malformed proximal, 
intermediate and distal tubule. The connecting tubule was not connected to the distal tubule 
in these embryos (Figure 20N’). The uninjected site as well as embryos injected with a Co 
MO showed a normal pronephric morphology (Figure 20L, N). These results suggest that 
Cav1α may act in kidney development in Xenopus embryos and that misexpression of Cav1α 
results in defects in pronephros formation. However, more experiments have to be conducted 
to verify this observation.  
 
Figure 20: Knockdown of Cav1α leads to mild morphological abnormalities. 
D-G Cartilage of stage 43 embryos injected unilateral with 20 ng MO was immuno-stained with anti-
collagen. Asterisk marks the injected side. D control and E Co MO injected embryos are shown. E = 
Results  70 
 
eye F-G Severely reduced cartilage in embryos injected with Cav1α MO (F) or Cav1α-Spl MO (G). H 
Schematic of the cartilage structures of control embryos. In= infrarostral, Me= meckel’s and quadrate, 
Ce = ceratoyal, Ba = basihyal, Br = branchial/gill cartilage. I Schematic view of the cartilage structures 
of Cav1α morphants. J Graph summarizing the percentage of embryos with cartilage defects. Data 
from three experiments are presented as the mean ± S.E.M. ***p-value ≤ 0.001. Significance was 
calculated using a Student’s t-test. For the Cav1α MO experiment only two experiments are shown as 
± S.E. K Schematic view of a Xenopus pronephros, pt = proximal tubule, it = intermediate tubule, dt = 
distal tubule, ct = connecting tubule. L-N Pronephros of stage 40 control (L) and morphant embryos 
(M-N) was stained with anti-β-Dystroglycan. Embryos were unilaterally injected with 20 ng MO and 80 
pg mGFP RNA. Uninjected (L-N) and injected (L’-N’) site is shown. L-L’ normal pronephros 
morphology Co MO injected embryos. M-M’ reduced proximal tubule on the injected site of Cav1α MO 
injected embryos (M’) in comparison to the uninjected site (M). N-N’ severely malformed proximal, 
intermediate and distal tubule on the injected site of Cav1α-Spl MO injected embryos (N’). The number 
of embryos displaying a phenotype and the total number of analyzed embryos is shown. 
 
3.5 Cav1 is predominantly expressed in the notochord and motoneurons 
 
The data shown above indicate that Cav1α plays an important role in the maintenance of 
muscle integrity and, moreover, embryonic mobility during early Xenopus development. In 
order to understand how Cav1α functions in the locomotor system, the expression profile of 
cav1α during the embryogenesis of Xenopus laevis was analyzed by reverse transcriptase 
PCR, whole mount in situ hybridization as well as immunofluorescence staining (Figure 21; 
Figure 22; Figure 23). Reverse transcriptase PCR showed that cav1 is maternally expressed 
in oocytes, in embryos of the early cleavage stages (2-4 cell) and also at low levels during 
gastrulation. Zygotic expression increased during neurulation, with the highest expression 
occurring in stage 28 and decreasing again from tadpole stage 30 (Figure 21A).  
In situ hybridization revealed that cav1 is highly expressed in the presumptive notochord and 
the epidermis from the early neurula stage 12.5 onwards (Figure 21B-K). Additionally, cav1 
expression could be found in the neuroectoderm as a thin stripe on both sites of the 
embryonic midline (Figure 21B-E). Transverse sections of these embryos demonstrated that 
cav1 expression localizes in the sensory layer (sl) of the epidermis, the notochord (nc) as 
well as in the superficial/ epithelial layer of the neural plate (Figure 22A-D). Interestingly, at 
stage 18 cav1 localizes at the most dorsal part of the neural folds, but no expression was 
detected once the neural tube is completely closed (Figure 22C, D). In contrast, cav1 remains 
expressed in the notochord and the epidermis during older embryonic stages (Figure 21; 
Figure 22D). To analyze if this staining in the neural tube coincides with primary neurons, 
double in situ hybridization using the neuronal marker neuronal tubulin (n-tubulin, beta 
tubulin) was performed. N-tubulin is expressed in three distinct stripes within the deep or 
sensorial layer of the neural ectoderm. These represent the precursors of motoneurons (m), 
the interneurons (i) as well as the sensory neurons (s), located from medial to distal. Cav1, 
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which is expressed in the epithelial layer of the neuro-ectoderm, showed no co-expression 
with n-tubulin in primary neurons (Figure 21G).  
At older developmental stages (37-43) cav1 is also expressed in the heart as well as the 
vasculature of the branchial arches (aortic arches) and the tail. Specifically, staining was 
detected in the intersomitic veins (isv), the lymph heart (lh), the posterior cardinal vein (pcv) 
and the dorsal longitudinal anastomosing vessels (dlav) (Figure 21I-K; Figure 22-K). 
Moreover, a strong signal for cav1 expression was also found in the developing lung (Figure 
21J, J’). Longitudinal sectioning of stage 43 embryos showed a rather ubiquitous staining of 
cav1 mRNA in the embryo, with a prominent expression in the epidermis (ep), the developing 
lung (lg) and the aortic arches (aa) and the heart (h) (Figure 22G-J). Transverse sections of 
a stage 43 embryo confirmed cav1 staining in the developing lung (lg) (Figure 22K-M). In situ 
hybridization using a cav1 sense probe showed no specific staining (Figure 21L-O).  
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Figure 21: Cav1α is expressed in the notochord during Xenopus development. 
A Temporal cav1α expression was analyzed by reverse transcriptase PCR at different developmental 
stages. H4 was used as a loading control. B Dorsal view of a stage 12.5 embryo. cav1α expression in 
the notochord (nc) and at two thin stripes on both sides at the dorsal midline is shown. C Dorsal view 
of an embryo at stage 15. Cav1α expression is visible in the notochord (nc) and in a punctuated pattern 
in the skin. D Stage 18 embryo showing the same expression pattern as described in C E-H Cav1 
expression is visible in the epidermis and around the eye of stage 20 (E), stage 23 (F), stage 26 (G) 
and stage 28 (H) embryos. I Stage 37 embryo. Cav1 expression is visible in the notochord (nc), 
epidermis and aortic arches (aa). J Stage 41 embryo. Cav1 expression in the notochord (nc), and the 
cardio-vasculature of the tail (dlav, pcv, isv). I’ Magnification of the embryo shown in I. Cav1 is 
expressed in the aortic arches (aa). J’ Magnification of the embryo shown in J. Cav1 is expressed in 
the lung (lg), lymph heart (lh) and aortic arches (aa). K Stage 43 embryo. Cav1 expression is shown 
in the cardio-vasculature of the tail (dlav, pcv, isv) and epidermis. L-O’ Cav1 sense probe in situ 
hybridization. L Embryos at stage 18. M Embryo at stage 28. N Embryo at stage 37. N’ Magnification 
of the embryo shown in N. O Embryo at stage 42. O’ Magnification of the embryo shown in O.  
 
Figure 22: Cav1α is strongly expressed in the notochord, cardio-vasculature and lung during 
Xenopus development. 
A-E Transverse sections of stage 12- 28 embryos shown in fig.5 A-B Stage 12.5 (A) and 15 (B) 
embryo: cav1α expression is located in the notochord (nc), and in the outer layer of the neural plate 
(np) at both sides of the midline. C Stage 18 embryo: cav1α expression is located in the notochord 
(nc), inner/deep layer (dl) of the epidermis and in the outer layer of the neural plate (np) at both sides 
of the midline (arrow). sl = sensory layer. D Stage 23 embryo: cav1α is expressed in the notochord 
(nc) and deep layer of the epidermis. E Schematic view of the expression profile of cav1α (violet) in a 
stage 12.5 embryo. cav1α (violet) can be found in the notochord, deep layer of the epidermis and 
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neural plate. Psm = paraxial mesoderm, np = neural plate, nc = notochord, sl= sensory layer, dl= deep 
layer. F Transverse section of a stage 15 embryo stained for n-tubulin (red) and cav1α (blue) 
expression. N-tubulin is expressed in three domains in the deep layer of the neural tube. m = medial 
domain, I = intermedial domain, l = lateral domain. G-N longitudinal (G-J) and transverse (K-N) sections 
of a stage 43 embryo stained for cav1α expression. G-K Schematic representation of the cutting 
position (red line). G’-N’ cav1α is expressed in the epidermis (ep), lung (lg), aortic arches (aa) and the 
heart (h). Abbreviations: e= eye, nc= notochord, nt= neural tube, so= somite, cg= cement gland. 
 
To validate the in situ expression pattern, Cav1 protein expression was analyzed by whole 
mount immunofluorescence using a polyclonal Cav1 antibody (Figure 23). In agreement with 
the results gained by in situ hybridization, Cav1 is expressed in the sensory layer of the 
epidermis as well as the notochord in Xenopus tadpoles (Figure 23K, D, J). Furthermore, 
Cav1 expression could also be detected in the developing lung (lg) (Figure 23D, F’) and the 
vasculature in stage 42 embryos (Figure 23F, G, I). This includes the posterior cardinal vein 
(pcv), the dorsal longitudinal anastomosing vessels (dlav) of the tail and in the aortic arches 
(aa) of the branchial arches (Figure 23F, G, I). Interestingly, in contrast to the in situ 
hybridization, staining Cav1 protein was also detected in cranial nerves as well as spinal 
motoneurons (Figure 23A-H). Transverse sections of stage 35 embryos verified that Cav1 is 
expressed in the neuronal cells of the spinal cord, the notochord and the sensorial epidermal 
cells (Figure 23J-L). No expression of Cav1 could be detected in the musculature neither by 
in situ hybridization nor by immunofluorescence staining, indicating that Cav1 likely functions 
in the neuronal circuits controlling muscular function.  
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Figure 23: Cav1 is strongly expressed in the notochord and the nervous system during 
Xenopus development. 
A Immunostaining of a stage 35 embryo showing Cav1 protein expression in the notochord and the 
cranial nerves (Vop= ophthalmic trigeminal ganglion, Vmd= mandibular trigeminal ganglion). B Dorsal 
view of a stage 35 embryo. Cav1 expression is visible in the cell bodies of the cranial nerve located in 
the brain C Stage 37 embryo. Cav1 is expressed in the notochord as well as the cranial nerves. D 
Stage 42 embryo showing Cav1 expression in the notochord neural tube, lung and cardio vasculature 
of the tail. E Dorsal view of the embryo shown in D. Cav1 is expressed in the cranial nerves. F 
Magnification of the embryo shown in D. Cav1 is expressed in the cranial nerves, aortic arches and 
the lymph heart. F’ Magnification of embryo shown in F showing Cav1 expression in the lung G ventral 
view of the embryo shown in F. Cav1 staining is visible in the heart, aortic arches and cranial nerves. 
H Tail of a stage 42 embryos showing Cav1 expression in the notochord, neural tube as well as the 
axons of the motor neurons. I Tail of a stage 42 embryos showing Cav1 expression in the cardio 
vasculature of the tail. J Transverse section of the hindbrain of a stage 37 embryo showing Cav1 
expression in red and DAPI staining in blue. Cav1 is expressed in neurons and the notochord. K 
Magnification of the epidermis of a stage 37 embryo. Cav1 is expressed in the inner layer of the 
epidermis. L Transverse section of the neural tube of a stage 37 embryo showing cav1 expression in 
the neural tube and notochord. Abbreviations: aa= aortic arches, Dlav = dorsal longitudinal 
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anastomosis vessel, ep = epidermis, h = heart, il = inner layer of the epidermis, Isv/Isa= intersomitic 
vessels/artery; lh = lymph heart, lg =lung, mn = motor neurons, nc = notochord, nt =notochord, Pcv = 
posterior cardinal vain, so= somites, sl= sensory layer of the epidermis, VII= facial nerve, IX= 
glossopharyngeal nerve, X= vagus nerve. 
 
As the Cav1 antibody both recognize the Cav1α and the β-isoform, the specificity of the 
Cav1α expression was analyzed by whole mount immunofluorescence staining on embryos 
injected with either 12 ng Co MO or Cav1α MO in both blastomere of two-cell stage embryos 
(Figure 24). The relative signal intensity of the Cav1 staining was determined in relation to 
the DAPI signal and normalized against Co MO-injected embryos. Knockdown of Cav1α 
visibly reduced the Cav1 signal in the morphant embryos in comparison to control embryos 
(Figure 24A-B). Quantification of the signal intensity showed, that the Cav1 fluorescence 
signal in the Cav1α morphants was reduced by up to 30 % compared to control embryos 




Figure 24: Cav1α MO successfully reduces endogenous Cav1 protein levels. 
A-C Stage 40 embryos injected with 12 ng Co MO or Cav1α MO in both blastomeres of two-cell stage 
embryos were stained for endogenous Cav1 protein. A-B anti-Cav1 staining visible in the notochord, 
lung and cranial nerves. Injection of the Cav1α MO (B) reduced the Cav1 signal in all Cav1-expressing 
tissue. Number (n) of analyzed embryos is shown. A’-B’ DAPI staining is shown. C Relative signal 
intensity of Cav1 signal in the Co MO and Cav1α MO injected embryos. The Cav1 signal was 
normalized to the DAPI signal. ± S.E. of two independent experiments is shown. 
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3.6 Loss-of-function of Cav1α in neural tissue, but not muscle tissue, 
causes severe swimming defects 
 
Cav1α is expressed in nerve but not muscle tissue in Xenopus embryos, implying a function 
for Cav1α in neuronal tissue. To verify that Cav1α functions in neuronal but not muscular 
tissue, the swimming behavior and muscle phenotypes were analyzed in embryos specifically 
injected into mesodermal or neuronal tissue (Figure 25). For this purpose, 10 ng of the Cav1α 
Morpholinos were co-injected with mGFP RNA as a lineage tracer into the dorsal marginal 
zone of the vegetal blastomeres (the dorsal-vegetal blastomere) of 8-cell stage embryos to 
mainly target muscle cells. Alternatively, the Morpholinos were injected into the dorsal 
blastomere of the animal hemisphere to target neuronal cells in the brain and spinal cord. 
Interestingly, while the muscle-specific knockdown of Cav1α did not affect the swimming 
behavior (Figure 25A, C), the knockdown of Cav1α in neuronal tissue caused severe 
swimming defects in the in the morphant embryos (Figure 25B, D). In detail, 74 % of the 
neural-injected Cav1α morphants (36% ±3% severe, 38% ±4% mild) and 87% of the Cav1α-
Spl morphants (56% ±5% severe; 31% ±5% mild) displayed an aberrant swimming behavior 
(Figure 25B, D). As previously shown, this swimming phenotype could be significantly 
improved by co-injection of the respective cav1α rescue constructs (Figure 25B, D). The total 
percentage of aberrant swimming behaviors could be significantly reduced by 23% (21% ±4% 
severe, 28% ±6% mild) upon co-expression of cav1α-rescue RNA in the Cav1α morphants 
(Figure 25D). Similarly, expression of the full-length cav1α- RNA was able to significantly 
improve the severe swimming defects by 21% (36% ±5% severe, 28% ±3% mild) in the 
Cav1α-Spl morphants (Figure 25B).  
In order to examine if the rescue of the swimming defects is not due to unspecific rescue 
effects caused by RNA injection, 100 pg LacZ RNA was co-injected as neutral RNA together 
with the Cav1α-Spl MO and swimming defects were analyzed. In contrast to Cav1α-HA, LacZ 
did not improve the swimming behavior of the morphant embryos when co-injected with the 
Cav1α-Spl MO (Figure 25B). This suggests that the rescue by the co-expression of the cav1α 
constructs is indeed specific.  
 
Injection of the Cav1α Morpholinos into one blastomere of two-cell stage embryos severely 
impaired the muscular integrity. In order to analyze if the neural-specific knockdown of Cav1α 
also affects the morphology of the musculature, muscular actin was stained by Phalloidin 
(Figure 25E-G). While control embryos show the characteristic striped muscular actin 
organization (Figure 25E-E’), the neural-injected Cav1α morphant embryos displayed a 
highly disrupted actin network in the muscle cells (Figure 25F-F’). This could again be 
restored by co-injection of the res-cav1α RNA (Figure 25G-G’).  
Collectively, these findings indicate that Cav1α is not directly required in the musculature but 
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functions in neuronal tissue affecting the neural muscular circuit that controls the embryonic 
swimming behavior.  
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Figure 25: Loss-of-function of Cav1α in neural tissue but not in the somites leads to 
swimming defects. 
Constructs were targeted to the mesodermal (A,C) or the neural tissue (B,D) and the percentage of 
swimming defects of at least three independent experiments was analyzed at stage 38. Morpholinos 
were injected at a concentration of 10 ng and cav1α- or lacZ RNA in a concentration of 100-200 pg. 
GFP (70 pg) was used as lineage tracer. A,C Targeted injection of the Cav1α-Spl MO (A) or Cav1α 
MO (C) in the somites only caused swimming defects in a low percentage of embryos. Data from at 
least three experiments are presented as the mean ± S.E.M. and number of injected embryos are 
indicated for each column. B-D Targeted injection of the Cav1α-Spl MO (B) or Cav1α MO (D) to neural 
tissue caused swimming defects. Graph summarizing the percentage of mild (light grey) or severe 
(dark grey) swimming defects of at least three independent experiments; ± S.E.M. and number of 
injected embryos are indicated for each column. Significance was calculated using the student’s t-test 
and ordinary one-way ANOVA. * p-value ≤ 0.05; **p-value ≤0.01; ***p-value ≤ 0.001. E-G Muscle 
morphology of neural-injected embryos was analyzed by sectioning and Phalloidin staining. Asterisks 
indicate the injected side. E’-G’ Higher magnification of the boxed areas shown in E, F, G. E-E’ Normal 
actin organization in a control embryo. F Highly disrupted actin organization on the injected side of 
Cav1α morphant embryo. G Co-expression of res-cav1α RNA in neural tissue restored actin 
organization of Cav1α morphant muscle cells. Number of analyzed embryos are shown. 
 
3.7 Swimming defects in the Cav1α morphants are not caused by defective 
notochord structure 
It has been demonstrated in several studies, that caveolae protect the notochord against 
mechanically induced cell damage (Garcia et al., 2017; Lim et al., 2017; Nixon et al., 2007; 
Nixon et al., 2005). Knockout of cavin 1 expression in zebrafish is associated with the loss of 
caveolae formation even in the presence of caveolin proteins and results in locomotor-
induced collapse of notochord cells (Garcia et al., 2017; Lim et al., 2017). As the notochord 
functions as an important axial-structural element in swimming larvae, it is not surprising that 
defects in this structure also correlate with an impaired swimming behaviour in these embryos 
(Lim et al., 2017). Similar to Cavin 1, Cav1 is also strongly expressed in the notochord. 
Injection of the Cav1α Morpholino into the animal blastomere caused severe swimming 
defects, which was not the case upon targeting the Morpholino into the dorsal/vegetal 
blastomere, suggesting a neural function for Cav1α. However, both blastomere also 
contribute equally to the presumptive notochord. To exclude the possibility, that the swimming 
phenotype in the Cav1α morphant embryos are due to defects in the notochord structure, 
Cavin1 knockdown studies were performed.  
As Cavin 1 Morpholino concentrations above 1.5 ng result in a high lethality rate (data not 
shown), 8 cell stage embryos were injected with either 1 ng or 1.5 ng Cavin 1 MO into the 
neural/animal blastomere and swimming defects were analyzed (Figure 26). Injection of 1.5 
ng Cavin 1 Morpholino significantly increased the number of embryos with convergent 
extension defects. Here, 56 % ±18% of the Cavin 1 morphant (1.5 ng) embryos displayed a 
significant shortened anterior/posterior axis, while embryos injected with either 1 ng Cavin 1 
MO (13% ±6%) or 10 ng Cav1α MO (13% ±3%) showed these defects only in a low 
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percentage (Figure 26C-F). Similarly, embryos injected with 10 ng Co MO showed a normal 
morphology (Figure 26B, F).  
As previously shown, the neural injection of the Cav1α Morpholino caused swimming 
abnormalities in the morphant embryos (Figure 26G). While knockdown of Cav1α led to mild 
swimming phenotype in 38% ±3% and severe swimming defects in 40% ±3% of the morphant 
embryos, the knockdown of Cavin 1 only resulted in a low percentage of swimming defects 
(Figure 26G). In comparison, injection of 1 ng Cavin 1 MO results in 8% ±5% mild and 5% 
±3% severe swimming defects. Similarly, 17% ±4% of the embryos injected with 1.5 ng 
Morpholino developed a mild and 12% ±8% a severe swimming phenotype (Figure 26G). 
However, these swimming abnormalities were not significant in contrast to the effect of Cav1α 
Morpholino injection. It should be noted that, while Cav1α morphant embryos were still able 
to contract the uninjected side, Cavin 1 morphants with a strongly shortened 
anterior/posterior axis were unable to swim and displayed only uncoordinated twitching 
movements. Therefore, embryos with a severely reduced anterior/posterior body axis were 
excluded from the statistical evaluation and only embryos with the classical swimming defects 
were counted. 
These data imply that the swimming defects in the Cav1α morphants are unlikely to be 
caused by defects in the notochord, since the loss-of-function of Cavin 1 does not causes 
swimming abnormalities to the same extent as the loss-of-function of Cav1α.  
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Figure 26: Knockdown of cavin1 does not affects the swimming behavior. 
A-G Co MO (10 ng), Cav1α MO (10 ng) or Cavin 1 MO (1-1.5ng) were targeted to the neural tube. 
GFP RNA served as lineage tracer. Injected side (B-E) and uninjected side (B’-E’) are shown. Embryos 
were analyzed at stage 37. A-A’ Stage 37 control embryo. B-B’ Wild-type morphology of a Co MO 
injected embryo. C-C’ stage 37 embryo injected with 10 ng Cav1α MO D-D’ stage 37 embryo injected 
with 1ng Cavin1 MO. E-E’ Stage 37 embryo injected with 1.5 ng Cavin 1 MO. F Graph summarizing 
the percentage of embryos with shortened anterior/posterior axes. Injection of 1.5 ng Cavin 1 MO 
significantly increased the number of embryos with a shortened anterior/posterior axis. G Graph 
summarizing the percentage of mild (light grey) or severe (dark grey) swimming defects of three 
independent experiments. Embryos were analyzed at stage 38. Number of analyzed embryos are 
indicated for each column. Data from at least three experiments are presented as the mean ± S.E.M. 
* p-value ≤ 0.05; **p-value ≤0.01; ***p-value ≤ 0.001. Significance of the total number of swimming 
defects was calculated using the Student’s t-test and ordinary one-way ANOVA. The total number of 
swimming defects was used for the statistical evaluation.   
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3.8 Inhibition of voltage- dependent sodium channels mimics the muscular 
defects of Cav1α morphants 
 
The neural but not muscular specific knockdown of Cav1α causes swimming defects as well 
as impaired somitic integrity, which implies a neuromuscular function for Cav1α. A well- 
established connection between motoneurons and the musculature is fundamental for a 
healthy development and integrity of muscles (Gutmann, 1962; Sohal and Holt, 1980). 
Several animal models of neuromuscular diseases, including Huntington and spinal muscular 
atrophy (SMA), have shown that defects in the development of motoneurons and an impaired 
establishment of a neuro-muscular connection can cause severe muscular atrophy (Hsieh-Li 
et al., 2000; Monani et al., 2000). 
To confirm that the muscular defects of the Cav1α morphants are due to defects in the neuro-
muscular system, embryos were anesthetized with Benzocaine (Figure 27). Benzocaine is 
an inhibitor for voltage gated sodium channels, which blocks the transmission of an action 
potential from the nerve towards the muscle cell, thereby mimicking a denervated muscle. If 
the muscular defects of the morphant embryos are caused by impaired muscle innervation, 
benzocaine treatment should mimic these defects. To verify this hypothesis, Cav1α morphant 
embryos were incubated in 0.01 % benzocaine from the beginning of the swimming stage 
(stage 26 to 37). Muscular actin of treated as well as untreated embryos was stained using 
Phalloidin (Figure 27).  
As previously shown, the knockdown of Cav1α leads to disorganized actin filaments in the 
musculature, while they were correctly aligned in control embryos (Figure 27B-C). 
Interestingly, Benzocaine-treated embryos – including the uninjected controls – displayed 
muscular defects, which are similar to those of the Cav1α morphant embryos. Independent 
of the side of MO injection, muscular actin filaments were disorganized and showed a wavy 
appearance in both the control and morphant embryos (Figure 27D-E). This observation 
indicates that a disruption in neuromuscular communication is sufficient to compromise 
muscle integrity.  
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Figure 27: Anesthetizing of Xenopus embryos mimics muscular actin disorganization 
observed in Cav1α morphants. 
A Schematic view of the experimental procedure. Embryos were injected with 20 ng MO in combination 
with GFP RNA into one blastomere at the two-cell stage and cultivated until stage 26 when Benzocaine 
was added to the medium. Embryos were fixed at stage 37/38, sectioned dorsally and stained with 
Phalloidin. B Normal muscle morphology in an untreated embryo injected with control MO. GFP signal 
indicates the injected side. The dashed line marks the magnified area shown in B’. C Loss-of-function 
of Cav1α disrupted somitic actin fiber organization. C’ Magnification of the marked area shown in C 
(dashed line). D-E Benzocaine treated embryos. The absence of muscle activity caused by 
Benzocaine treatment results in disorganized actin fibers in controls (D) as well as Cav1α morphant 
embryos (E’). 
 
3.9 Cav1α loss-of-function affects axonal outgrowth of motoneurons 
 
The data shown above indicate that Cav1α likely has a function in the neuromuscular system 
of Xenopus embryos and, thus, affects both muscular integrity and embryonic mobility. 
Furthermore, expression of Cav1 could be detected in neurons of the spinal cord, suggesting 
a function in the neuromuscular system. To examine how Cav1α loss-of-function affects the 
muscular integrity, the morphology of the motor nerves was analyzed by immunofluorescence 
staining in the morphant embryos (Figure 28). To this end, embryos were unilaterally injected 
with either 20 ng Cav1α MO or Cav1α-Spl MO. mGFP or lacZ were co-injected as a lineage 
tracer. 
In control embryos axons of motoneurons protruded dorso-ventrally from the ventral neural 
tube to the somitic muscle, which led to a characteristic chevron-shaped pattern (Figure 28A-
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A’). In contrast, motor nerve growth was severely impaired in 89% ±4% Cav1α MO and in 
86% ±2% of the Cav1α-Spl MO-injected embryos (Figure 28E). Although the neurons of 
Cav1α MO-injected embryos were still able to extent axons, they randomly projected their 
axons in the periphery not following the boundaries of the somitic muscles (Figure 28B-B’). 
Motoneurons from embryos injected with the Cav1α-Spl MO, which is also more effective in 
blocking Cav1α expression compared to the translation blocking Cav1α MO, showed a similar 
pathfinding phenotype (Figure 28C-C’) but also severe axonal outgrowth defects (Figure 28D-
D’). In order to analyze if the neuronal phenotype is specific for Cav1α loss of function, rescue 
experiments were performed by the unilateral injection of 10 ng Cav1α-Spl MO in combination 
with 200 pg cav1α-HA RNA (Figure 29A-E). While the injection of the Cav1α-Spl MO caused 
motoneuron pathfinding (Figure 29B’) as well as outgrowth defects (Figure 29C’) in 64% ±3% 
of the morphant embryos, co-expression of cav1α-HA RNA significantly rescued these 
defects (31% ±4%; Figure 29D, E). These results indicate that the observed neuronal 
abnormalities are indeed specific to Cav1α loss-of-function. 
Collectively, these data demonstrate that the muscular defects in the morphant embryos are 
likely caused by deficiencies in axonal outgrowth and pathfinding of motoneurons and 
consequently resulting in defective muscular innervation.  
 
The injection of the Cav1α-Spl MO led to the formation of fewer axons that innervate the 
musculature, which could also be the result of a reduced number of motoneurons in the spinal 
cord. To investigate if loss-of-function of Cav1α affects early neuronal patterning, the 
expression of the neuronal marker n-tubulin (neuron specific class IIβ tubulin) was analyzed 
by in situ hybridization during early neurula stages (Figure 29F-J). N-tubulin is expressed in 
three longitudinal stripes on each site of the open neural plate: the medial domain, 
representing the future motoneurons; the intermediate stripe, which give rise to interneurons; 
and the lateral stripe, from which sensory neurons will derive. Additionally, it is also expressed 
in the trigeminal ganglion, a small domain located in the anterior part of the neural plate 
(Moody et al., 1996; Oschwald et al., 1991; Roberts, 2000a). Control embryos (Figure 29F-
G,I) as well as the majority of the of the Cav1α morphant embryos (Figure 29H-I) showed 
normal n-tubulin expression in all four domains, indicating that loss-of-function of Cav1α has 
no impact on early neurogenesis and neuronal patterning in Xenopus embryos.  
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Figure 28: Knockdown of Cav1α affects axonal morphology. 
A-D Embryos were injected with 20 ng MO in combination with mGFP RNA into one blastomere at the 
two-cell stage. The nervous system of stage 40 embryos was stained by whole mount immunostaining 
using the neuronal surface marker NCAM. A Motoneurons innervating the muscles of control embryos 
displaying the characteristic chevron-shaped pattern. A’ Magnification of the dashed area shown in 
panel A. B Motoneuron pathfinding is severely impaired in Cav1α morphants. C-D Cav1α-Splice 
morphants showing severe motoneuron pathfinding (C) as well as outgrowth defects (D). Axons of 
motoneurons were highly disoriented and failed to innervate somitic muscles properly. B-D’ 
Magnification of the dashed area shown in panel B and D. nt = neural tube E Graph summarizing the 
percentages of Co MO and Cav1α morphant embryos with motoneuron defects of at least four 
independent experiments; ± S.E.M. and number of analyzed embryos are indicated for each column. 
Significance was calculated using the Student’s t-test and ordinary one-way ANOVA. ***p-value ≤ 
0.001.  
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Figure 29: Cav1α-HA overexpression rescues motoneuron defects. 
A-E Embryos were injected with 10 ng MO alone or in combination with 200 pg cav1α-HA RNA into 
one blastomere of two-cell stage embryos. mGFP RNA was co-injected as a lineage tracer. The 
nervous system of stage 37 embryos was stained by whole mount immunostaining using the neuronal 
Results  87 
 
surface marker NCAM. Injected (A-D) and magnified area highlighted in A-D shown (A’-D’). A-A’ 
Motoneurons of an embryo injected with Co MO. B’-C’ Motoneuron outgrowth (B) as well as 
pathfinding (C’) is severely affected by Cav1α knockdown. D-D’ Co-expression of cav1α-HA RNA 
rescues motoneuron defects. E Graph summarizing the percentages of embryos with motoneuron 
defects of three independent experiments; ± S.E.M. and number of analyzed embryos are indicated 
for each column. Significance was calculated using the Student’s t-test and ordinary one-way ANOVA. 
**p-value ≤ 0.01, ***p-value ≤ 0.001. F-J Control embryos (F) or embryos injected unilaterally with 20 
ng Co MO (G), Cav1α MO (H) or Cav1α-Spl MO (I) were analyzed for n-tubulin expression by whole 
mount in situ hybridization. LacZ RNA was co-injected as a lineage tracer (blue staining). Asterisk 
indicates the injected side. F-I n-tubulin is expressed in the m= medial domain, I = intermedial domain 
and l = lateral domain as well as in the tg = trigeminal ganglion. J Percentage of reduced n-tubulin 
expression is shown from two independent experiments, ± S.E. and number of analyzed embryos is 
indicated for each column. 
 
3.10 Cav1α loss-of-function affects axonal outgrowth and morphology in 
vitro 
 
To understand how Cav1α loss-of-function affects axonal outgrowth, the morphological 
properties of spinal cord neurons were analyzed in cultured neural tube explants. Therefore, 
embryos were injected with 12 ng of the Cav1α Morpholinos and mGFP or lifeact-RFP RNA 
as a lineage tracer either into both blastomeres of the two-cell stage or into the two neural 
blastomeres of four-cell stage embryos. Neural tubes were isolated from stage 20-22 
embryos and axonal outgrowth and morphology were analyzed by live-cell microscopy after 
approximately 24 h of incubation (Figure 30A). By whole mount immunofluorescence staining 
it could be shown that axonal outgrowth was severely affected in the Cav1α-Spl morphant 
embryos in vivo (Figure 30D). Similarly, injection of the Cav1α-Spl MO but not the translation 
blocking Morpholino Cav1α MO significantly reduced the outgrowth of axons in cultured 
spinal cord explants (Figure 30B). Interestingly, in addition to axonal outgrowth their 
morphology was affected by Cav1α knockdown. While control neurons extended long axons 
with a dynamic, actin-rich growth cone (Figure 30C, F, I-K), the axonal morphology in Cav1α 
morphant samples was severely affected. A significantly larger proportion of these neurons 
extended axons with an increased number of actin-rich filopodia-like structures on the axon 
shaft. This increased filopodia formation was observed in 55% ±5% of the Cav1α morphant 
and 52% ±5% of the Cav1α-Spl morphant axons (Figure 30D-J). Furthermore, also the 
number of axons with excessive lamellipodia formation was significantly increased both in 
Cav1α morphant (33% ±3%) and Cav1α-Spl morphant axons (48% ±5%) (Figure 30K). 
Quantification of this phenotype showed that these lamellipodia covered a significantly larger 
portion of the total axonal area in the axons of Cav1α morphant (50% ±2%) as well as Cav1α-
Spl morphant (47% ±1%) explants in comparison to control axons (14% ±1%) (Figure 30L). 
Most axon shafts of control neurons showed only a low number of filopodia or lamellipodia 
protrusions (Figure 30, I, K).  
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To analyze if these morphological abnormalities are specific to the Cav1α knockdown, rescue 
experiments were performed (Figure 30M-O). To this end, 10 ng of the Cav1α-Spl MO was 
injected alone or in combination with 200 pg cav1α-HA RNA into both blastomeres of two-
cell stage embryos followed by the isolation of neural tubes at stage 20-22. As described 
above, the Morpholino-mediated knockdown of Cav1α by Cav1α-Spl MO significantly impairs 
axonal outgrowth and led to an increased number of axons with excessive filopodia (50% 
±3%) as well as lamellipodia (32%±8%) formation (Figure 30M-O). Co-expression of cav1α-
HA RNA significantly rescued the axonal outgrowth defects as well as the increased filopodia 
(25% ±4%) and lamellipodia (9%±3%) formation observed in the Cav1α-Spl morphant 
explants (Figure 30M-O).  
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Figure 30: Cav1α knockdown affects axonal growth and morphology in vitro. 
A Schematic representation of the experimental procedure. Embryos were injected into both 
blastomeres with 12 ng Co MO, Cav1α Mo or Cav1α-Spl MO in combination with 70 pg mGFP or 200 
pg Lifeact-RFP RNA. Neural tubes of stage 20-22 embryos were isolated, evenly dissected and 
cultured on poly-lysine and laminin-coated dishes. Axonal growth was monitored after 12-24h. B Graph 
showing the number of axons per explant for each condition. Injection of the Cav1α-Spl MO 
significantly decreases the outgrowth of axons per explant. ***p-value ≤ 0.001, ns = not significant. 
Significance was calculated using a Mann-Whitney test. Number of axons and explants is indicated 
for each column. C-L LOF of Caveolin increased filopodia and lamellipodia formation in cultured spinal 
cord neurons. C, F Control axons showed typical actin-positive growth cones. D, G, E, H Injection of 
either Cav1α Mo (D, G) or Cav1α-Spl MO (E, H) increased the formation of filopodia-like and 
lamellipodia-like actin-rich structures in cultured neurons. I-L Graphs summarizing percentages of 
axons with increased filopodia-like structures (I) or lamellipodia formation (K). J Graph summarizing 
the number of filopodia-like structures per 100 µm axon length. L Percentage of lamellipodia area in 
relation to total axon area. Data from at least three experiments are presented as ± S.E.M. ***p-value 
≤ 0.001. Significance was calculated using a two-tailed unpaired Student’s t-test, ordinary one-way 
ANOVA (Dunnett’s multiple comparisons) or Mann-Whitney test (Box blots). Numbers of analyzed 
axons are indicated for each column. M-O Axonal outgrowth as well as filopodia and lamellipodia 
formation was analyzed in embryos injected with 10 ng Co MO, Cav1α Mo or Cav1α-Spl MO alone or 
in combination with 200 pg cav1α-HA RNA. Data of four independent experiments are shown. M Graph 
showing the number of axons per explant for each condition. Co-injection of cav1α-HA RNA 
significantly rescued the outgrowth of axons per explant. ***p-value ≤ 0.001. Significance was 
calculated using a Mann-Whitney test. N-O Graphs showing the numbers of axons with increased 
filopodia (N) or lamellipodia (O) formation. Co-injection of cav1α-HA RNA significantly rescued the 
excessive filopodia and lamellipodia formation. ± S.E.M. Significance was calculated using the 
Student’s t-test and ordinary one-way ANOVA. * p-value ≤ 0.05; **p-value ≤0.01; ***p-value ≤ 0.001.  
 
To investigate how these membrane protrusions are formed, the axonal outgrowth in control 
as well as Cav1α morphant neurons was analyzed by live-cell imaging (Figure 31). Growth 
cones from control axons dynamically extended and retracted the majority of the filopodia 
and lamellipodia protrusions over time (Figure 31A, B, Supplementary Movie 6, 7). Although 
axons from morphant explants showed similar dynamic growth cones as control axons, they 
fail to properly retract their lamellipodia and filopodia structures during growth (Figure 31C, 
D, Supplementary Movie 8, 9). It could be frequently observed that lamellipodia structures 
remained attached to the substrate as the growth cone continued to move (Figure 31D, 
Supplementary Movie 9). 
Taken together, it could be demonstrated that Cav1α is not only expressed in the central 
nervous system, but also plays an important role during outgrowth and pathfinding of both 
cranial nerves and motoneurons in vivo as well as in vitro. These results provide strong 
evidence for an incorrect innervation as the main cause of the disrupted muscular integrity in 
the Cav1α morphant embryos. 
 




Figure 31: Cav1α morphant axons fail to retract filopodia and lamellipodia structures during 
axonal growth. 
A-D Axonal outgrowth of control (A-B) as well as Cav1α morphant (C-D) neurons was analyzed by 
live-cell imaging over a time period of 30 min. A-B Growth cones of control axons dynamically 
extended and retracted the majority of their filopodia and lamellipodia protrusions during axonal growth 
over time. Arrows indicate retracting filopodia structures. C-D Cav1α morphant axons failed to retract 
filopodia (C, arrowhead) and lamellipodia (D, double arrowhead) structures during axonal growth. 
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3.11 Cav1α modulates Rho GTPase activity during axonal outgrowth 
 
Rho GTPases are known regulators for lamellipodia and filopodia dynamics during axonal 
growth and guidance (Hall and Lalli, 2010; Heasman and Ridley, 2008). Further, it has 
already been shown, that knockdown of Cav1α in migrating mouse fibroblasts interferes with 
the activity of the small Rho GTPases RhoA and Rac1 (Grande-García et al., 2007). 
Both filopodia and lamellipodia formation was significantly increased in axons upon Cav1α 
knockdown, suggesting that Cav1α also modulates the activity of the small Rho GTPases 
during axonal outgrowth. To understand how Cav1α functions in this process, 
rescue experiments with either constitutively active (ca) or dominant negative (dn) mutants 
of the small Rho GTPases Cdc42, Rac1 or RhoA were performed. To this end, 10 ng of Co 
MO or Cav1α-Spl MO were co-injected with 10 pg DNA of the respective mutant construct 
into the dorsal blastomere of the animal hemisphere. The swimming behavior of embryos 
was analyzed at stage 37 (Figure 32). mGFP RNA was injected as a lineage tracer. As 
previously demonstrated, the neural-specific knockdown of Cav1α causes severe swimming 
defects in morphant embryos (Figure 32A-C). Interestingly, the total percentage of swimming 
defects of the Cav1α-Spl morphants (23% ±2% mild, 60% ±5% severe) was significantly 
improved by co-expression of dnRhoA (25 ±1% mild, 29% ±5% severe) but not caRhoA (19% 
±1% mild, 61% ±4% severe) (Figure 32A). Similarly, dnRac1 (26% ±3% mild, 28% ±5% 
severe), but not the constitutive active mutant (37% ±6% mild, 44% ±5% severe) could 
partially rescued the swimming behavior of Cav1α-Spl morphants (21% ±2% mild, 60%±4% 
severe) by 27% (Figure 32B). Conversely, the swimming defects of the Cav1α-Spl morphant 
embryos (22% ±3% mild, 59% ±5% severe) could be significantly improved by 37% with 
simultaneous expression of ca (18% ±3% mild, 29% ±4% severe) but not dnCdc42 (13% ±4% 
mild, 71% ±5% severe) (Figure 32C). Co-injection of Co MO with the Rho GTPase mutants 
caused swimming defects only in a low percentage of embryos (Figure 32A-C). In summary, 
the swimming defects in the Cav1α morphant embryos could be improved by the co-
expression of dnRac1, dnRhoA as well as caCdc42.  
Consistently, co-expression of the dominant negative mutant of Rac1 and RhoA as well as 
the constitutive active mutant of Cdc42 also rescued the motoneuron defects caused by 
Cav1α knockdown (Figure 32D-I). While 79% ±2% of the Cav1α-Spl morphant motoneurons 
displayed shorter or missing axons, co-injection of these RhoGTPase mutants partially 
restored this phenotype. In detail, co-expression of dnRac1 could improve the motoneuron 
defects by 35% (44% ±2% motoneuron defects), dnRhoA by 36% (43% ±6% motoneuron 
defects) and caCdc42 by 36% (43% ±6%) (Figure 32D). These data demonstrate that Cav1α 
is likely required for the Rho GTPase-dependent axonal growth. 




Figure 32: Cav1α is required for Rho GTPase-dependent axonal outgrowth and pathfinding of 
motoneurons. 
A 10ng of Co MO or Cav1α-Spl MO alone or in combination with 10 pg of either dominant or 
constitutive active mutants of the Rho GTPases Rac1, RhoA and Cdc42 were injected into the dorsal 
blastomere of the animal hemisphere of 8-cell stage embryos. The swimming behavior (A-D) and 
neuronal phenotype (E-J) were analyzed A-D Graphs summarizing the percentage of embryos with 
mild (light grey) or severe (dark grey) swimming defects. Data from at least three experiments are 
presented as ± S.E.M. ***p-value ≤ 0.001. Significance was calculated using a two-tailed unpaired 
Student’s t-test, ordinary one-way ANOVA (Dunnett’s multiple comparisons). Numbers above each 
column indicate the number of analyzed embryos. A Co-injection of dnRhoA, but not caRhoA, into 
neural tissue in combination with Cav1α-Spl MO could significantly improve the swimming defect. B 
The swimming behavior could be significantly improved by neural expression of 10 pg dnRac1 but not 
10 pg caRac1 in Cav1α-Spl morphant embryos. C Neural-injected caCdc42, but not dnCdc42, in 
combination with Cav1α-Spl MO partially rescued the aberrant swimming behavior of Cav1α-Spl 
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morphant embryos. D-I Motoneuron outgrowth was analyzed by NCAM immunostaining. The injected 
constructs are indicated. D Graph summarizing the percentage of embryos with motoneuron defects. 
Data from at least three experiments are presented as ± S.E.M. ***p-value ≤ 0.001. Significance was 
calculated using a two-tailed unpaired Student’s t-test, ordinary one-way ANOVA (Dunnett’s multiple 
comparisons). Numbers above each column indicate the number of analyzed embryos. E-E’ 
Motoneurons of stage 38 embryos injected with Co MO. F-F’ Motoneurons of stage 38 embryos 
injected with Cav1α-Spl MO. Asterisk marks motoneuron with pathfinding defects, arrowheads indicate 
motoneurons with outgrowth defects. G-I Co-expression of dnRac1 (G), dnRhoA (H) and caCdc42 (I) 
rescued the motoneuron defects shown in Cav1α-Spl morphant embryos (F). E’-I’ Magnified areas 
shown in E-I.  
Src-dependent tyrosine (Y14) phosphorylation of Cav1α plays an important role in the 
regulation of RhoA and Rac/Cdc42 activity in mouse embryonic fibroblasts (Grande-García 
et al., 2007; Nethe et al., 2010; Núñez-Wehinger et al., 2014). To understand how Cav1α 
controls axonal outgrowth and subsequently muscular integrity, it was first analyzed whether 
this posttranslational modification is required for Cav1α function in the locomotor system of 
Xenopus embryos. To this end, rescue experiments were performed by co-injecting either 
200 pg of the full length caveolin 1α mRNA (cav1α-HA) or a non-phosphorylatable Cav1α 
mutant (cavY14A) in combination with 10 pg MO into one animal blastomere of two-cell stage 
embryos (Figure 33). While co-injection of cav1α-HA could reduce the swimming defects in 
the morphant embryos significantly from 80% (28% ±5% mild, 52% ±7% severe) to 47% (34% 
±4% mild, 13% ±4% severe), the phosphorylation mutant was not able to rescue this 
phenotype if co-expressed with the Cav1α-Spl Morpholino (9% ±0% mild, 80% ±1% severe) 
(Figure 33). In contrast, expression of cav1Y14A in the Cav1α-morpholino background 
increased the severity of swimming defects in the morphants. While injection of the Cav1α-
Spl led to severe swimming defects in 52% ±7% of the injected embryos, co-injection of the 
CavY14A mutant increased the number of severe swimming defects to 80% ±1%, suggesting 
a dominant-negative function of this mutant (Figure 33B). Overall, these findings indicate that 
Y14 phosphorylation is indeed required for Cav1α function and possibly for the regulation of 
Rho GTPases in the locomotor system of Xenopus laevis. 
 




Figure 33: Y14 phosphorylation of Cav1α is necessary for Cav1α neural function. 
A Schematic view of the caveolin 1α structure. Tyrosine (Y14) phosphorylation site is shown. B Two-
cell stage embryos were injected unilaterally with 10 ng Co MO or Cav1α-Spl MO alone or in 
combination with 200 pg Cav1α Y14A or Cav1α RNA. Co-expression of Cav1α RNA but not Cav1α 
Y14A RNA in Cav1α morphant embryos rescued the swimming defect. Numbers above each column 
indicate the number of analyzed embryos. Data from at least three experiments are presented as ± 
S.E.M. ***p-value ≤ 0.001. Significance was calculated using a two-tailed unpaired Student’s t-test. 
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3.12 Serine (S82) phosphorylation is required for Cav1α membrane 
localization but not for its neural function. 
 
The biological function of the post-translational phosphorylation of Cav1α on tyrosine 14 is 
well understood. However, Cav1 contains a second conserved phosphorylation site, serine 
80, the function of which is still largely unknown. It has been suggested that this 
phosphorylation site is required for the secretion of Cav1 in pancreas cells (Schlegel et al., 
2001) as well as for sterol binding (Fielding et al., 2004). 
In order to analyze the functional role of the serine phosphorylation, Cav1α localization 
studies were performed in Xenopus ectodermal explants with either a serine phosphorylation 
null (S82E) or a phospho-mimicking (S82A) mutant (Figure 34A). Xenopus ectodermal 
explants were isolated from stage 8 embryos injected with 500 pg of the respective Cav1α 
mutant (cav1α-S80A-HA, cav1α-S80E-HA) or a wild type Cav1α together with membrane-
GFP as a lineage tracer.  
In Xenopus ectodermal explants Cav1α-HA as well as Cav1α-S82A-HA co-localized with 
membrane GFP at the apical plasma membrane and in vesicle-like structures in the 
cytoplasm (Figure 34B-C). In contrast, the phosphorylation-mimicking mutant Cav1α-S82E-
HA failed to localize at the plasma membrane and accumulated in large clusters in the 
cytoplasm with no visible polarization within these cells (Figure 34D).  
Caveolin proteins accumulate as large oligomers at the plasma membrane to form the 
caveolae coat (Hayer et al., 2010). In order to analyze whether the mutation of the serine 
phosphorylation site affects the ability of Cav1α to form oligomers with other Caveolin 
proteins, the serine phosphorylation mutants were co-expressed with a GFP-tagged Cav1α 
in Xenopus ectodermal explants. Interestingly, while wild-type Cav1α as well as the phospho-
mimicking mutant Cav1α-S82A-HA co-localized with Cav1α-GFP at the plasma membrane 
(Figure 35A-B), Cav1α-GFP showed no membrane localization when it was expressed 
together with the phospho-null mutant Cav1α-S82E-HA. However, Cav1α-GFP mainly co-
localized together with Cav1α-S82E-HA in the cytoplasm and vesicular structures (Figure 
35C). In summary, phosphorylation at serine residue 80 seems to be important for the 
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Figure 34: S82 phosphorylation is required for Cav1 membrane localization.  
A Schematic of the caveolin 1α structure. Serine (S82) phosphorylation site is shown. Serine 82 was 
substituted with an alanine (S82A) or a glutamic acid. B-C One-cell stage embryos were injected with 
500 pg of the indicated constructs in combination with mGFP as a lineage tracer. Xenopus ectodermal 
explants were isolated at stage 88. Explants were stained with anti-HA (red) and anti-GFP (green). B-
C Cav1α-HA (B) and Cav1α-S82A-HA (C) co-localized with mGFP (B’’-C’’) at the plasma membrane 
of Xenopus ectodermal explants. D Cav1α-S82E-HA failed to co-localize with mGFP at the plasma 
membrane and showed cytoplasmic localization in vesicle-like structures. 
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Post-translational tyrosine (T14) phosphorylation of Cav1α has a potential function during 
axonal growth. Mutation of this phosphorylation site was not able to rescue the swimming 
defects of the Cav1α morphant embryos, indicating that this phosphorylation event is crucial 
for Cav1α function in this context. In order to analyze whether serine phosphorylation is also 
necessary for the neuronal function of Cav1α and subsequently for muscle innervation, 
rescue experiments with the serine phosphorylation mutants were carried out. To this end, 
500 pg of the phospho-mimicking mutant (S82A) was co-injected with 10 ng Cav1α 
Morpholino into one blastomere of two cell stage embryos and swimming defects were 
analyzed (Figure 35D). Since injection of the phospho-null mutant (S82E) into two-cell stage 
embryos resulted in a high mortality rate during gastrulation, 100 pg of this mutant was co-
injected with 10 pg Cav1α MO into the animal blastomere of 8-cell stage embryos (Figure 
35E). Both the cav1α-S82A phospho-mimicking as well as the cav1α-S82E phospho-null 
mutant were able to partially rescue the swimming defect caused by Cav1α loss-of-function. 
In case of the cav1α-S82A mutant, the swimming defect could be restored by 21% (19% 
severe, 45% mild) in comparison to the Cav1α morphant embryos (35% severe, 49% mild) 
(Figure 35D). Co-expression of cav1α-S82E (17% severe, 42% mild) improved the swimming 
behavior by 30% in the morphant embryos (51% severe, 35% mild) (Figure 35E). These data 
suggest that the phosphorylation on serine 80 is not required for the neuronal function of 
Cav1α as demonstrated for the tyrosine (Y) phosphorylation. However, the rescue 
experiments using the serine phosphorylation mutants were carried out only once, thus, 
further repetitions must be carried out to validate these results. 
 




Figure 35: S82E mutant is required for membrane localization but not for Cav1 neural 
function.  
B-C One-cell stage embryos were injected with 500 pg of the indicated constructs in combination with 
Cav1α-GFP. Xenopus ectodermal explants were isolated from stage 8 embryos. Explants were stained 
with anti-HA (red) and anti-GFP (green). A-B Cav1α-HA (A) and Cav1α-S82A-HA (B) co-localized with 
Cav1α-GFP (A’’-B’’) at the plasma membrane and in vesicle-like structures within the cytoplasm. D 
Cav1α-S82E-HA co-localized with Cav1α-GFP (C’’) in vesicular-like structures within the cytoplasm 
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but failed to localize at the plasma membrane. D Two-cell stage embryos were unilaterally injected 
with 10 ng Co MO or Cav1α MO alone or in combination with 500 pg Cav1α-S82A-HA and swimming 
defects were analyzed in stage 37 embryos. Co-expression of Cav1α-S82A-HA improved the 
swimming behavior. Percentage of swimming defects are shown from one experiment. Number of 
analyzed embryos is indicated for each column. E 8-cell stage embryos were injected with 10 ng Co 
MO or Cav1α MO alone or in combination with 100 pg cav1α-S82E-HA into the animal/neural 
blastomere. Swimming defects were analyzed in stage 37 embryos. Co-expression of cav1α-S82E-
HA improved the swimming behavior. Percentage of swimming defects is shown from one experiment. 
Number of analyzed embryos is indicated for each column. 
 
  




Cav1 is an essential structural protein driving the formation of caveolae in many cell types. 
The loss-of-function of this protein is associated with motor dysfunction and 
neurodegeneration in humans as well as in mice (Berger et al., 2002; Cao et al., 2008; 
Trushina et al., 2006a). However, so far, the underlying cellular mechanisms are not fully 
understood. For this purpose, detailed studies on the neuromuscular function of Cav1α in the 
model organism Xenopus laevis were carried out in the present study.  
 
4.1 Cav1α loss-of-function impairs axonal growth during early development 
of Xenopus laevis embryos 
 
Neuromotor activity plays an important role for the development and integrity of muscles  
(Midrio, 2006). It has been shown in several studies that loss of neural connectivity, for 
example due to denervation or spinal cord injuries, causes severe muscle atrophy. This is 
characterized by reduced muscle strength resulting from a loss of sarcomeric organization, 
reduced number of ribosomes and mitochondria and finally by myofiber apoptosis (Gutmann, 
1962; Gutmann and Zelená, 1962; Heck and Davis, 1988; Hník, 1962; Tower, 1935). 
Here, Cav1α was identified to function in the neuromuscular system during early 
development of Xenopus laevis. Morpholino-mediated knockdown of Cav1α leads to 
swimming defects as well as severely compromised muscle integrity (Figure 18). This was 
characterized by disorganized muscular actin (Figure 18) and a loss of sarcomeric 
organization within the somitic muscle cells (Breuer, 2016, M.Sc.). In previous studies, a 
potential defect on muscle differentiation and maturation has been excluded, as these 
processes were not affected by the loss of Cav1α expression (Breuer, 2016, M.Sc.). 
Interestingly, treatment with Benzocaine, which inhibits nerve to muscle communication by 
the inhibition of voltage-dependent sodium channels, mimics the muscle defects observed in 
the Cav1α morphant embryos (Figure 27). Further, Cav1α protein is expressed in Xenopus 
spinal cord neurons, including motoneurons, but not the musculature, suggesting that Cav1α 
functions in the neuro-muscular circuits controlling muscular integrity rather than in the 
musculature directly (Figure 21). This was confirmed by targeted knockdown studies of 
Cav1α in neural tissue as well as immunological analysis of the muscle innervation. Targeted 
loss-of-function of Cav1α in neural tissue, but not in muscle tissue, caused the characteristic 
swimming as well as muscular defects. Further, immunolabelling of the nervous system 
demonstrated that axonal growth of motoneurons was severely affected by Cav1α loss-of-
function (Figure 28B-D). Here, the phenotypes ranged from aberrant axonal projections, 
which were mainly observed in the Cav1α morphants, to outgrowth defects in the Cav1α-Spl 
MO injected embryos.  
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A potential neuromuscular function of Cav1α in other model organisms has not been 
described so far. However, similar to the knockdown of Cav1α in Xenopus, the morpholino-
mediated knockdown of Cav1α in zebrafish also leads to severe defects in the muscular actin 
organization (Fang et al., 2006). Although, the authors of this paper did not report any 
behavioral abnormalities in their zebrafish embryos, the depletion of Cav1α resulted in the 
loss of neuronal structures, as shown by the reduced expression of the neuronal markers pax 
2.1 and otx2 (Fang et al., 2006). Interestingly, in Xenopus, the loss of Cav1α expression also 
leads to a temporal reduction of neuronal markers, such as NCAM, nrp1 as well as sox10 in 
early neurula stages (13-18) (Breuer, 2016, M.Sc. ; Maximillian Staps, 2016, B.Sc. ). 
However, the expression of these markers recovered in older developmental stages (19 
onwards, data not shown). This indicates that the reduced marker expressions in the 
morphant embryos are due to a developmental delay rather than a defect during early 
neuronal patterning. In agreement with this, no abnormalities of early neuronal patterning 
could be observed by n-tubulin staining, suggesting that Cav1α functions later during 
neuronal development and axogenesis (Figure 28). This could be confirmed by an in vitro 
spinal cord explantation assay, in which Cav1α morphant axons displayed both outgrowth 
defects, similar to the in vivo situation, and also an increased formation of lamellipodia as 
well as filopodia protrusions. This is likely due to the impaired activity of the small 
RhoGTPases Rac1, Cdc42 and RhoA, as both the aberrant swimming behavior and the 
motoneuron defect in vivo could be rescued by a constitutive active mutant of Cdc42 or a 
dominant negative mutant of Rac1 or RhoA, respectively. Thus, the findings of this thesis 
suggest a model whereby Cav1 regulates axonal growth by modulating the activity of the 
small RhoGTPases Rac1, Cdc42 and RhoA (Figure 36). In the wild-type situation this is 
mediated by supporting Cdc42 activity and suppressing RhoA and Rac1 activity. Further, this 
process likely requires the phosphorylation of Cav1α on tyrosine 14, as a phosphor-deficient 
mutant (Y14A) of Cav1 was not able to rescue the morphant swimming defects (Figure 33).  
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Figure 36: Model of Cav1α function in motor neuron outgrowth. 
The morphology of a wild-type (WT) and Cav1α morphant motor neuron is shown; microtubules 
(green) and actin bundles (red) are shown. Tyrosine phosphorylated Cav1α (blue, with red Y14 
phosphorylation) modulates the activity of the small RhoGTPases during axonal growth of Xenopus 
spinal cord neurons. In wild type neurons, Cav1α likely supports the activity of Cdc42 and suppresses 
the activity of Rac1 and RhoA. 
 
4.2 Cav1α modulates the activity of small RhoGTPases during axonal 
growth 
 
To reach their synaptic target and build new neural circuits, axons need to navigate long 
distances through the developing tissue. Thereby, the dynamic growth cones at the distal 
end of the migrating axons need to sense and adapt to the surrounding environment to enable 
a directional and targeted growth to the synaptic target (reviewed in Vitriol and Zheng, 2012). 
During this process, the small RhoGTPases Cdc42, Rac1 and RhoA act as molecular 
switches that translate extracellular cues, such as guidance as well as repellent cues, but 
also adhesiveness to the substratum, to directional responses by modulating actin 
cytoskeleton dynamics (reviewed in Luo, 2000). Thereby, RhoA regulates microtubule 
stabilization and stress fiber formation, while Rac1 promotes lamellipodia and Cdc42 filopodia 
formation by promoting actin polymerization (reviewed in da Silva and Dotti, 2002; Kozma et 
al., 1995; Ridley et al., 1992; Ridley and Hall, 1992). 
Although, the function of Cav1 has been excessively studied in different cellular systems, so 
far, not much is known about the function of Cav1 in the regulation of small RhoGTPases in 
neuronal cells. Recently, Wang et al. proposed that tyrosine phosphorylated Cav1α regulates 
neuronal differentiation and axonal outgrowth downstream of Rac1/Cdc42 signaling in 
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cultured human neurons derived from iPSCs (Wang et al., 2019). The results obtained during 
this study, however, suggest a regulatory function of Cav1α upstream of these Rho GTPases 
by supporting the activity of Cdc42 and suppressing the activity of Rac1 and RhoA during 
axonal growth, as both the swimming as well as the motoneuron defects could be rescued 
by the co-injection of dnRac1, dnRhoA or caCdc42 (Figure 32). It has been shown that Cav1 
modulates the spatial-temporal RhoGTPase activity during focal adhesion assembly and 
maturation and thereby regulating cell polarization and migration of mouse embryonic 
fobroblasts (Grande-García et al., 2007; Nethe et al., 2010; Nethe and Hordijk, 2011): 
Activated Rac1 at newly formed focal adhesion sites mediates the recruitment and the src-
dependent phosphorylation of Cav1α (Nethe et al., 2010; Nethe and Hordijk, 2011). This 
initiates a negative feedback loop, involving the Cav1α-dependent ubiquitination and 
subsequent degradation of Rac1 as well as the activation of RhoA through Cav1α-mediated 
inactivation of the Src-p190RhoGAP pathway (Grande-García et al., 2007; Nethe et al., 
2010): Src-dependent phosphorylation of Cav1 on Tyrosine 14 (Y14) induces the recruitment 
and activation of Csk at focal adhesion sites, which in turn phosphorylates and inactivates 
Src (Grande-García et al., 2007). In mouse embryonic fibroblasts, the Cav1α loss-of-function 
is associated with impaired cell polarity and directional migration due to the misregulation of 
the small RhoGTPases RhoA, Rac1 and Cdc42 at focal adhesion sites (Grande-García et 
al., 2007; Nethe et al., 2010; Nethe and Hordijk, 2011). Further, these cells also display an 
impaired maturation and increased turnover of focal adhesions, caused by elevated Rac1 
activity and decreased RhoA activation (Grande-García et al., 2007; Nethe et al., 2010).  
Focal adhesions (FA) are macromolecular complexes that functions as local anchor points of 
the cell to the extracellular matrix to stabilizes lamellipodia and filopodia structures (Myers 
and Gomez, 2011; Robles and Gomez, 2006). They are also domains for actin organization 
and remodeling during cell migration and growth cone steering in response to guidance cues 
during axonal growth (reviewed in DeMali and Burridge, 2003). The dynamics of focal 
adhesions are controlled by the cycling activation of the RhoGTPases Rac1 and RhoA 
(Hotchin and Hall, 1995; reviewed in Lawson and Burridge, 2014). Thereby, initial Rac1 
activation and RhoA suppression is required for the formation of nascent FAs. In contrast, 
activated RhoA and repressed Rac1 results in the maturation and stabilization of FA sites 
(Lawson and Burridge, 2014). For example, the overexpression of either dominant negative 
or constitutive active Rac1 mutants in Xenopus spinal cord neurons led to impaired focal 
adhesion dynamics (Woo and Gomez, 2006). While expression of a dominant negative 
mutant of Rac1 reduced the number of focal adhesion sites but increased their stability, 
expression of a constitutively active mutant resulted in a decreased stability of these contact 
sites and consequently impaired axonal outgrowth (Woo and Gomez, 2006). By promoting 
actin polymerization as well as focal adhesion formation, Rac1 is a positive regulator for 
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lamellipodia formation (Ridley et al., 1992). Thus, constitutively active Rac1 activity is 
associated with an increased formation of this membrane structures (Ehrlich et al., 2002; 
Ridley et al., 1992). As Cav1 morphant axons also display increased lamellipodia-like 
structures as well as the inability to retract those during growth cone advance (Figure 31), it 
seems likely, that Cav1 negatively regulates the activity of Rac1 at focal adhesion sites during 
axonal outgrowth in Xenopus spinal cord neurons.  
 
Interestingly, the data shown in this study also indicate that Cav1α suppresses RhoA and 
supports Cdc42 activity in neuronal cells (Figure 32). In contrast to that, loss-of-function 
studies in MEFs demonstrated, that Cav1α positively regulates the activity of RhoA by the 
inactivation of the Src-p190RhoGAP pathway (Grande-García et al., 2007). Consequently, 
loss-of-function of Cav1α in these cells leads to an elevated activity of Rac1/Cdc42 and 
decreased activity of RhoA in response to increased Src activity (Grande-García et al., 2007). 
How can these contractionary findings in the regulation of the RhoGTPases RhoA and Cdc42 
in neuronal cells by Cav1α be explained? Although the role of these RhoGTPases has been 
extensively studied in fibroblasts, it has been shown that the functions of the RhoGTPases 
in neurons appear to be more complex. During axonal growth and navigation, axons are 
exposed to a variety of extracellular cues, such as guidance signals, differences in the ECM 
composition as well as receptor-ligand interactions that can elicit different regulatory 
mechanisms and crosstalk of these RhoGTPases during the various steps in neurogenesis 
and axonal outgrowth (Kim et al., 2002; Li et al., 2002; Matsuura et al., 2004; Myers et al., 
2011; Woo and Gomez, 2006). In Drosophila, it has been demonstrated that Rac functions 
as a positive regulator for axonal growth by promoting this process in a Pak independent 
pathway, acting antagonistically to LIM kinase 1 (LIMK1) (Ng and Luo, 2004). Conversely, 
both Rho as well as Rac/Cdc42 GTPases also inhibit axonal growth via the Pak dependent 
activation of LIMK1 (Ng and Luo, 2004). Further, a growing body of evidence suggests that 
various levels of RhoGTPase activity can also target different downstream targets (Ng et al., 
2002). Ng et al. were able to show that the progressive loss of Rac1 activity in the growth 
cone of Drosophila neurons leads first to impaired axonal branching, then guidance and 
finally to axonal growth defects (Ng et al., 2002). Likewise, while RhoA functions as negative 
regulator for axonal growth, its activity is also associated with axonal fasciculation and 
guidance (Brouns et al., 2001). The mis-regulation of RhoA, due to the loss of the 
p190RhoGAP, leads to axonal guidance as well as fasciculation defects of cortical neurons 
as well as cranial nerves in mice (Brouns et al., 2001). Further, the small RhoGTPases Rac1, 
Cdc42 and RhoA show a distinct spatial-temporal expression during neuronal development, 
suggesting that they regulate different aspects of neurogenesis. For example, while Cdc42 
is mostly ubiquitously expressed in immature and mature neurons, Rac1 preferably localizes 
in putative axons, branching points and growth cone and RhoA is mostly expressed in 
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dendrites during neuronal maturation (Santos Da Silva et al., 2004). In line with this,  Rac1 
activity is mainly required for axonal plasticity and guidance, RhoA functions as negative 
regulator for axonal and dendritic growth and Cdc42 is required for neuronal polarity, but also 
for both axonal and dendritic growth (reviwed in Gonzalez-Billault et al., 2012). Interestingly, 
in vivo expression studies of Cav1 also revealed a spatial-temporal expression of this protein 
during neuronal development in the mouse hippocampus (Shikanai et al., 2018). Cav1 is 
highly expressed in the neurites of immature neurons located in the intermediate and 
marginal zone of the cortex. In contrast, while it is down-regulated in migrating neurons in the 
cortical plate, it is later up-regulated again in a subset of mature neurons (Shikanai et al., 
2018). This suggests that Cav1 also regulates different aspects of neuronal development. 
And indeed, Shikanai and colleagues demonstrated that Cav1 functions in the early 
maturation of hippocampal mice neurons by regulating the recycling of N-cadherin and L-
CAM during this process (Shikanai et al., 2018). Sh-RNA mediated knockdown of Cav1 in 
these neurons causes impaired pruning of the immature neurites as well as disrupted leading 
process elongation, leading to an delayed onset of neuronal maturation and migration 
(Shikanai et al., 2018). In view of this, it seems likely that Cav1 functions for the “fine-tuning” 
of the spatial-temporal regulation of the RhoGTPases Rac1, Cdc42 and RhoA during axonal 
development.  
 
4.3 Cav1α expression is required for a healthy neuronal development  
 
Evidence for a neuronal function of Cav1 in higher vertebrates has already been 
demonstrated by in vivo loss-of-function studies. For example, cav1 knockout (KO) mice 
displayed distinct traits associated with neurodegeneration, including deficits in motor 
coordination, gait abnormalities (shorter stride length), muscle weakness as well as a 
clasping and spinning phenotype (Trushina et al., 2006a). Further, cav1 KO mice show 
behavioral changes associated with cholinergic dysfunction, characterized by impaired 
spatial memory, increased anxiety and reduced exploratory behavior in a new environment 
(Gioiosa et al., 2008; Trushina et al., 2006a). Trushina et al. also reported an age-dependent 
decrease in both brain size as well as brain weight in the Cav1 KO mice, which is likely due 
to the progressive neuronal degeneration observed in these mice (Head et al., 2010; Trushina 
et al., 2006a). This indicates, that Cav1 is also required for the maintenance of neuronal 
integrity and normal brain aging. In vivo as well as overexpression studies in hippocampal 
cell cultures have shown that Cav1 positively regulates neuronal plasticity and neuronal 
intracellular signaling by recruiting neurotransmitters and neutrophil factors to synaptic 
membrane lipid rafts (MRLs) (Egawa et al., 2018; Stern and Mermelstein, 2010; Wang et al., 
2019). Cav1 KO mice display a decreased membrane lipid raft (MRL) localization of synaptic 
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signaling components such as PSD-95 (postsynaptic density protein 95), NR2A (subunit of 
NMDA receptor), NR2B (subunit of NMDA receptor), and AMPAR (AMPA receptor) and show 
an increased vulnerability to ischemic stress (Head et al., 2010). Membrane lipid rafts are 
especially important for pro-survival and pro-growth receptor signaling in neuronal cells, as 
receptors and proteins required for synaptic communication and plasticity mainly localize in 
these membrane domains (Sebastião et al., 2013). These includes signaling molecules, such 
as RhoGTPases, integrins and N-cadherins, which are essential modulators for actin 
dynamics and adhesion (Causeret et al., 2005; Guirland et al., 2004; Guirland and Zheng, 
2007; Kamiguchi, 2006; Michaely et al., 1999; Palazzo et al., 2004).  
Cav1 has been shown to modulate the nanoscale organization of membrane lipid raft 
domains by regulating the expression of metabolic proteins, that are involved in 
glycosphingolipid, sphingolipid and ganglioside biosynthesis, including Ppap2A (Lpp1), 
B3GNT5 and Siat9 (GM3 synthase) (Ariotti et al., 2014). Misexpression of these proteins also 
correlate with the reduced content of GM3 (monosialodihexosylganglioside), the precursor 
for more complex gangliosides, observed in Cav1 KO mouse embryonic fibroblast (Ariotti et 
al., 2014; Sandhoff and Kolter, 2003). The expression of gangliosides is tightly regulated 
during the development of the brain and appears to be essential for the peripheral and central 
nervous system development and maintenance. Misexpression of gangliosides are 
associated with either severe early neurological defects and lethality or progressive 
neurodegenerative changes in mice, depending on which step the ganglioside biosynthesis 
is disrupted (Jennemann et al., 2005; Ohmi et al., 2009; Yu et al., 2009). Interestingly, mice 
lacking the GM3-synthase (Siat9) and thus the expression of complex gangliosides, display 
similar neurological abnormalities observed in Cav1 KO mice, including decreased balance, 
gait abnormalities (shorter stride length), reduced muscle strength and diminished 
exploration behavior (Chiavegatto et al., 2000; Niimi et al., 2011). So far, no detailed studies 
are available that analyze the possible regulatory function of Cav1 in the biosynthesis of 
neuronal gangliosides during brain development. However, there is evidence for a possible 
regulatory function between ganglioside biosynthesis and Cav1 expression in neurons. For 
example, the inhibition of glucosylceramide synthase and the subsequent reduction of 
gangliosides in the brain also leads to a reduced expression of Cav1 (Herzer et al., 2016). 
Conversely, overexpression of Cav1 increases gangliosides expression in hippocampal 
neurons, as shown by an increased membrane staining with cholera toxin B, which binds to 
glycosphingolipids in lipid raft domains (Head et al., 2011).  
As MRLs are important signaling centers, it is likely that the observed neurological 
abnormalities in the Cav1α morphant embryos are due to impaired nanoscale organization 
of MRLs and consequently due to mis-localized signaling molecules regulating axonal growth 
and guidance. Interestingly, in comparison to the severe neuronal phenotypes obtained by 
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knockdown studies of Cav1 in Xenopus, the loss-of-function phenotype in mice is relatively 
mild in comparison. This suggests that compensatory mechanism might exist in mammals. A 
potential mechanism how mammalian cells could compensate for the loss of Cav1 
expression, is through the Flotillin protein family consisting of Flotillin 1 and 2. Both Cav and 
Flotillin proteins are integral membrane proteins that organize signaling platforms in lipid raft 
regions by acting as scaffolds for a diverse number of signaling molecules (reviewed in 
Langhorst et al., 2005; and Razani et al., 2002c). Flotillin proteins are expressed in 
membrane lipid raft microdomains and, interestingly, have a membrane topology comparable 
to that of Cav proteins (Frick et al., 2007). In addition, like Cav proteins, they are able to 
induce membrane structures that are morphological similar to caveolae (Fra et al., 1994; 
Frick et al., 2007; Lang et al., 1998; Stuermer et al., 2001). Flotillin’s have also been linked 
to the regulation of the actin cytoskeleton, as overexpression of either flotillin 1 or 2 induces 
actin-rich filopodia as well as lamellipodia formation in endothelial cells (Hazarika et al., 1999; 
Neumann-Giesen et al., 2004). In hippocampal neurons, the downregulation of Flotillin 1 
results in impaired neurite growth and increased lamellipodia formation (Munderloh et al., 
2009). Interestingly, however, the loss-of-function of Flotillin 1 in in mouse neuroblastoma 
cells (N2a) leads to elevated levels of activated RhoA and Rac1 as well as decreased levels 
of Cdc42 (Munderloh et al., 2009), similar to the knockdown of Cav1α in Xenopus. This in 
turn impairs downstream signaling pathways, such as decreased cofilin activation and 
impaired N-WASP, cortactin, and Arp2/3 complex formation that regulate actin cytoskeleton 
dynamics (Munderloh et al., 2009). The authors of this paper also found, that Flotillin proteins 
are involved in focal adhesion dynamics by regulating p38 and FAK signaling (Langhorst et 
al., 2008; Munderloh et al., 2009; Schrock et al., 2009). Due to the high similarity of the 
phenotypes between the Cav1α and Flotillin loss-of-function it seems likely that both proteins 
function in similar pathways controlling axonal growth. Thus, this suggests that the neuronal 
defects caused by Cav1α knockdown shown in this study are attributed to disrupted lipid raft 
integrity resulting in impaired signaling in these domains.  
A potential candidate by which Cav1 could affect neuromuscular development is via the 
BDNF (Brain derived neurotrophic factor) signaling pathway. Head et al. reported that the 
loss-of-function of Cav1 leads to a reduced BDNF/TrkB-mediated signaling in neuronal cells 
(Head et al., 2011). Although the neurotrophin BDNF is not directly involved in axonal 
guidance, it controls processes such as axon growth and branching as well as targeted 
innervation by acting as a short range signal (Hellard et al., 2004; Huang et al., 2007; Marshak 
et al., 2007; Thanos et al., 1989). At nerve terminals, secreted BDNF binds its receptor TrkB 
and induces its translocation to membrane lipid rafts.  This mediates the activation of 
downstream signaling cascades that regulate the activity of the small RhoGTPases Rac1, 
RhoA and Cdc42 and thereby affecting actin dynamics (Ravindran et al., 2019; Suzuki et al., 
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2004; Yuan et al., 2003). The Morpholino-mediated loss-of-function of BDNF in Xenopus 
leads to paralysis and impaired end stage target innervation of peripheral sensory axons 
(Huang et al., 2007). Thus, it seems likely that Cav1 acts via BDNF to regulate the activity of 
the small RhoGTPases during axonal development of Xenopus motoneurons. 
4.4 Serine phosphorylation of Cav1α is not required for its neuronal 
function 
 
In this thesis, it could be shown that the tyrosine phosphorylation (pT14) is required for the 
neural function of Cav1α. The overexpression of a phosphorylation null mutant (Y14T) in the 
Cav1α morphant background was not able to rescue the swimming defects (Figure 33). As 
Cav1α contains a second phosphorylation site at serine residue 80 (Schlegel et al., 2001), 
the question arises whether this modification is also required for the neuronal function of 
Cav1α. To this end, localization studies as well as rescue experiments were performed with 
either a phosphorylation-mimicking mutant (S82A) or a phosphorylation-null mutant (S82E). 
In Xenopus ectodermal explants, both full-length Cav1α as well as Cav1αS82A localized at 
the apical plasma membrane and in vesicular-like structures within the cytoplasm (Figure 
34A-B). In contrast, the phosphorylation-null mutant Cav1αS82E accumulated in large 
clusters and showed no membrane localization and visible polarization within these cells 
(Figure 34C). Interestingly, it has been shown that serine 80 phosphorylation of Cav1 seems 
to be required for its binding to cholesterol (Fielding et al., 2004): Substitution of the serine 
80 with alanine (S80A) increases sterol binding and conversely mutation of the serine to 
glutamate (S80E) reduces the ability of Cav1 to bind to sterols (Fielding et al., 2004). 
Cholesterol is essential for the trans-localization of Cav proteins from the Golgi apparatus to 
the membrane and ultimately for the formation of caveolae (Pol et al., 2005). Cholesterol 
depletion, by methyl-β-cyclodextrin treatment, decreases caveolae at the membrane and 
increases the mobility of Cav1 within the membrane (Rothberg et al., 1992; Thomsen et al., 
2002; Westermann et al., 2005). Thus, it seems likely, that the lack of membrane localization 
of the serine phosphorylation-null mutant is due to impaired binding to cholesterol and 
consequently membrane transport.  
In addition to that, while full-length Cav1α as well as the phosphorylation-mimicking mutant 
Cav1αS82A were able to co-localize with Cav1α-GFP at the plasma membrane, Cav1α-GFP 
remained at the cytoplasm when co-expressed with Cav1αS82E (Figure 35). Caveolin 
proteins can form large homo-and hetero-oligomeric complexes with themselves as well as 
other Cav proteins (Hayer et al., 2010). It seems likely, that the Cav1αS82E oligomerize with 
the co-expressed Cav1α-GFP and traps it in vesicular like structures in the cytoplasm. 
Interestingly, despite its impaired ability to localize to the plasma membrane, the expression 
of this mutant in the Cav1α Morpholino background was still able to rescue the swimming 
defects.  
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It is suggested, that Cav proteins also have caveolae-independent function (reviewed in Pol 
et al., 2020). For example, in MDCK cells (Madin-Darby canine kidney), caveolae have been 
found in the basolateral but not in the apical membrane by EM analysis (Scheiffele et al., 
1998). However, Rangel et al. demonstrated that, while both Cav1α and Cav1β localizes to 
the basal membrane, only Cav1α shows localization at the apical membrane of MDCK cells 
(Rangel et al., 2019). There, phosphorylated Cav1α regulates the integrity of the actin 
meshwork by modulating the RhoGTPase activity (Rangel et al., 2019), indicating that Cav1 
functions outside of caveolae at this membrane side. Interestingly, studies have shown that 
less than 1% of the total cellular Cav1 population is phosphorylated on Tyr14 (del Pozo et 
al., 2005). It is likely, that the function of tyrosine phosphorylated Cav1α in neuronal cells is 
also caveolae independent, as the serine phosphorylation deficient mutant Cav1S82E traps 
the majority of Cav1 in vesicular like structures, but is still able to rescue the morphant 
phenotype (Figure 35) 
 
4.1 Caveolae are essential mechano-protectors in the notochord  
 
Expression analysis showed that cav1α is highly expressed in the notochord, which serves 
as important structural element supporting locomotion in free-swimming larvae (Figure 21, 
Figure 22). Secreted signals derived from the notochord are essential for the patterning of 
adjacent tissues, including somites as well as the neural tube (Münsterberg and Lassar, 
1995; Pourquié et al., 1993; Yamada et al., 1993; Yamada et al., 1991). It has been shown 
in zebrafish, that defects in notochord development can affect both the axial skeleton as well 
as the muscular innervation (Ferrari et al., 2014; Pagnon-Minot et al., 2008). Similarly, the 
knockdown of Cav1α in Xenopus leads both to impaired muscular integrity as well as 
defective motoneuron outgrowth. Cav1α is expressed in motoneurons and the notochord in 
the developing Xenopus embryo (Figure 22; Figure 21). Since both impairments of muscle 
innervation as well as defects in notochord development can affect muscle integrity (Midrio, 
2006), the function of Cav1α in neuronal vs. notochord cells must be carefully evaluated. 
The importance of caveolae for protecting the notochord from mechanical stress has already 
been emphasized in several studies (Garcia et al., 2017; Nixon et al., 2007; Nixon et al., 
2005). Moreover, evolutionary analysis and loss-of-function studies have demonstrated a 
shared function of Cav proteins in the notochord among different species (Bhattachan et al., 
2020; Garcia et al., 2017; Kirkham et al., 2008; Nixon et al., 2007). For instance, the ascidian 
Caveolin-a expression, which is closely related to the vertebrate Cav1 and 3, is required for 
the elongation as well as vacuolization of the ascidian notochord (Bhattachan et al., 2020). 
In the zebrafish, the depletion of caveolae, by either the double knockout of cav1 and 3 or a 
single KO of cavin 1, causes the mechanical induced collapse of notochord cells (Garcia et 
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al., 2017; Lim et al., 2017). Interestingly, Lim and colleagues reported an impaired swimming 
behavior in the cavin 1 knockout zebrafish embryos, although they did not further analyze the 
musculature or the nervous system (Lim et al., 2017). However, the swimming phenotype 
observed in these zebrafish embryos differs from the swimming defects caused by Cav1α 
loss-of-function in Xenopus embryos: While Cav1α morphant Xenopus embryos showed a 
clear paralysis of the injected site (Supplementary Movie 2, 3, 5), zebrafish depleted for 
caveolae only displayed a shorter swimming distance in comparison to wild type zebrafish, 
but were otherwise still able to swim normally (Lim et al., 2017). Thus, this indicates that the 
aberrant swimming behavior of the Cav1α morphant Xenopus embryos are likely not caused 
by impaired notochord integrity. 
This is further supported by the results of the targeted injections performed in this study: 
Here, to distinguish between a muscular and neuronal function of Cav1α, the Cav1α 
Morpholinos were targeted into either the dorsal marginal zone (dorsal/ ventral blastomere; 
muscle) or the dorsal/ animal blastomere (neural tissue) at the 8-cell stage (Figure 25). 
Although this method allows a distinction between muscular versus neural function, it does 
not rule out a possible function of Cav1α in the notochord, as both blastomeres contribute 
equally to this structure (see also fate map on Xenbase). However, only the injection into the 
dorsal/animal blastomere, which also gives rise to neural tissue, but not injections into the 
dorsal/vegetal blastomere resulted in the characteristic swimming defects (Figure 25). 
Moreover, to rule out a possible contribution of notochord defects to the aberrant swimming 
behavior, knockdown studies for cavin 1, which is known to impair caveolae formation even 
in the presence of caveolin proteins, were performed (Figure 26). The injection of higher cavin 
1 Morpholino concentrations (1.5 ng or higher) caused severe convergent extension (CE) 
defects, which resulted in a shortening of the anterior-posterior axis of these embryos. This 
agrees with the findings obtained by Puzik et al.. They were able to show that Cavin 1 as well 
as Cav1 mediates convergent extension as well as gastrulation movements by regulating the 
endocytosis of Wnt5a/RhoA complexes during this process (Puzik et al., 2019). Interestingly, 
analysis of the swimming behavior of Cavin 1 morphant embryos (1.5 ng MO) revealed that 
only a minor, but insignificant percentage of these embryos displayed a swimming defect that 
was comparable to that of the Cav1α morphant embryos (Figure 26). In comparison, injection 
of the Cav1α MO into the neural blastomere caused a high percentage of swimming defects, 
but only a low number of embryos with a shortened anterior-posterior axis. These data imply 
that the swimming defect observed in the Cav1α morphant embryos is likely not due to 
defects in the notochord or impaired CE movements, but rather caused by impairments of 
the neuromuscular system in these embryos.  
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Electron microscopic analysis of Cav1 morphants showed that their notochord, similar to the 
notochord of wild type embryos, still contained a large number of the classical flask shaped 
invagination of approximately 50-100 nm in size (Figure 19), indicating that loss-of-function 
of Cav1α alone is not sufficient to completely abolish caveolae formation in the notochord. In 
support of these findings, studies in zebrafish demonstrated, that, in contrast to the double 
knockout, the single loss-of-function of either Cav1 or Cav 3, is not sufficient to cause the 
mechanical induced collapse of notochord cells (Garcia et al., 2017; Lim et al., 2017). This 
suggests, that other Cav proteins likely compensate for the loss of a single Caveolin isoform 
in the notochord. 
While humans and mice only express three cav genes (cav1, 2 and 3), evolutionary analysis 
of Cav proteins showed that the Xenopus (tropicalis and laevis) genome encodes for six cav 
genes, namely cav 1, 2, cav2R, cav3-1, cav3-2 and CavY (Kirkham et al., 2008). In addition, 
due to gene duplications in the allotetraploid Xenopus leavis, most genes are expressed in 
two isoforms, the L and the S form, which are encoded on either the long (L) chromosome or 
the homologous short (S) chromosome, respectively (Lentini et al., 2008). For cav1, for 
example, there are two isoforms expressed: the full-length cav1L isoform as well as the 
shorter S-isoform, which misses the first N-terminal 32 amino acids of the L-isoform. 
Sequence analysis showed high homology between the two isoforms. It is striking, however, 
that the cavL isoform closely resembles the human cav1α isoform and the S isoform also 
shows homology to human and zebrafish cav1β isoform (Supplementary Figure 1). In 
contrast to Xenopus, in humans, mice as well as in zebrafish the cav1α an β isoforms are 
encoded by the same gene but are translated from distinct mRNA arising from alternative 
splice events (Fang et al., 2006; Kogo and Fujimoto, 2000; Scherer et al., 1995). However, 
similar to the human cav1α, the Xenopus cav1L isoform also has a putative alternative 
translation start site encoded on exon 2, which likely also leads to an expression of a Cav1L-
α and Cav1L-β isoform. It is important to mention that both Cav1α Morpholinos used in this 
study, target the cav1-L but not the shorter cav1-S isoform, suggesting that the shorter cav1 
isoform is still expressed in the cav1α morphants and possible compensates for the loss of 
Cav1L expression in the notochord. Supporting this, Morpholino mediated knockdown of 
Cav1β (Cav1S) causes swimming defects similar to Cav1α (Cav1L) knockdown in Xenopus 
embryos, suggesting that these two isoforms also have comparable functions in this model 
organism (Berger, 2016, PhD). 
Although a growing body of evidence suggests that the swimming defects in the Cav1α 
morphant embryos are not caused by impaired notochord integrity, more refined experiments 
have to be carried out to further rule out a contribution of the notochord to the observed 
phenotypes and to what extent other caveolin proteins may compensate for the loss of Cav1 
in this tissue. 
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4.1 Cav1 expression is highly conserved between different species 
 
The similarity of cav1 RNA and protein expression pattern in different organisms indicate a 
high degree of evolutionary conservation between amniotes and anamniotes species. In 
Xenopus cav1 is already maternally expressed in the developing Xenopus embryo. Zygotic 
expression of cav1 can be detected first around stage 12 by in situ hybridization in the 
presumptive notochord and epidermis. Additionally, expression was also found in a distinct 
domain on both sites of the embryonic midline in the superficial or epithelial layer of the neural 
plate (Figure 21, Figure 23). The identity of this expression region is yet not known. However, 
the superficial layer of the Xenopus neural tube gives rise to precursors of the secondary 
neurons. They differentiate with the onset of metamorphosis (st. 54) during a secondary 
neurogenic wave, to form the adult central nervous system (Hartenstein, 1989b; Thuret et al., 
2015). It is likely that cav1 may be expressed in secondary neuron precursor cells, as protein 
expression could also be detected in primary neurons. However, intriguingly, RNA expression 
of cav1 in the neural tube is no longer detectable as soon as the superficial layer and deep 
layer are intercalated and the neural tube has closed (Figure 23). Therefore, further studies 
are required to identify the exact cell type of the neural tube that expresses cav1.  
Cav1 expression in later developmental stages was analyzed by in situ hybridization, an also 
by whole mount immunofluorescence staining using an antibody that recognizes both Cav1 
isoforms (Cav1α and β) (Figure 24). Morpholino-mediated knockdown of Cav1α successfully 
suppressed the Cav1 signal in all Cav1 expressing tissues, confirming that this staining is 
also specific for Cav1α expression (Figure 24). In zebrafish, it has already been shown that 
Cav1α and Cav1β share a similar but distinct expression pattern during development (Fang 
et al., 2006). The authors demonstrated that both isoforms are co-expresses in most tissues, 
except the intestinal epithelium, where only Cav1α expression was detected. Likewise, the 
respective loss-of-function of these two isoforms yielded similar phenotypes, which included 
neural, somitic, and vascular tissue defects. The loss-of-function of Cav1α resulted both in 
vascular as well as neural defects, while the knockdown of Cav1β only affected neural tissue 
(Fang et al., 2006). Further, the phenotypes caused by the loss-of-function of one Cav1 
isoform could not be rescued with the other isoform, suggesting that Cav1α and Cav1β 
perform similar but non-overlapping roles during zebrafish development (Fang et al., 2006).  
In situ hybridization as well as immunofluorescence assays suggest that cav1 RNA and 
consequently also protein can be found in the cardiovascular system, the developing lungs 
and in the epithelium during later developmental stages (Figure 21, Figure 22). These 
findings are further corroborated by in vivo experiments in mice and zebrafish. In zebrafish, 
cav1α is expressed mainly in the epidermis, the heart, the vasculature of the pharyngeal 
arches, intestinal epithelium, the pronephric duct, neuromasts as well as the notochord. 
Likewise, in mice cav1 RNA as well as protein expression can be found in the heart, 
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intersomitic vessels, the lung (lung epithelium, parenchyma and alveolar endothelial cells), 
kidney, gut as well as the brain (brain vasculature, neuronal cells) (Bullejos et al., 2002; 
Engelman et al., 1998b; Newman et al., 1999; Ramirez et al., 2002). Due to the high similarity 
of the expression pattern of Cav1 in Xenopus compared to higher vertebrates, Xenopus offers 
an ideal model to examine the tissue-specific function of Cav1 during development. 
 
4.2 Cav1α is required for normal heart function 
 
Both RNA as well as protein expression of Cav1α was detected in the cardio vasculature and 
the heart of Xenopus embryos, suggesting a function of Cav1α in heart development (Figure 
21, Figure 22). And indeed, the knockdown of Cav1α in Xenopus resulted in the formation of 
severe pericardial edemas (Figure 20). A function of Cav1 in the cardiovascular system has 
already been demonstrated in other model organisms. Similar to Xenopus, the Morpholino-
mediated knockdown of Cav1α in zebrafish also leads to edema, which is caused by defective 
cardiac development. The heart of these embryos shows an abnormal heart looping and an 
incorrect development of the heart chambers (Fang et al., 2006; Nixon et al., 2007). In 
addition, Cav1 plays a role in zebrafish heart regeneration: It has been shown, that the 
genetic ablation of Cav1 leads to decreased cardiomyocyte proliferation and regeneration 
after cardiac injury (Cao et al., 2016; Grivas et al., 2020). Similarly, the genetic ablation of 
Cav1 in mice leads to cardiac dysfunctions, such as pulmonary hypertension, cardiac 
hypertrophy with enlarged right ventricular cavity and thickening of the ventricular wall as well 
as systolic and diastolic dysfunctions (Cohen et al., 2003; Wunderlich et al., 2006; Zhao et 
al., 2002). Hyperactivation of ERK1/2 in the p42/44 MAP kinase cascade and increased 
levels in systemic NO (nitric oxide) leading to increased cardiac fibrosis are thought to be the 
cause of these cardiac defects in the cav1-KO mice (Cohen et al., 2003; Zhao et al., 2002). 
These findings point towards a conserved function of Cav1α in the development and integrity 
of the heart in amniotes as well as anamniotes species. Since a role of Cav1 has already 
been demonstrated in the heart of other model organisms, it is likely that the edema in the 
Cav1α morphants appear to be the result of defective heart development or morphology.  
 
4.3 Cav1α function is required for pronephric morphology and convergent 
extension movements 
 
Edema can develop not only due to malfunctions in the cardiovascular system, but also by 
disturbed osmoregulation of the pronephros (Nieuwkoop and Faber, 1994). Although 
expression of Cav1 could not be detected in the pronephros of Xenopus embryos, the 
knockdown of Cav1α leads to morphological abnormalities of the pronephric kidneys, such 
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as malformed proximal, intermediate as well as distal tubules (Figure 20Interestingly, other 
studies have already confirmed cav1 expression in both the larval pronephros and in the adult 
Xenopus laevis kidney, which also suggest a function of Cav1 in the development of this 
organ (Cerqueira et al., 2014; Razani et al., 2002b). So far, relatively few studies are known 
that describe a function of Cav1 in the vertebrate kidney. It has been shown that Cav1 is 
expressed in the mice, rat as well as human kidney (Breton et al., 1998; Cao et al., 2003; 
McMahon et al., 2009). The loss-of-function of Cav1 in mice causes severe hypercalciuria 
and urolithiasis, which is due to impaired plasma membrane Ca2+ ATPase (PMCA) mediated 
Ca2+ absorption in the adult kidney (Breton et al., 1998; Cao et al., 2003; McMahon et al., 
2009). However, a function of Cav1 in embryonic kidney development has yet not been 
described. A potential mechanism by which Cav1α could affect pronephric development, is 
its function in the lipid homeostasis of membrane lipid raft domains, since the integrity of 
these domains is crucial for the development of many organ systems (Ariotti et al., 2014; Fra 
et al., 1995; Murata et al., 1995; Ortegren et al., 2004; Thiele et al., 2000). Studies in Xenopus 
embryos have already illustrated the importance of a dynamic regulation of the lipid balance 
of membrane lipid rafts during pronephros development. For example, the knockdown of 
sterol carrier protein-2, a crucial regulator in sphingolipid metabolism, leads to a drastic 
reduction in the pronephric proximal tubule size (Cerqueira et al., 2014). These defects are 
directly related to the altered lipid composition of the membrane lipid raft domains and likely 
also due to the mis-localization of signaling molecules that could play a role in kidney 
development.  
 
It has been shown, that Cav1 also functions in convergent extension movements during 
gastrulation in Xenopus embryos (Puzik et al., 2019). Convergent extension is a highly 
conserved process among different species, which is defined by the narrowing and extension 
of tissue that involve cell intercalation along an axis and the extension along a perpendicular 
axis through cell movements (Wallingford et al., 2002). In Xenopus, for example, both the 
notochord as well as the pronephros are formed by convergent extension movements (Keller 
et al., 1989; Lienkamp et al., 2012). Interestingly, Puzik and colleagues were able to show 
that the loss of Cav1α expression interferes with gastrulation and subsequently convergent 
extension in Xenopus embryos due to impaired Wnt5a/Ror2 signaling (Puzik et al., 2019). As 
mentioned above, the knockdown of Cav1α severely affects the morphology of the embryonic 
kidney; the proximal as well as intermediate tubule of the pronephros were significantly 
smaller in comparison to control kidneys (Figure 20J-K). Interestingly, this phenotype is highly 
similar to kidney defects induced by impaired CE movements, caused by either blebbistatin 
treatment or a dominant-negative form of Dishevelled-2 in Xenopus (Lienkamp et al., 2012). 
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Interfering with CE by disrupting planar cell polarity in the embryonic kidney, results in 
decreased nephron elongation and an increased tubule diameter (Lienkamp et al., 2012).  
In summary, Cav1α likely affects the kidney development by either affecting the lipid 
composition of membrane lipid raft domains and thereby interfering with signaling pathways 
regulating kidney morphogenesis or by regulating convergent extension movements during 
pronephros development.  
 
4.4 Loss of Cav1α expression affects neural crest-derived cartilage 
formation  
 
In this study it was shown that Morpholino mediated knockdown of Cav1α significantly 
reduces cartilage structures. Interestingly only the neural crest, but not the mesodermal 
derived cartilage was affected by the loss-of-function of Cav1α, which implies a function of 
this protein in neural crest development (Figure 20C-D). Expression of Cav1α was not 
detected in Xenopus neural crest cells, neither by in situ hybridization nor by whole mount 
immunofluorescence staining. However, the expression pattern of Cav1 protein during 
embryonic development was only examined in stages where the neural crest cell migration 
is completed and neural crest cells start to differentiate (St. 35 onward) (Pauli et al., 2017). It 
is possible, that small amounts of cav1α mRNA are expressed in neural crest cells, but in situ 
hybridization may not be sensitive enough to detect this low level of expression. A function 
of Cav1α in neural crest development has not been reported in other model organisms so 
far. However, Berger et al. were able to demonstrate that the canonical Wnt dependent PTK7 
(protein tyrosine kinase 7) internalization is mediated by Cav1 in Xenopus ectodermal 
explants (Berger et al., 2017). PTK7 is a versatile non-canonical Wnt co-receptor, which 
functions in diverse embryonic processes such as neural crest migration and the 
establishment of cell polarity (Paudyal et al., 2010; Shnitsar and Borchers, 2008). Morpholino-
mediated knockdown of PTK7 severely affects neural crest migration in Xenopus embryos 
(Shnitsar and Borchers, 2008). It has been demonstrated that Cav1α expression contributes 
to the ability of PTK7 to inhibit canonical Wnt dependent secondary axis formation in Xenopus 
(Berger et al., 2017). Since PTK7 functions in neural crest migration and its Wnt-dependent 
endocytosis is mediated by Cav1α, a function of Cav1α during migration of neural crests 
seems likely (Berger, 2016, PhD; Shnitsar and Borchers, 2008).  
In order to understand whether Cav1α has a function during neural crest migration, the 
migratory behavior of Cav1α morphant neural crest cells should be analyzed, for example, 
by performing explanation assays or whole mount in situ hybridization of the neural crest 
marker twist.  
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4.5 Future perspectives 
 
In the present study Cav1α was identified to function in neuronal development by modulating 
the activity of small RhoGTPases during axonal development. However, there are still some 
open questions that should be addressed for further studies. 
Studies performed in this laboratory have shown that nicotinic acetylcholine receptors 
(nAChR) clustering was perturbed in the Cav1α morphant embryos (Breuer, 2016, M.Sc.). 
Motoneuron and muscle cells communicate via chemical synapses called the neuromuscular 
junctions. During the establishment of the neuromuscular junction, nicotinic acetylcholine 
receptors (nAChR) become clustered at the postsynaptic membrane, which allows the 
muscle to respond to neurotransmitters secreted from motoneurons (Chow and Cohen, 
1983). This process is initiated by the contact of the motoneuron synapse with the muscle 
cell, which induces an agrin/MuSK dependent clustering of nAChR at the postsynaptic 
contact site of the muscle cell (Bowe and Fallon, 1995; Cole and Halfter, 1996; DeChiara et 
al., 1996; Glass et al., 1996; Ruegg and Bixby, 1998). It is yet not known how Cav1α affects 
the clustering of the nicotinic acetylcholine receptors in the morphant embryos. Cav1 is 
expressed in motoneurons and the loss of Cav1α expression leads to severe pathfinding 
defects. It is likely that the diffuse nAChR staining observed in the morphant embryos is due 
to the fact, that the aberrant axonal branches of the motoneurons form synapses at several 
sites on the muscle cells. To visualize these contact sites, double immunostainings could be 
performed by using a presynaptic marker, such as synaptotagmin, and a postsynaptic marker 
like nAChR. This would also provide information on whether the morphant motoneurons are 
still able to form functional synapses or if the loss of Cav1α expression also interferes with 
synaptic transmission. 
 
Further, albeit the present study primarily focused on the axonal growth of motoneurons, it is 
likely that other neurons of the spinal cord, such as GABAeric and glycerineric inhibitory as 
well as glutamateric excitatory interneurons and sensory Rohon-Beard neurons, are also 
affected by Cav1α loss-of-function (Roberts et al., 2010; Roberts, 2000b; Roberts and Clarke, 
1982). This seems likely, as studies of this lab have already demonstrated, that Cav1α loss-
of-function disrupts the outgrowth of cranial nerves in Xenopus embryos (Breuer, 2016, 
M.Sc.). Moreover, axonal growth but not dendritic morphology, which is also important for the 
establishment of synaptic connectivity and ultimately for locomotion, was analyzed (Heckman 
et al., 2003; Ryglewski et al., 2014; Scheibel and Scheibel, 1970). Furthermore, it is 
suggested that Cav1 is important for dendritic plasticity: Cav1 has been found to be 
expressed in the dendrites of hippocampal neurons and neuronal overexpression of this 
protein enhances dendritic growth and arborization (Bu et al., 2003; Head et al., 2011). To 
this end it would be interesting to analyze the effect of Cav1α knockdown on the dendritic 
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and synaptic physiology as well as axonal growth of both motoneurons, interneurons as well 
as sensory neurons of the Xenopus spinal cord. 
 
The results of this thesis indicate that Cav1α regulates axonal growth by suppressing the 
activity of Rac1 and RhoA and supporting the activity of Cdc42. However, both the swimming 
as well as motoneuron defect were only rescued by the overexpression of either dominant 
negative or constitutive active mutants of this RhoGTPases, which means that it is not yet 
possible to make a precise assertion about the endogenous expression levels of the 
RhoGTPases in the morphant embryos. To this end, it would be important to analyze the 
endogenous spatial-temporal activity of these small RhoGTPases in the cultured morphant 
spinal cord neurons either by western blotting or by using activity assays. There are several 
reporters available for Xenopus, which contain the fluorophore-tagged GTPase-binding 
domain of effector proteins specific for the respective RhoGTPase, such as Rhotekin binding 
active RhoA, N-WASP detecting active Cdc42 and Pak3 binding active Rac1 (reviewed in 
Stephenson and Miller, 2017). This would allow to assess the activity of Rac1, RhoA and 








As an essential component of caveolae, Cav1 is a key regulator for membrane dynamics. 
Over the last decades, the role of Cav1 in a diverse number of signaling pathways was 
analyzed in various cellular systems. However, its function in neuronal cells has long been 
ignored. This study demonstrates that Cav1α is required for the neuromuscular integrity of 
Xenopus embryos. Morpholino mediated knockdown of Cav1α results in severe swimming 
defects and a drastic loss of muscular integrity. Expression analysis revealed that Cav1 is 
strongly expressed in the embryonic notochord, cardio vasculature, skin as well as cranial- 
and spinal cord neurons, but not in the musculature. Targeted injection demonstrated that 
Cav1α is required in the neuronal circuits controlling locomotion, as loss-of-function of Cav1α 
in neural tissue causes paralysis of the morphant embryos. Further, axonal outgrowth as well 
as pathfinding was severely affected by Cav1α knockdown and treatment with Benzocaine, 
an inhibitor for voltage gated sodium channels, showed that the muscle defects in the Cav1α 
morphant embryos are likely due to impaired muscle innervation. In spinal cord explantation 
assays, it could be shown that axonal growth as well as morphology was severely affected 
by Cav1α knockdown. Spinal cord neurons extended axons with an increased formation of 
filopodia- as well as lamellipodia-like structures. Axonal growth defects of the spinal motor 
neuron as well as the swimming defects could be rescued by the overexpression of a 
dominant negative Rac1 and RhoA as well as by constitutively active Cdc42, which suggests 
that Cav1α modulates the activity of these small RhoGTPases during axonal development in 
Xenopus. This process is likely mediated by the tyrosine phosphorylation (pY14) of Cav1α, 
as a phosphomutant of Cav1α was not able to rescue the morphant phenotype. Taken 
together, these finding suggest a novel and previously unrecognized function of Cav1α in the 
development of the neuromuscular system of Xenopus embryos.  
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6 Supplementary information: 
 
Movie 1: Normal swimming behavior of embryos injected with 20 ng Co MO into one 
blastomere at the two-cell stage.  
Movie 2: Embryos injected unilaterally with 20 ng Cav1α MO at the two-cell stage show 
circular swimming behavior due to the paralysis of the injected site.  
Movie 3: Circular swimming movements of embryos unilaterally injected with 20 ng Cav1α 
Spl-MO at the two-cell stage.  
Movie 4: Normal swimming behavior of embryos injected with 10 ng Co MO in both 
blastomeres of two-cell stage embryos. 
Movie 5: Embryos injected with 10 ng Cav1α MO into both blastomeres of two-cell stage 
embryos. Embryos are completely paralyzed.  
Movie 6: Axonal outgrowth of control neuron analyzed by live-cell imaging over a time period 
of 30 min. Growth cones of control axons dynamically extended and retracted the majority of 
their filopodia and lamellipodia protrusions during axonal growth  
 
Movie 7: Axonal outgrowth of control neuron analyzed by live-cell imaging over a time period 
of 30 min. 
 
Movie 8: Axonal outgrowth of Cav1α morphant neuron analyzed by live-cell imaging over a 
time period of 30 min. Cav1α morphant axon fail to retract their filopodia protrusions during 
axonal growth. 
 
Movie 9: Axonal outgrowth of Cav1α morphant neuron analyzed by live-cell imaging over a 
time period of 30 min. Cav1α morphant axon fail to retract their lamellipodia protrusions during 
axonal growth. 
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Supplementary Figure 1: Sequence analysis of Xenopus cav1 L and S with human and zebrafish cav1. 
Xenopus cav1L (NM_001088831.1) and cav1S (NM_001090118.1), homo sapiens cav1 (GenBank: BT007143.1), Danio rerio cav1α 
(NM_212651.1) and cav1β (NM_001024162.1). Sequence analysis was performed by using SnapGene the Multiple DNA Alignment tool 
(Clustal Omega). Matched sequences are highlighted in green. 
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